<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Exercise as adjunctive therapy for systemic lupus erythematosus - Frade, S - 2023 | Cochrane Library</title> <meta content="Exercise as adjunctive therapy for systemic lupus erythematosus - Frade, S - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014816.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Exercise as adjunctive therapy for systemic lupus erythematosus - Frade, S - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014816.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD014816.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Exercise as adjunctive therapy for systemic lupus erythematosus" name="citation_title"/> <meta content="Stephanie Frade" name="citation_author"/> <meta content="u1124490@umail.usq.edu.au" name="citation_author_email"/> <meta content="Sean O'Neill" name="citation_author"/> <meta content="David Greene" name="citation_author"/> <meta content="Australian Catholic University" name="citation_author_institution"/> <meta content="Elise Nutter" name="citation_author"/> <meta content="University of Southern Queensland" name="citation_author_institution"/> <meta content="Melainie Cameron" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD014816.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/04/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014816.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014816.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014816.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Exanthema; *Exercise; Exercise Therapy [methods]; Fatigue [etiology, therapy]; *Lupus Erythematosus, Systemic [complications, therapy]; Pain; Quality of Life" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014816.pub2&amp;doi=10.1002/14651858.CD014816.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="Nio3SV1W";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD014816\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD014816\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","th","ms","ja","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD014816.pub2",title:"Exercise as adjunctive therapy for systemic lupus erythematosus",firstPublishedDate:"Apr 19, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Musculoskeletal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014816.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD014816.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD014816.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD014816.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014816.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD014816.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD014816.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD014816.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD014816.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD014816.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4101 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD014816.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-sec-0125"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-sec-0119"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/appendices#CD014816-sec-0130"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/supinfo/CD014816StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/supinfo/CD014816StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Exercise as adjunctive therapy for systemic lupus erythematosus</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#CD014816-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Stephanie Frade</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#CD014816-cr-0005">Sean O'Neill</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#CD014816-cr-0006">David Greene</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#CD014816-cr-0007">Elise Nutter</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information#CD014816-cr-0008">Melainie Cameron</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information/en#CD014816-sec-0139">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 April 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD014816.pub2">https://doi.org/10.1002/14651858.CD014816.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD014816-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD014816-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD014816-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD014816-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD014816-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD014816-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD014816-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD014816-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD014816-abs-0001" lang="en"> <section id="CD014816-sec-0001"> <h3 class="title" id="CD014816-sec-0001">Background</h3> <p>Systemic lupus erythematosus (SLE) is a rare, chronic autoimmune inflammatory disease with a prevalence varying from 4.3 to 150 people in 100,000, or approximately five million people worldwide. Systemic manifestations frequently include internal organ involvement, a characteristic malar rash on the face, pain in joints and muscles, and profound fatigue. Exercise is purported to be beneficial for people with SLE. For this review, we focused on studies that examined all types of structured exercise as an adjunctive therapy in the management of SLE. </p> </section> <section id="CD014816-sec-0002"> <h3 class="title" id="CD014816-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of structured exercise as adjunctive therapy for adults with SLE compared with usual pharmacological care, usual pharmacological care plus placebo and usual pharmacological care plus non‐pharmacological care. </p> </section> <section id="CD014816-sec-0003"> <h3 class="title" id="CD014816-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 30 March 2022. </p> </section> <section id="CD014816-sec-0004"> <h3 class="title" id="CD014816-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) of exercise as an adjunct to usual pharmacological treatment in SLE compared with placebo, usual pharmacological care alone and another non‐pharmacological treatment. Major outcomes were fatigue, functional capacity, disease activity, quality of life, pain, serious adverse events, and withdrawals due to any reason, including any adverse events. </p> </section> <section id="CD014816-sec-0005"> <h3 class="title" id="CD014816-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our major outcomes were 1. fatigue, 2. functional capacity, 3. disease activity, 4. quality of life, 5. pain, 6. serious adverse events, and 7. withdrawals due to any reason. Our minor outcomes were 8. responder rate, 9. aerobic fitness, 10. depression, and 11. anxiety. We used GRADE to assess certainty of evidence. The primary comparison was exercise compared with placebo. </p> </section> <section id="CD014816-sec-0006"> <h3 class="title" id="CD014816-sec-0006">Main results</h3> <p>We included 13 studies (540 participants) in this review. Studies compared exercise as an adjunct to usual pharmacological care (antimalarials, immunosuppressants, and oral glucocorticoids) with usual pharmacological care plus placebo (one study); usual pharmacological care (six studies); and another non‐pharmacological treatment such as relaxation therapy (seven studies). Most studies had selection bias, and all studies had performance and detection bias. We downgraded the evidence for all comparisons because of a high risk of bias and imprecision. </p> <p><b>Exercise plus usual pharmacological care versus placebo plus usual pharmacological care</b> </p> <p>Evidence from a single small study (17 participants) that compared whole body vibration exercise to whole body placebo vibration exercise (vibrations switched off) indicated that exercise may have little to no effect on fatigue, functional capacity, and pain (low‐certainty evidence). We are uncertain whether exercise results in fewer or more withdrawals (very low‐certainty evidence). The study did not report disease activity, quality of life, and serious adverse events. </p> <p>The study measured fatigue using the self‐reported Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT‐Fatigue), scale 0 to 52; lower score means less fatigue. People who did not exercise rated their fatigue at 38 points and those who did exercise rated their fatigue at 33 points (mean difference (MD) 5 points lower, 95% confidence interval (CI) 13.29 lower to 3.29 higher). </p> <p>The study measured functional capacity using the self‐reported 36‐item Short Form health questionnaire (SF‐36) Physical Function domain, scale 0 to 100; higher score means better function. People who did not exercise rated their functional capacity at 70 points and those who did exercise rated their functional capacity at 67.5 points (MD 2.5 points lower, 95% CI 23.78 lower to 18.78 higher). </p> <p>The study measured pain using the SF‐36 Pain domain, scale 0 to 100; lower scores mean less pain. People who did not exercise rated their pain at 43 points and those who did exercise rated their pain at 34 points (MD 9 points lower, 95% CI 28.88 lower to 10.88 higher). </p> <p>More participants from the exercise group (3/11, 27%) withdrew from the study than the placebo group (1/10, 10%) (risk ratio (RR) 2.73, 95% CI 0.34 to 22.16). </p> <p><b>Exercise plus usual pharmacological care versus usual pharmacological care alone</b> </p> <p>The addition of exercise to usual pharmacological care may have little to no effect on fatigue, functional capacity, and disease activity (low‐certainty evidence). We are uncertain whether the addition of exercise improves pain (very low‐certainty evidence), or results in fewer or more withdrawals (very low‐certainty evidence). Serious adverse events and quality of life were not reported. </p> <p><b>Exercise plus usual care versus another non‐pharmacological intervention such as receiving information about the disease or relaxation therapy</b> </p> <p>Compared with education or relaxation therapy, exercise may reduce fatigue slightly (low‐certainty evidence), may improve functional capacity (low‐certainty evidence), probably results in little to no difference in disease activity (moderate‐certainty evidence), and may result in little to no difference in pain (low‐certainty evidence). We are uncertain whether exercise results in fewer or more withdrawals (very low‐certainty evidence). Quality of life and serious adverse events were not reported. </p> </section> <section id="CD014816-sec-0007"> <h3 class="title" id="CD014816-sec-0007">Authors' conclusions</h3> <p>Due to low‐ to very low‐certainty evidence, we are not confident on the benefits of exercise on fatigue, functional capacity, disease activity, and pain, compared with placebo, usual care, or advice and relaxation therapy. Harms data were not well reported. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD014816-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD014816-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD014816-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD014816-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD014816-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD014816-abs-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD014816-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD014816-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD014816-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD014816-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD014816-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD014816-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD014816-abs-0002" lang="en"> <h3>What are the benefits and risks of exercise for people with systemic lupus erythematosus?</h3> <p><b>Key messages</b> </p> <p>Exercise in addition to 'usual care' may have little benefit on fatigue, functional capacity, and pain in people with systemic lupus erythematosus (SLE). </p> <p>No studies reported side effects during exercise. However, we have low confidence in the overall evidence. </p> <p><b>What is systemic lupus erythematosus?</b> </p> <p>SLE (or 'lupus') is a disease in which the body's immune (defence) system mistakenly attacks healthy tissue in many parts of the body. It is a long‐term disease (one that lasts longer than six weeks and is usually life‐long). Often, SLE causes pain in joints and muscles, and extreme tiredness. Symptoms can improve temporarily, or worsen suddenly (flares). </p> <p><b>How is systemic lupus erythematosus treated?</b> </p> <p>Management or usual care in SLE may include, but is not limited to, treatment with medicines such as disease‐modifying antirheumatic drugs (DMARDs) or non‐steroidal anti‐inflammatory drugs (NSAIDs). It may also include treatments that are not medicines such as sun avoidance, supplementation (i.e. vitamin D), education about the disease and other illnesses (i.e. hypertension), and physical activity or exercise. Regular exercise training could serve as an adjunct treatment for people with SLE. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out if exercise in addition to usual care improved fatigue, functional capacity (ability to perform normal everyday tasks), quality of life, pain, and disease activity, and caused no harm.  </p> <p><b>What did we do? </b> </p> <p>We searched for studies that investigated structured exercise programmes such as aerobic exercise, resistance, stretching or combinations of these (including a specific dosage of exercise, e.g. frequency, intensity, time, type)  in addition to usual care compared with placebo (pretend medicine), usual care alone, or another non‐medicine intervention (e.g. relaxation therapy) in people with SLE.  </p> <p>We compared and summarised the results of the studies and rated our confidence in the evidence, based on factors such as study methods and sizes. </p> <p><b>What did we find? </b> </p> <p>We found 13 studies that involved 540 participants with SLE that included a structured exercise programme that lasted up to 12 weeks in duration. Usual care included DMARDs and glucocorticoids. </p> <p>The main results of the review are:</p> <p>1. Whole body vibration exercise plus usual care may result in little to no effect on fatigue, functional capacity, and pain when compared to whole body placebo vibration exercise (vibration switched off) plus usual care (1 study, 17 participants). </p> <p><i>The study measured fatigue using the Functional Assessment of Chronic Illness Therapy – Fatigue domain (FACIT‐Fatigue) (0 to 52 scale, where 0 means no fatigue) and, at 12 weeks, fatigue improved by 5 points in the exercise group compared to the group that did not exercise:</i> </p> <p>– People who exercised rated their fatigue at 33 points.</p> <p>– People who did not exercise rated their fatigue at 38 points.</p> <p><i>The study measured functional capacity using the Functional Capacity domain in the 36‐item Short Form health questionnaire (SF‐36) (0 to 100 scale, where 100 means best function) and, at 12 weeks, function worsened by 2.5 points in the exercise group compared to the group that did not exercise:</i> </p> <p>– People who exercised rated their functional capacity at 67.5 points.</p> <p>– People who did not exercise rated their functional capacity at 70 points.</p> <p><i>The study measured pain on the Pain domain of the SF‐36 (0 to 100 scale, where 0 means no pain) and, at 12 weeks, pain improved by 9 points in the exercise group compared to the group that did not exercise:</i> </p> <p>– People who exercised rated their pain at 34 points.</p> <p>– People who did not exercise rated their pain at 43 points.</p> <p><i>More people from the exercise group (27%) withdrew from the study compared those in the placebo group (10%). </i> </p> <p>The study did not measure disease activity or quality of life.</p> <p>2. Exercise plus usual care may result in little to no effect on fatigue, functional capacity, and disease activity when compared to usual care alone. And we are uncertain whether exercise improves pain when compared to usual care alone. </p> <p>3. Exercise plus usual care may reduce fatigue, improve functional capacity, and probably results in little to no difference in disease activity, and may result in little to no difference in pain when compared to another non‐medicine intervention plus usual care. </p> <p>No studies reported any serious side effects that were related to the exercise programme during or following the intervention. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We have little confidence in the evidence because the number of studies was very small, and it is possible that people in the studies were aware of which treatment they were getting. </p> <p>Most studies assessed the effectiveness of exercise for a short duration (12 weeks or less) and it is unclear if people would adhere to exercise over time. More rigorous studies of structured exercise over a period of time longer than 12 weeks are needed to improve our confidence in the benefits and safety of exercise in people with SLE.  </p> <p><b>How up to date is this evidence?</b> </p> <p>The evidence is up to date to 30 March 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD014816-sec-0125" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD014816-sec-0125"></div> <h3 class="title" id="CD014816-sec-0126">Implications for practice</h3> <section id="CD014816-sec-0126"> <p>We found low‐certainty evidence indicating that structured exercise plus usual care compared to placebo plus usual care may result in little to no effect on fatigue, functional capacity, and pain, measured after the completion of the intervention. We are uncertain whether exercise results in fewer or more withdrawals (very low‐certainty evidence). </p> <p>We found low‐certainty evidence that structured exercise plus usual care compared with usual care alone may result in little to no effect on fatigue, functional capacity, and disease activity, measured after the completion of the intervention. We are uncertain whether exercise improves pain (very low‐certainty evidence) or results in fewer or more withdrawals (very low‐certainty evidence). </p> <p>We found moderate‐ to low‐certainty evidence that structured exercise plus usual care compared to another non‐pharmacological intervention (relaxation, education, support aids) plus usual care may reduce fatigue (low‐certainty evidence), may improve functional capacity (low‐certainty evidence), probably results in little to no difference in disease activity (moderate‐certainty evidence), and may result in little to no difference in pain (low‐certainty evidence), measured after the completion of the intervention. We are uncertain whether exercise results in fewer or more withdrawals (very low‐certainty evidence). </p> <p>We are uncertain of the potential for harm from structured exercise, because of the limited number of studies reporting adverse events. We are unable to distinguish the best dosage of exercise, including frequency, intensity, type, or its mode of delivery. </p> <p>Considering there is low‐certainty evidence on the benefits and harms of exercise, clinicians should ensure that exercise is tailored to the individual, prescribed according to the individuals' physical abilities and limitations, and monitored by an exercise professional (e.g. exercise physiologist, physical therapist, physiotherapist). People with systemic lupus erythematosus (SLE) should seek advice from their healthcare team when starting any new exercise programme, choose exercise that they enjoy, that is individually appropriate to their physical ability, and avoid exercising in the sun when the ultraviolet index is high (greater than 3). </p> </section> <h3 class="title" id="CD014816-sec-0127">Implications for research</h3> <section id="CD014816-sec-0127"> <p>The evidence for the major outcomes was moderate, low, or very low certainty, so new studies could change the estimate effects. This review has raised new questions to answer and implications for further research. </p> <p>The long‐term effects of structured exercise for people with SLE, and whether they are clinically relevant are unclear. Longitudinal studies of exercise in SLE that report harms data (adverse events and withdrawals, with reason) on more people with SLE, followed for a longer duration (i.e. exercise performed for more than three months) are needed to improve our understanding of the benefit/risk ratio of exercise. Furthermore, well‐designed trials are needed to elucidate the benefits/harms of exercise in SLE, focusing on important outcomes such as disease activity using standardise outcome tools such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)‐2K, damage indices such as Systemic Lupus International Collaborating Clinics Damage Indices (SLICC‐DI), and specifically looking at changes in serological markers including anti‐double stranded DNA (anti‐dsDNA), complement levels C3 and C4, as well as inflammatory markers erythrocyte sedimentation rate, C‐reactive protein, and interleukin‐6. Adverse events were rarely measured or reported (or both) in the included trials. Whether structured exercise as an adjunct therapy to usual care produces harmful effects is difficult to determine. Studies should systematically investigate and report adverse events. </p> <p>Future trials of exercise in SLE should provide an accurate description of the content, dose, application, and adherence to the exercise interventions. The Consensus on Exercise Reporting Template, or the CONSORT Template for Intervention Description and Replication should be used in future trials of exercise to improve the description of exercise programmes and facilitate its application and findings in clinical practical. Furthermore, new trials of exercise in SLE could be well‐designed and double blinded to effectively compare different modes (aerobic, resistance, range of motion), intensities (low, moderate, and high according to rating of perceived exertion or percentage of maximum heart rate), time of exercise (i.e. 10‐minute or 60‐minutes bouts), or a combination of these. We also recommend that future trials include more diverse participants (disease activity, age, sex, race/ethnicity, functional capacity), and results be further analysed by subgroups. In particular, we recommend that participants with higher disease activity (SLEDAI greater than 4) be included in future exercise trials. Further research should aim to determine the efficacy of exercise interventions in people with SLE receiving different therapies (non‐steroidal anti‐inflammatory drugs, disease‐modifying antirheumatic drugs, biological agents, and no treatment). </p> <p>Last, standardised efficacy outcomes in exercise trials for people with SLE are needed. For example, all studies using the 36‐item Short Form questionnaire to assess quality of life should report the Mental Component Summary and Physical Component Summary scores. All trials should report disease activity using a standardised and validated tool such as SLEDAI to report changes in disease activity before and following an intervention, to add further information regarding the potential harms or benefits of exercise. Furthermore, all trials should measure and report fatigue, functional capacity, and other exercise capacity measures such as aerobic capacity and strength to determine the effectiveness of the exercise intervention. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD014816-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD014816-sec-0008"></div> <div class="table" id="CD014816-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to placebo plus usual pharmacological care for systemic lupus erythematosus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise plus usual pharmacological care compared to placebo plus usual pharmacological care for systemic lupus erythematosus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> systemic lupus erythematosus<br/><b>Setting:</b> community<br/><b>Intervention:</b> exercise plus usual pharmacological care <br/><b>Comparison:</b> placebo plus usual pharmacological care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo plus usual pharmacological care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with exercise plus usual pharmacological care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue (FACIT‐Fatigue, score 0‐52, lower scores indicate less fatigue)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fatigue (FACIT‐Fatigue, score 0‐52, lower scores indicate less fatigue) was <b>38</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>5 points lower</b><br/>(13.29 lower to 3.29 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may have little to no effect on fatigue.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional capacity (SF‐36 Function Capacity domain, score 0‐100, higher scores indicate better functional capacity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional capacity (SF‐36 Function Capacity domain, score 0‐100, higher scores indicate better functional capacity) was <b>70</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.5 points lower</b><br/>(23.78 lower to 18.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may have little to no effect on functional capacity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (SF‐36 Pain domain, score 0‐100, lower scores indicate less pain)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain (SF‐36 Pain domain, score 0‐100, lower scores indicate less pain) was <b>43</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>9 points lower</b><br/>(28.88 lower to 10.88 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may have little to no effect on pain.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease activity ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured at baseline, but it was not reported at end of intervention.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured, but the Mental Component Summary score was not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals due to any reason<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>273 per 1000</b><br/>(34 to 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.73</b><br/>(0.34 to 22.16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise results in fewer or more withdrawals.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_432987629440706015" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_432987629440706015</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Usual pharmacological care consisted of immunosuppressants and glucocorticoids.<br/><sup>b</sup> Downgraded one level due to risk of detection and potentially selection bias.<br/><sup>c</sup> Downgraded one level due to small number of participants from a single trial. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014816-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to usual pharmacological care alone for systemic lupus erythematosus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise plus usual pharmacological care compared to usual pharmacological care alone for systemic lupus erythematosus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> systemic lupus erythematosus<br/><b>Setting:</b> community<br/><b>Intervention:</b> exercise plus usual pharmacological care<br/><b>Comparison:</b> usual pharmacological care alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with usual pharmacological care alone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with exercise plus usual pharmacological care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue (Fatigue Severity Scale, score 1‐7, lower score indicates less fatigue)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fatigue (Fatigue Severity Scale, score 1‐7, lower score indicates less fatigue) was <b>5.4</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 points lower</b><br/>(1.4 lower to 0.2 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may have little to no effect on fatigue.<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity) was <b>60</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>5.4 points higher</b><br/>(5.97 lower to 16.75 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may have little to no effect on functional capacity. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease activity (SLEDAI scale, scores 0‐105, lower scores indicate less disease activity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease activity (SLEDAI scale, scores 0‐105, lower scores indicate less disease activity) was <b>0.5</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.26 points lower</b><br/>(3.69 lower to 3.17 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may have little to no effect on disease activity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured, but the Mental Component Summary score was not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) was <b>38</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>16 points higher</b><br/>(0.18 lower to 32.18 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise improves pain.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals due to any reason<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>161 per 1000</b><br/>(93 to 280) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b><br/>(0.53 to 1.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise results in fewer or more withdrawals.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149155812397472" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149155812397472</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for risk of detection bias in unblinded trials with self‐reported outcomes.<br/><sup>b</sup> Downgraded one level due to low participant numbers and the confidence intervals included a large effect and no effect.<br/><sup>c</sup> Usual pharmacological care consists of immunosuppressants, steroids and antimalarials </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014816-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to another intervention (education, joint aids, or relaxation) plus usual pharmacological care for systemic lupus erythematosus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise plus usual pharmacological care compared to another intervention (education, joint aids, or relaxation) plus usual pharmacological care for systemic lupus erythematosus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> systemic lupus erythematosus<br/><b>Setting:</b> community<br/><b>Intervention:</b> exercise plus usual pharmacological care<br/><b>Comparison:</b> another intervention (education, joint aids, or relaxation) plus usual pharmacological care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with another intervention (education, joint aids, or relaxation) plus usual pharmacological care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with exercise plus usual pharmacological care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue (Fatigue Severity Scale, scores 0‐7, lower scores indicate less fatigue)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fatigue (Fatigue Severity Scale, scores 0‐7, lower scores indicate less fatigue) was <b>5.3</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.51 points lower</b><br/>(0.88 lower to 0.14 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may reduce fatigue slightly.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity) was <b>41.4</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>13.2 points higher</b><br/>(6.17 higher to 20.22 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>182<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may increase functional capacity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease activity (SLEDAI scale, score 0‐105, lower scores indicate less disease activity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease activity (SLEDAI scale, score 0‐105, lower scores indicate less disease activity) was <b>1.2</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.034 points higher</b><br/>(0.476 lower to 0.544 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care probably results in little to no difference in disease activity. SMD 0.02 (95% CI ‐0.28 to 0.32). Baseline control group SD for converting SMD to MD was 1.7 and taken from Abrahão 2016. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (VAS Pain scale, score 0‐10, lower scores indicate less pain)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain (VAS Pain scale, score 0‐10, lower scores indicate less pain) was <b>4.97</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.59 points lower</b><br/>(2.46 lower to 0.71 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may result in little to no difference in pain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals due to any reason<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b><br/>(6 to 289) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b><br/>(0.13 to 5.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise results in fewer or more withdrawals.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured, but the Mental Component Summary score was not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149459092821699" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149459092821699</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level due to risk of detection bias in unblinded trials with self‐reported outcomes.<br/><sup>b</sup> Downgraded one level due to low participant numbers and the confidence intervals included a large effect and no effect.<br/><sup>c</sup> Downgraded one level due to possible imprecision. The confidence intervals included a small effect and a large effect.<br/><sup>d</sup> Downgraded two levels due to very few events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD014816-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD014816-sec-0009"></div> <section id="CD014816-sec-0010"> <h3 class="title" id="CD014816-sec-0010">Description of the condition</h3> <p>Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease with a wide spectrum of clinical and serological manifestations caused by autoantibody production, complement activation, and immune complex deposition. The pathogenesis of SLE is characterised by the formation of autoantibodies and a breakdown in the immune milieu of the body leading to an unregulated inflammatory response and consequent internal organ and tissue damage (<a href="./references#CD014816-bbs2-0058" title="FanouriakisA , KostopoulouM , AlunnoA , AringerM , BajemaI , BoletisJN , et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases2019;78:736-45.">Fanouriakis 2019</a>). Systemic manifestations frequently include internal organ involvement, a characteristic malar rash on the face, sicca symptoms, and profound fatigue. People with SLE experience multiple, varied symptoms and laboratory abnormalities that occur in different combinations, at different time points. SLE is heterogeneous, meaning that symptoms vary widely from one person to the next, for example, one person may develop a rash, while another may have high blood pressure, joint pain, and anaemia. Although SLE constitutes the most common form of lupus, which is the broad term to describe the disease, there are other forms of lupus which include discoid lupus erythematosus (DLE) or cutaneous lupus erythematosus (CLE), characterised by mostly cutaneous involvement (<a href="./references#CD014816-bbs2-0058" title="FanouriakisA , KostopoulouM , AlunnoA , AringerM , BajemaI , BoletisJN , et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases2019;78:736-45.">Fanouriakis 2019</a>).  </p> <p>SLE is a rare disease with an incidence of approximately 1 to 10 per 100,000 person‐years and a prevalence varying from 4.3 to 150 people in 100,000 (<a href="./references#CD014816-bbs2-0083" title="NikpourM , BridgeJA , RichterS . A systematic review of prevalence, disease characteristics and management of systemic lupus erythematosus in Australia: identifying areas of unmet need. Internal Medicine Journal2014;44(12a):1170-9.">Nikpour 2014</a>), or approximately five million people worldwide. The prevalence in Australia varies between 19.3 and 39 people in 100,000 for non‐Aboriginal Australians and 52.0 to 92.8 people in 100,000 for Aboriginal Australians (<a href="./references#CD014816-bbs2-0046" title="BossinghamD . Systemic lupus erythematosus in the far north of Queensland. Lupus2003;12(4):327-31.">Bossingham 2003</a>; <a href="./references#CD014816-bbs2-0099" title="SegasothyM , PhillipsPA . Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus2001;10:439-44.">Segasothy 2001</a>). There is a higher SLE incidence in Asian (especially Chinese), African, and Hispanic populations. These last two populations are especially associated with high disease activity and damage. SLE can affect both men and women of any age, with 90% being female. It predominantly affects young women and middle‐aged women, between the ages of 15 and 45 years. By age, the female:male ratio is 3:1 before puberty, 10 to 15:1 during childbearing years, with a slight decrease again after menopause at 8:1 (<a href="./references#CD014816-bbs2-0044" title="AskanaseA , ShumK , MitnickH . Systemic lupus erythematosus: an overview. Social Work in Health Care2012;51(7):576-86.">Askanase 2012</a>). </p> <p>SLE has a severe and pervasive effect on people living with the disease, with people reporting the disease to cause debilitating fatigue; mental deterioration; pervasive pain; disrupted identity from feeling of hopelessness, guilt and punishment, or feeling as though they are a burden (<a href="./references#CD014816-bbs2-0102" title="SutantoB , Singh-GrewalD , McNeilHP , O'NeillS , CraigJC , JonesJ , et al. Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care &amp; Research2013;65(11):1752-65.">Sutanto 2013</a>). In contrast, some people have also reported the disease to have increased their resilience, empowerment, and optimism. Debilitating pain, musculoskeletal manifestations, fatigue, and renal and cutaneous problems were reported to limit people's ability to work and participate in family and social activities (<a href="./references#CD014816-bbs2-0102" title="SutantoB , Singh-GrewalD , McNeilHP , O'NeillS , CraigJC , JonesJ , et al. Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care &amp; Research2013;65(11):1752-65.">Sutanto 2013</a>). </p> <p>People with SLE are at higher risk of developing comorbidities such as osteoporosis (<a href="./references#CD014816-bbs2-0063" title="GuC , ZhaoR , ZhangX , GuZ , ZhouW , GuoJ , et al. A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors. Archives of Osteoporosis2020;15(1):1-12.">Gu 2020</a>) and atherosclerotic cardiovascular disease (CVD) (<a href="./references#CD014816-bbs2-0074" title="ManziS , MeilahnEN , RairieJE , ConteCG , Medsger TA Jr, Jansen-McWilliamsL , et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. American Journal of Epidemiology1997;145(5):408-15.">Manzi 1997</a>; <a href="./references#CD014816-bbs2-0096" title="SchoenfeldR , KasturiS , CostenbaderKH . The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Seminars in Arthritis and Rheumatism2013;43(1):77-95.">Schoenfeld 2013</a>). CVD risk amongst people with SLE compared to the general population is at least doubled. While older people with SLE appear to have the highest absolute risks of CVD, young women have alarmingly high relative risks, given the rarity of CVD in the comparable general population (<a href="./references#CD014816-bbs2-0096" title="SchoenfeldR , KasturiS , CostenbaderKH . The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Seminars in Arthritis and Rheumatism2013;43(1):77-95.">Schoenfeld 2013</a>). People with SLE are also less physically active than people without SLE (<a href="./references#CD014816-bbs2-0075" title="MargiottaDP , BastaF , DolciniG , BataniV , Lo VulloM , VernuccioA , et al. Physical activity and sedentary behavior in patients with systemic lupus erythematosus. PLOS One2018;13(3):1-16.">Margiotta 2018</a>), with 60% of people not meeting sufficient physical activity guidelines according to the World Health Organization (WHO) recommendations. Subsequent inactivity may add to the heightened risk of secondary complications, as well as lead to physical deconditioning and poor health‐related quality of life.  </p> <p>Management or 'usual care' in SLE may include, but is not limited to, the following pharmacological treatments; conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) such as hydroxychloroquine, prednisolone or glucocorticoids, mycophenolate mofetil, methotrexate, azathioprine, cyclophosphamide, or a combination of these; biological disease‐modifying antirheumatic drugs (bDMARDs) such as rituximab  or belimumab; non‐steroidal anti‐inflammatory drugs (NSAIDs) such as naproxen or celecoxib (<a href="./references#CD014816-bbs2-0058" title="FanouriakisA , KostopoulouM , AlunnoA , AringerM , BajemaI , BoletisJN , et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases2019;78:736-45.">Fanouriakis 2019</a>).  It may also include non‐pharmacological measures such as sun avoidance; supplementation (i.e. vitamin D); education about the disease or comorbidities (i.e. hypertension), or both; and physical activity or exercise (<a href="./references#CD014816-bbs2-0058" title="FanouriakisA , KostopoulouM , AlunnoA , AringerM , BajemaI , BoletisJN , et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases2019;78:736-45.">Fanouriakis 2019</a>). Regular exercise training could serve as an adjunct treatment for people with SLE to reduce the risk of developing secondary complications, help manage symptoms related to the disease, and improve key clinical outcomes such as quality of life and fatigue. </p> </section> <section id="CD014816-sec-0011"> <h3 class="title" id="CD014816-sec-0011">Description of the intervention</h3> <p>The treatment for SLE depends on the organs and systems involved as well as disease severity. It can include topical applications for skin problems, NSAIDs for musculoskeletal diseases, and immunosuppression. Common medications to treat the inflammatory response associated with subsequent widespread organ involvement include corticosteroids, immune suppressants, hydroxychloroquine, and biological agents (<a href="./references#CD014816-bbs2-0043" title="AliA , SayyedZ , AmeerMA , ArifAW , KiranF , IftikharA , et al. Systemic lupus erythematosus: an overview of the disease pathology and its management. Cureus2018;10:1-13.">Ali 2018</a>). </p> <p>Exercise is generally used as an adjunct to pharmacological management of SLE (<a href="./references#CD014816-bbs2-0106" title="YorganciE , EvansCJ , JohnsonH , BarclayS , MurtaghFE , YiD , et al. Understanding usual care in randomised controlled trials of complex interventions: a multi-method approach. Palliative Medicine2020;34(5):667-79.">Yorganci 2020</a>). For this review, we focused on studies that examined all types of structured exercise as an adjunctive therapy in the management of SLE. Evidence suggests that exercise interventions are safe, with no change in disease activity or adverse events, and effective in managing key clinical outcomes such as fatigue (<a href="./references#CD014816-bbs2-0054" title="Del Pino-SedenoT , Trujillo-MartinMM , Ruiz-IrastorzaG , Cuellar-PompaL , dePascual-MedinaAM , Serrano-AguilarP , et al. Effectiveness of nonpharmacologic interventions for decreasing fatigue in adults with systemic lupus erythematosus: a systematic review. Arthritis Care &amp; Research2016;68(1):141-8.">Del Pino‐Sedeno 2016</a>; <a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a>; <a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>; <a href="./references#CD014816-bbs2-0107" title="YuenHK , CunninghamMA . Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review. Therapeutics and Clinical Risk Management2014;10:775-8.">Yuen 2014</a>). According to the American College of Sports Medicine (ACSM), exercise is defined as a type of physical activity consisting of planned, structured, and repetitive bodily movement done to improve or maintain (or both) one or more components of physical fitness (<a href="./references#CD014816-bbs2-0089" title="PescatelloLS . ACSM's Guidelines for Exercise Testing and Prescription. 9th edition. Philadelphia (PA): Wolters Kluwer/Lippincott Williams &amp; Wilkins Health, 2014.">Pescatello 2014</a>). </p> <p>The three main types of exercise include aerobic, resistance, and range of movement. Aerobic exercise relies primarily on the cardiovascular system and represents a broad range of physical activities such as walking, jogging, cycling, and dancing (<a href="./references#CD014816-bbs2-0089" title="PescatelloLS . ACSM's Guidelines for Exercise Testing and Prescription. 9th edition. Philadelphia (PA): Wolters Kluwer/Lippincott Williams &amp; Wilkins Health, 2014.">Pescatello 2014</a>). Resistance exercise can be provided via specifically designed equipment such as resistance bands, hand weights, and machines, or achieved via functional means such as stair climbing, rising from a chair, and lifting groceries to induce muscular contraction, which builds the strength, anaerobic endurance, and size of skeletal muscles (<a href="./references#CD014816-bbs2-0089" title="PescatelloLS . ACSM's Guidelines for Exercise Testing and Prescription. 9th edition. Philadelphia (PA): Wolters Kluwer/Lippincott Williams &amp; Wilkins Health, 2014.">Pescatello 2014</a>). Range of motion exercise refers to activity aimed to improve movement of a specific joint, for example, yoga, tai chi, or stretching (<a href="./references#CD014816-bbs2-0089" title="PescatelloLS . ACSM's Guidelines for Exercise Testing and Prescription. 9th edition. Philadelphia (PA): Wolters Kluwer/Lippincott Williams &amp; Wilkins Health, 2014.">Pescatello 2014</a>). Exercise intensity may be high (70% to less than 90% of heart rate maximum (HR<sub>max</sub>) or a rating of perceived exertion (RPE) value of 5/10 to 7/10), moderate (55% to less than 70% HR<sub>max</sub> or an RPE value of 3/10 to 4/10), or light (40% to less than 55% HR<sub>max</sub> OR an RPE value of 1/10 to 2/10). </p> <p>The exercise intervention may be supervised by allied health practitioners, medical health practitioners, or other exercise professionals, and can be individually supervised or supervised in a group setting, or it can be completely unsupervised and performed independently. Unsupervised exercise is usually reported as home‐based exercise, but can also include exercising in a park or in a gym without supervision. While people with SLE are advised to avoid sun exposure, which may limit their interest or raise concern about exercise, it is important to know that not all exercise is performed outdoors. The exercise environment may be water‐based (indoors or outdoors), land‐based (indoors or outdoors), in a gym or clinic, outdoors at a park or along a walking or bike track, or in ones' home (<a href="./references#CD014816-bbs2-0089" title="PescatelloLS . ACSM's Guidelines for Exercise Testing and Prescription. 9th edition. Philadelphia (PA): Wolters Kluwer/Lippincott Williams &amp; Wilkins Health, 2014.">Pescatello 2014</a>). </p> </section> <section id="CD014816-sec-0012"> <h3 class="title" id="CD014816-sec-0012">How the intervention might work</h3> <p>Regular exercise training may lead to anti‐inflammatory benefits in chronic diseases with systemic low‐grade inflammation (i.e. type 2 diabetes) by reducing inflammatory markers (<a href="./references#CD014816-bbs2-0088" title="PerandiniLA , De Sa-PintoAL , RoschelH , BenattiFB , LimaFR , BonfaE , et al. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Autoimmunity Reviews2012;12(2):218-24.">Perandini 2012</a>), and is regarded as a valuable self‐care intervention for this population. Given the potential role of inflammation in the aetiology and clinical symptoms of SLE, including pain, redness, and swelling, if exercise training is able to alleviate the inflammatory process, it could be a helpful intervention in treating the symptoms related to inflammation in SLE (<a href="./references#CD014816-bbs2-0088" title="PerandiniLA , De Sa-PintoAL , RoschelH , BenattiFB , LimaFR , BonfaE , et al. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Autoimmunity Reviews2012;12(2):218-24.">Perandini 2012</a>). Exercise is beneficial in reducing fatigue (<a href="./references#CD014816-bbs2-0054" title="Del Pino-SedenoT , Trujillo-MartinMM , Ruiz-IrastorzaG , Cuellar-PompaL , dePascual-MedinaAM , Serrano-AguilarP , et al. Effectiveness of nonpharmacologic interventions for decreasing fatigue in adults with systemic lupus erythematosus: a systematic review. Arthritis Care &amp; Research2016;68(1):141-8.">Del Pino‐Sedeno 2016</a>; <a href="./references#CD014816-bbs2-0082" title="NeillJ , BelanI , RiedK . Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. Journal Advance Nursing2006;56(6):617-35.">Neill 2006</a>; <a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>; <a href="./references#CD014816-bbs2-0107" title="YuenHK , CunninghamMA . Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review. Therapeutics and Clinical Risk Management2014;10:775-8.">Yuen 2014</a>), improving symptoms of depression (<a href="./references#CD014816-bbs2-0052" title="Da HoraTC , LimaK , MacielRR . The effect of therapies on the quality of life of patients with systemic lupus erythematosus: a meta-analysis of randomized trials. Advance Rheumatology2019;59(34):1-8.">Da Hora 2019</a>; <a href="./references#CD014816-bbs2-0069" title="KelleyGA , KelleyKS , HootmanJM . Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials. Arthritis Research Therapy2015;17(1):1-22.">Kelley 2015</a>), and improving quality of life (<a href="./references#CD014816-bbs2-0052" title="Da HoraTC , LimaK , MacielRR . The effect of therapies on the quality of life of patients with systemic lupus erythematosus: a meta-analysis of randomized trials. Advance Rheumatology2019;59(34):1-8.">Da Hora 2019</a>; <a href="./references#CD014816-bbs2-0100" title="SieczkowskaaSM , CoimbrabDR , VilarinoaGT , AndradeA . Effects of resistance training on the health-related quality of life of patients with rheumatic diseases: systematic review with meta-analysis and meta-regression. Seminars in Arthritis and Rheumatism2020;50(2):342-53.">Sieczkowskaa 2020</a>). The benefits of exercise are similar in other rheumatic, inflammatory conditions with improvements in quality of life (<a href="./references#CD014816-bbs2-0100" title="SieczkowskaaSM , CoimbrabDR , VilarinoaGT , AndradeA . Effects of resistance training on the health-related quality of life of patients with rheumatic diseases: systematic review with meta-analysis and meta-regression. Seminars in Arthritis and Rheumatism2020;50(2):342-53.">Sieczkowskaa 2020</a>), reduced inflammation (<a href="./references#CD014816-bbs2-0080" title="MetsiosGS , MoeRH , KitasGD . Exercise and inflammation. Best Practice Research &amp; Clinical Rheumatology2020;34(2):1-12.">Metsios 2020</a>; <a href="./references#CD014816-bbs2-0088" title="PerandiniLA , De Sa-PintoAL , RoschelH , BenattiFB , LimaFR , BonfaE , et al. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Autoimmunity Reviews2012;12(2):218-24.">Perandini 2012</a>), and reduced joint damage and symptoms (<a href="./references#CD014816-bbs2-0103" title="SveaasSH , SmedslundG , BirgerHK , DagfinrudH . Effect of cardiorespiratory and strength exercises on disease activity in patients with inflammatory rheumatic diseases: a systematic review and meta-analysis. British Journal of Sports Medicine2017;51:1065-72.">Sveaas 2017</a>). Importantly, it is suggested that exercise does not deleteriously affect disease activity (<a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a>), and positively influences fatigue (<a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a>; <a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>; <a href="./references#CD014816-bbs2-0107" title="YuenHK , CunninghamMA . Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review. Therapeutics and Clinical Risk Management2014;10:775-8.">Yuen 2014</a>), which is a significant concern for most people with SLE. As such, exercise could serve as an adjunct non‐pharmaceutical therapy for people with SLE to assist in the management of disease‐related symptoms such as fatigue and pain, as well as preventing comorbidities such as osteoporosis and CVD. </p> </section> <section id="CD014816-sec-0013"> <h3 class="title" id="CD014816-sec-0013">Why it is important to do this review</h3> <p>To date, there are currently three systematic reviews that assess the safety and effectiveness of exercise in adults with SLE, two of which were published in 2017 and one in 2021 (<a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a>; <a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>; <a href="./references#CD014816-bbs2-0073" title="Lu M-C, KooM . Effects of exercise intervention on health-related quality of life in patients with systemic lupus erythematosus: a systematic review and meta-analysis of controlled trials. Healthcare (Basel)2021;9(1215):1-15.">Lu 2021</a>). </p> <p>The first review found exercise improved depression and fatigue and not alter disease activity in adults with SLE compared to control groups (<a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a>). Meta‐analyses of seven studies found that disease activity was unchanged following exercise interventions (mean difference (MD) 0.01, 95% confidence interval (CI) −0.54 to 0.56), fatigue decreased in the exercise intervention group compared to controls (MD −0.52, 95% CI −0.91 to −0.13), and depression scores decreased in the exercise groups compared to the controls (standardised mean difference (SMD) −0.40 standard deviations (SD), 95% CI −0.71 to −0.09) (<a href="./references#CD014816-bbs2-0042" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201.">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0047" title="BoströmC , ElfvingB , DupréB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25:602-16.">Boström 2016</a>; <a href="./references#CD014816-bbs2-0051" title="CarvalhoMR , SatoEI , TebexreniAS , HeidecherRT , SchenkmanS , NetoTL . Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis and Rheumatism2005;53(6):838-44.">Carvalho 2005</a>; <a href="./references#CD014816-bbs2-0055" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52:2187-95.">Dos Reis‐Neto  2013</a>; <a href="./references#CD014816-bbs2-0081" title="MiossiR , BenattiFB , Lúciade de Sá PintoA , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counter balance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64:1159-66.">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0095" title="Robb-NicholsonLC , DaltroyL , EatonH , GallV , WrightE , HartleyLH , et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. British Journal of Rheumatology1989;28:500-5.">Robb‐Nicholson 1989</a>; <a href="./references#CD014816-bbs2-0104" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology2003;42(9):1050-4.">Tench 2003</a>). Most of these studies were at risk of selection and reporting bias. </p> <p>The second review found that a 12‐week supervised aerobic exercise programme reduced fatigue for people with SLE with mild disease activity (<a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>). Meta‐analysis of three trials showed that aerobic exercise training decreased fatigue severity compared to controls (MD −0.52, 95% CI −0.91 to −0.13), and had a positive effect on the 36‐item Short Form (SF‐36) Vitality subscale (MD 14.98, 95% CI 7.45 to 22.52) (<a href="./references#CD014816-bbs2-0051" title="CarvalhoMR , SatoEI , TebexreniAS , HeidecherRT , SchenkmanS , NetoTL . Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis and Rheumatism2005;53(6):838-44.">Carvalho 2005</a>; <a href="./references#CD014816-bbs2-0093" title="Ramsey-GoldmanR , SchillingEM , DunlopD , LangmanC , GreenlandP , ThomasRJ , et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2000;13(5):262-9.">Ramsey‐Goldman 2000</a>; <a href="./references#CD014816-bbs2-0104" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology2003;42(9):1050-4.">Tench 2003</a>). However, the quality of evidence assessed using PEDro was downgraded to fair (<a href="./references#CD014816-bbs2-0104" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology2003;42(9):1050-4.">Tench 2003</a>) or poor (<a href="./references#CD014816-bbs2-0093" title="Ramsey-GoldmanR , SchillingEM , DunlopD , LangmanC , GreenlandP , ThomasRJ , et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2000;13(5):262-9.">Ramsey‐Goldman 2000</a>). </p> <p>The third review found that exercise improved some aspects of quality of life in people with SLE (<a href="./references#CD014816-bbs2-0073" title="Lu M-C, KooM . Effects of exercise intervention on health-related quality of life in patients with systemic lupus erythematosus: a systematic review and meta-analysis of controlled trials. Healthcare (Basel)2021;9(1215):1-15.">Lu 2021</a>). Meta‐analysis of five RCTs showed a positive effect of exercise on the physical health and function aspect (SF‐36 Physical Function and LupusQOL Physical Health) of health‐related quality of life amongst participants with SLE (Hedges' g 0.468, 95% CI 0.206 to 0.730; P &lt; 0.001). Heterogeneity between studies was low (I<sup>2</sup> = 19.2%; P = 0.292) (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>These three reviews found that exercise is effective in managing concerning symptoms of SLE including fatigue, depression, and some aspects of qualify of life. However, more studies with more participants are needed to strengthen these results, and the optimal exercise protocol is yet to be determined. Therefore, it is important to perform this systematic review to capture any additional trials, update the existing evidence, and identify the safety and effectiveness of exercise in adults with SLE. We conducted the review according to the guidelines recommended by the Cochrane Musculoskeletal Editorial Board (<a href="./references#CD014816-bbs2-0060" title="GhogomuEA , MaxwellLJ , BuchbinderR , RaderT , Pardo PardoJ , JohnstonRV , et al. Updated method guidelines for Cochrane Musculoskeletal Group systematic reviews and meta-analyses. Journal of Rheumatology2014;41(2):194-205.">Ghogomu 2014</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD014816-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD014816-sec-0014"></div> <p>To evaluate the benefits and harms of structured exercise as adjunctive therapy for adults with SLE compared with usual pharmacological care, usual pharmacological care plus placebo and usual pharmacological care plus non‐pharmacological care. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD014816-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD014816-sec-0015"></div> <section id="CD014816-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD014816-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) and quasi‐RCTs. We included parallel and cross‐over trials, and cluster‐RCTs, using either non‐intervention or active controls. There were no language restrictions. We included abstracts and studies with unpublished data. </p> </section> <section id="CD014816-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included trials of adults (aged 18 years or greater), diagnosed with SLE according to the study author's report; American College of Rheumatology (ACR) criteria or European League Against Rheumatism (EULAR) criteria (or both), with systemic disease involving at least two body sites or organ systems. We excluded trials of participants with SLE and another diagnosed condition in different groups (i.e. group one = people with SLE, group 2 = people with rheumatoid arthritis) if the effect of the intervention could not be determined on the participants with SLE alone. We included intervention trials without regard to race, sex, or disease duration of participants. </p> </section> <section id="CD014816-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD014816-sec-0020"> <h5 class="title">Structured exercise </h5> <p>Adjunct to usual care, an intervention consisting of structured exercise performed at any duration, frequency, intensity, and of any type was included. The type of exercise intervention included either an individual type of exercise or a combination of various types (e.g. resistance training alone or resistance training combined with aerobic training). Exercise interventions were structured, recurring, and prescriptions included specific dosage information (i.e. frequency, intensity, timing, type). Aerobic exercise could include, but was not limited to, walking (treadmill or free), cycling (stationary or free), swimming, or aerobics classes. Range of movement exercise could include Pilates; yoga; tai chi; or active, ballistic, and static stretching. Other forms of exercise such as sports, games, and recreational activities such as dancing, lawn bowls, and Wii fit could be included. Exercise environments could include water‐ or, land‐based exercise, indoor or outdoor settings, home‐based or community led, supervised or unsupervised, face‐to‐face or telehealth. </p> </section> <section id="CD014816-sec-0021"> <h5 class="title">Usual pharmacological care</h5> <p>Usual pharmacological care could include, but was not limited to, the following standard pharmacological drug treatments; antimalarials such as hydroxychloroquine, NSAIDs, glucocorticoids such as prednisone, immunosuppressives such as mycophenolate, and biologicals such as belimumab or rituximab. Other non‐pharmacological measures may also have included sun avoidance, commonly prescribed supplementation (i.e. vitamin D), and education about the disease or managing comorbidities such as hypertension, for example (<a href="./references#CD014816-bbs2-0058" title="FanouriakisA , KostopoulouM , AlunnoA , AringerM , BajemaI , BoletisJN , et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases2019;78:736-45.">Fanouriakis 2019</a>). </p> </section> <section id="CD014816-sec-0022"> <h5 class="title">Comparisons</h5> <p>We included any RCT that evaluated the effect of exercise as an adjunct therapy to usual care, compared to: </p> <p> <ol id="CD014816-list-0001"> <li> <p>usual pharmacological care plus placebo;</p> </li> <li> <p>usual pharmacological care alone;</p> </li> <li> <p>usual pharmacological care plus another intervention that was non‐pharmacological (e.g. relaxation, counselling, education, support group). </p> </li> </ol> </p> <p>We excluded studies if the exercise intervention was not structured (i.e. the exercise intervention did not have a dosage for frequency, intensity, or duration of exercise) or if the exercise intervention was an acute or single bout of exercise (i.e. one individual session of exercise or one exercise test). </p> </section> </section> <section id="CD014816-sec-0023"> <h4 class="title">Types of outcome measures</h4> <p>Studies were not excluded on the basis of outcome reporting.</p> <section id="CD014816-sec-0024"> <h5 class="title">Major outcomes</h5> <p> <ol id="CD014816-list-0002"> <li> <p><b>Fatigue:</b> mean or mean change in fatigue assessed by Fatigue Severity Scale (FSS), Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT‐F) (<a href="./references#CD014816-bbs2-0057" title="FACIT group. The Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT-F) scale: summary of development and validation. www.facit.org/FACITOrg/Questionnaires (accessed prior to 1 October 2021).">FACIT group</a>; <a href="./references#CD014816-bbs2-0070" title="Lai J-S, BeaumontJL , OgaleS , BrunettaP , CellaD . Validation of the Functional Assessment of Chronic Illness Therapy – Fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. Journal of Rheumatology2011;38(4):672-9.">Lai 2011</a>), or other relevant fatigue scales such as Profile Of Moods State (POMS). </p> </li> <li> <p><b>Functional capacity:</b> mean or mean change in functional capacity measured by the Physical Component Score (PCS) of the 36‐item Short‐Form (SF‐36), or Physical Function subscale of the SF‐36, or other physical function or disability scales. </p> </li> <li> <p><b>Disease activity:</b> mean or mean change in SLE scores on validated disease activity indices such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Systemic Lupus Erythematosus Disease Activity Index SELENA Modification (SELENA‐SLEDAI), modified SELENA‐SLEDAI Flare Index (SFI) (<a href="./references#CD014816-bbs2-0090" title="PetriM , BuyonJ , KimM . Classification and definition of major flares in SLE clinical trials. Lupus1999;8(8):685-91.">Petri 1999</a>; <a href="./references#CD014816-bbs2-0091" title="PetriM , KimMY , KalunianKC , GrossmanJ , HahnBH , SammaritanoLR , et al, OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. New England Journal of Medicine2005;353(24):2550-8.">Petri 2005</a>); British Isles Lupus Assessment Group index (BILAG) (<a href="./references#CD014816-bbs2-0064" title="HayEM , BaconPA , GordonC , IsenbergDA , MaddisonP , SnaithML , et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Quarterly Journal of Medicine1993;86(7):447-58.">Hay 1993</a>; <a href="./references#CD014816-bbs2-0068" title="IsenbergDA , GordonC , BILAG Group, British Isles Lupus Assessment Group. From BILAG to BLIPS – disease activity assessment in lupus past, present and future. Lupus2000;9(9):651-4.">Isenberg 2000</a>); or other similar validated indices. </p> </li> <li> <p><b>Quality of life:</b> mean or mean change in quality of life assessed by the Mental Component Score (MCS) of the SF‐36, or similar assessments such as Lupus Quality Of Life (LupusQOL) (<a href="./references#CD014816-bbs2-0056" title="DowardLC , McKennaSP , WhalleyD , TennantA , GriffithsB , EmeryP , et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Annals of the Rheumatic Diseases2009;68:196-200.">Doward 2009</a>; <a href="./references#CD014816-bbs2-0076" title="McElhoneK , AbbottJ , ShelmerdineJ , BruceIN , AhmadY , GordonC , et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis &amp; Rheumatology2007;57:972–9.">McElhone 2007</a>). </p> </li> <li> <p><b>Pain:</b> mean or mean change in pain measured by the Visual Analogue Scale (VAS) for pain, the numerical rating scale (NRS) for pain, or the Bodily Pain subscale of the SF‐36. </p> </li> <li> <p><b>Serious adverse events (SAEs):</b> including number of SAEs, or number of people with one or more SAE. </p> </li> <li> <p><b>Withdrawals due to any reason</b> </p> </li> </ol> </p> </section> <section id="CD014816-sec-0025"> <h5 class="title">Minor outcomes</h5> <p> <ol id="CD014816-list-0003"> <li> <p><b>Composite responder rate</b>, as defined with the Systemic lupus erythematosus Responder Index (SRI), where a responder is defined as a person with </p> <ol id="CD014816-list-0004"> <li> <p>a 4‐point or greater reduction in SELENA‐SLEDAI score;</p> </li> <li> <p>no new BILAG A or no more than one new BILAG B domain score; and</p> </li> <li> <p>no deterioration from baseline in the physician's global assessment by 0.3 points or greater (<a href="./references#CD014816-bbs2-0059" title="FurieRA , PetriMA , WallaceDJ , GinzlerEM , MerrillJT , StohlW , et al. Novel evidence-based systemic lupus erythematosus responder index. Arthritis &amp; Rheumatology2009;61(9):1143-51.">Furie 2009</a>). </p> </li> </ol> </li> <li> <p><b>Aerobic capacity:</b> mean or mean change in aerobic capacity assessed by predicted or absolute value of maximum rate of oxygen consumption (VO<sub>2max</sub>). </p> </li> <li> <p><b>Depression:</b> mean or mean change in depression assessed by Beck‐Depression Index (BDI) or other relevant depression scales such as Hospital Anxiety and Depression Scale (HADS). </p> </li> <li> <p><b>Anxiety:</b> mean or mean change in anxiety assessed using HADS or other relevant anxiety scales. </p> </li> </ol> </p> <p>We analysed all exercise interventions in the pooled primary analysis. For efficacy outcomes, we extracted data from the end of intervention time point. We defined the end of intervention as the time when the structured exercise intervention had completed. We extracted adverse event outcomes at the last time point (i.e. proportion who had an event by the end of the trial). </p> </section> </section> </section> <section id="CD014816-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD014816-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE Ovid, Embase Ovid, CINAHL (EBSCO), SPORTDiscus (EBSCO), and Web of Science. We also conducted a search of ClinicalTrials.gov (<a href="http://www.ClinicalTrials.gov" target="_blank">www.clinicaltrials.gov</a>) and the WHO trials portal (<a href="https://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>). We searched all databases from their inception to 30 March 2022, and we imposed no restriction on language of publication. </p> <p>See <a href="./appendices#CD014816-sec-0131">Appendix 1</a>; <a href="./appendices#CD014816-sec-0132">Appendix 2</a>; <a href="./appendices#CD014816-sec-0133">Appendix 3</a>; <a href="./appendices#CD014816-sec-0134">Appendix 4</a>; <a href="./appendices#CD014816-sec-0135">Appendix 5</a>; and <a href="./appendices#CD014816-sec-0136">Appendix 6</a> for the search strategies.  </p> </section> <section id="CD014816-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We did not contact organisations to obtain additional references.</p> </section> </section> <section id="CD014816-sec-0029"> <h3 class="title" id="CD014816-sec-0029">Data collection and analysis</h3> <section id="CD014816-sec-0030"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SF, EN) independently screened titles and abstracts for inclusion of all the potentially relevant studies we identified as a result of the search, and coded them as 'retrieved' (eligible or potentially eligible/unclear) or 'did not retrieve'. We retrieved the full‐text study reports/publications and two review authors (SF, EN) independently screened the full texts and identified studies for inclusion, and identified and recorded reasons for exclusion of the ineligible studies. We resolved any disagreements through discussion with a third review author (MC). We identified and excluded duplicates. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram (<a href="#CD014816-fig-0001">Figure 1</a>; <a href="./references#CD014816-bbs2-0092" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. BMJ2009;339:b2535.">PRISMA Group 2009</a>; <a href="http://prisma-statement.org/PRISMAStatement/Default.aspx" target="_blank">prisma-statement.org/PRISMAStatement/Default.aspx</a>). </p> <div class="figure" id="CD014816-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD014816-fig-0001" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD014816-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SF, EN) extracted the following study characteristics from included studies. </p> <p> <ol id="CD014816-list-0005"> <li> <p>Methods: study design, total duration of study, number of study centres and location, study setting, withdrawals, and date of study. </p> </li> <li> <p>Participants: number, mean age, age range, sex, disease duration, severity of condition, diagnostic criteria, important SLE baseline data, medication, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention; comparison; concomitant medications; and specific components of the intervention including type, frequency, intensity, and duration of the exercise intervention, and whether the exercise intervention was supervised. This was assessed using the Consensus on Exercise Reporting Template (CERT): Explanation and Elaboration Statement (<a href="https://bjsm.bmj.com/content/50/23/1428" target="_blank">bjsm.bmj.com/content/50/23/1428</a><a href="./references#CD014816-bbs2-0101" title="SladeS , DionneCE , UnderwoodM , BuchbinderR . Consensus on Exercise Reporting Template (CERT): explanation and elaboration statement. British Journal of Sports Medicine2016;50:1428-37.">Slade 2016</a>). </p> </li> <li> <p>Outcomes: major and minor outcomes specified and collected, and time points reported.</p> </li> <li> <p>Characteristics of the design of the trial as outlined in the <a href="#CD014816-sec-0032">Assessment of risk of bias in included studies</a> section. </p> </li> <li> <p>Notes: funding for trial, and notable declarations of interest of trial authors.</p> </li> </ol> </p> <p>Two review authors (SF, MC) independently extracted outcome data from included studies. We extracted the number of events and number of participants per treatment group for dichotomous outcomes, and means, SDs, and number of participants per treatment group for continuous outcomes. We noted in the <a href="./references#CD014816-sec-0145" title="">Characteristics of included studies</a> table if outcome data were not reported in a usable way and when data were transformed or estimated from a graph. We resolved disagreements by consensus or by involving a third review author (SO). One review author (SF) transferred data into RevMan Web. We double‐checked that data were entered correctly by comparing the data presented in the systematic review with the study reports. </p> <p>If more than one measure for an outcome was reported, we extracted only the one reported by most of the included trials (i.e. FSS for fatigue). In the event of multiple outcome reporting, if both final values and change from baseline values were reported for the same outcome, we extracted the final values, as reported in the publication. Similarly, if data were analysed based on an intention‐to‐treat (ITT) sample and another sample (e.g. per‐protocol, as‐treated), we extracted the ITT sample for both outcomes assessing benefits and outcomes assessing harms. If data for more than one time point were provided, we used the 'end of structured exercise intervention' time point for the meta‐analysis. </p> </section> <section id="CD014816-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SF, MC) independently assessed risk of bias using the RoB 1 tool for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 8; <a href="./references#CD014816-bbs2-0065" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We resolved any disagreements by discussion or by involving other review authors (SO, DG). We assessed the risk of bias according to the following domains. </p> <p> <ol id="CD014816-list-0006"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias (potential threats to validity such as unit of analysis issues, inappropriate or unequal application of co‐intervention across treatment groups).  </p> </li> </ol> </p> <p>We graded each potential source of bias as high, low, or unclear risk, and provided a quote from the study report together with a justification for our judgement in the risk of bias table. We summarised the risk of bias judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes where necessary (e.g. for unblinded outcome assessment, risk of bias for objective outcome measures which may be different from a participant‐reported scale). In addition, we considered the impact of missing data by key outcomes. </p> <p>Where information on risk of bias related to unpublished data or correspondence with a trialist, we noted this in the risk of bias table. </p> <p>When considering treatment effects, we considered the risk of bias for the studies that contributed to that outcome. </p> <p>We presented the figures generated by the RoB 1 tool to provide summary assessments of the risk of bias. </p> <section id="CD014816-sec-0033"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol (<a href="./references#CD014816-bbs2-0108" title="FradeS , O'NeillS , GreeneD , CameronM . Exercise as adjunctive therapy for systemic lupus erythematosus. Cochrane Database of Systematic Reviews2021, Issue 10. Art. No: CD014816. [DOI: 10.1002/14651858.CD014816]">Frade 2021</a>), and reported any deviations from it in the <a href="#CD014816-sec-0143">Differences between protocol and review</a> section. </p> </section> </section> <section id="CD014816-sec-0034"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as RRs when the outcome was a rare event (approximately less than 10%), with 95% CIs. We analysed continuous data as MD (if studies use the same scale) or SMD (if studies use different scales) with 95% CIs. We entered data presented as a scale with a consistent direction of effect across studies. </p> <p>When studies used different scales to measure the same conceptual outcome (e.g. disability), we calculated SMDs instead, with corresponding 95% CIs. We back‐translated SMDs to a typical scale (e.g. 0 to 10 for pain) by multiplying the SMD by a typical among‐person SD (e.g. the SD of the control group at baseline from the most representative trial) as recommended in <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014816-bbs2-0066" title="HigginsJP , LiT , DeeksJJ . Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Higgins 2020a</a>). </p> <p>We assumed a minimal clinically important difference (MCID) of 1.5 points in a 10‐point Likert scale for pain; and 10 points on a 100‐point Likert scale for function or disability into the calculator. Using a cross‐sectional approach (<a href="./references#CD014816-bbs2-0061" title="GoligherEC , PouchotJ , BrantR , KheraniRB , Aviña-ZubietaJA , LacailleD , et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. Journal of Rheumatology2008;35:635-42.">Goligher 2008</a>) derived 5.9 points as the MCID for the FACIT‐Fatigue scale in people with SLE. The MCID for the FSS has been reported as a decrease of 1 point on the 7‐point scale (<a href="./references#CD014816-bbs2-0084" title="NordinA , TaftC , Lundgren-NilssonA , DenckerA . Minimal important differences for fatigue patient reported outcome measures – a systematic review. BMC Medical Research Methodology2016;16(62):1-16.">Nordin 2016</a>). The MCID for LupusQOL is estimated using an anchor‐based approach as mean changes in LupusQOL domains when minimal change (deterioration = −3 or −2 points; improvement = 2 or 3 points) (<a href="./references#CD014816-bbs2-0078" title="McElhoneK , AbbottJ , SuttonC , MullenM , LanyonP , RahmanA , et al. Sensitivity to change and minimal important differences of the LupusQoL in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2016;68:1505-13.">McElhone 2016</a>). SF‐36 score can be expressed in two subscores according to the domains they explore: a PCS and an MCS. We considered 3.74 for PCS and 1.7 for MCS as minimal important differences (<a href="./references#CD014816-bbs2-0072" title="LeungYY , ZhuTY , TamLS , KunEW , LiEK . Minimal important difference and responsiveness to change of the SF-36 in patients with psoriatic arthritis receiving tumor necrosis factor-alpha blockers. Journal of Rheumatology2011;38(9):2077-9.">Leung 2011</a>). For measures with no previously reported clinically important threshold, we used the SMD interpretation where values greater than 0.8 were considered clinically significant (large effect). A change of 4 points on the SLEDAI scale is considered the MCID; however, this has not yet been well established (<a href="./references#CD014816-bbs2-0048" title="BrunnerHI , HigginsGC , Klein-GitelmanMS . Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus. Arthritis Care &amp; Research (Hoboken)2010;62(7):950-9.">Brunner 2010</a>). </p> <p>For dichotomous outcomes, we calculated the absolute percent change from the difference in the risks between the intervention and control groups using GRADEpro GDT and expressed as a percentage (<a href="./references#CD014816-bbs2-0062" title="GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available from www.gradepro.org.">GRADEpro GDT</a>). </p> <p>For continuous outcomes, we calculated the absolute percent change by dividing the MD by the scale of the measure. </p> </section> <section id="CD014816-sec-0035"> <h4 class="title">Unit of analysis issues</h4> <p>Where a single trial reported multiple trial arms, we included only the relevant arms. If two comparisons (e.g. exercise programme 1 and exercise programme 2 versus placebo) were combined in the same meta‐analysis, we combined the two exercise groups into one intervention to avoid double‐counting. We listed all treatment arms in the <a href="./references#CD014816-sec-0145" title="">Characteristics of included studies</a> table, even if they were not used in the review. </p> <p>We analysed non‐standard designs (i.e. cluster‐RCTs and crossover RCTs) using methods appropriate to the design as suggested in Sections 23.1.4, 23.1.5, and 23.2.5 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014816-bbs2-0067" title="HigginsJP , EldridgeS , LiT . Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Higgins 2020b</a>). </p> </section> <section id="CD014816-sec-0036"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors to verify key study characteristics and obtain missing numerical outcome data where possible (e.g. when data were not available for all participants). Where this was not possible, and the missing data were thought to introduce serious bias, we explored the impact of including such studies in the overall assessment of results using a sensitivity analysis. We described any assumptions and imputations to handle missing data and explored the effect of imputation using sensitivity analyses. </p> <p>For dichotomous outcomes (e.g. number of withdrawals due to adverse events), we calculated the withdrawal rate using the number of participants randomised in the group as the denominator. </p> <p>For continuous outcomes (e.g. mean change in pain score), we calculated the MD or SMD based on the number of participants analysed at that time point. If the number of participants analysed was not presented for each time point, we used the number of randomised participants in each group at baseline. </p> <p>Where possible, we computed missing SDs from other statistics such as standard errors, CIs, or P values, according to the methods recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 10; <a href="./references#CD014816-bbs2-0053" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Deeks 2020</a>). If SDs could not be calculated, we imputed them (e.g. from other studies in the meta‐analysis) (<a href="./references#CD014816-bbs2-0053" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Deeks 2020</a>). </p> </section> <section id="CD014816-sec-0037"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical and methodological diversity in terms of participants, interventions, outcomes, and study characteristics for the included studies to determine whether a meta‐analysis was appropriate. This was conducted by observing these data from the data extraction tables. We assessed statistical heterogeneity by visual inspection of the forest plot to assess obvious differences in results between the studies, and using the I² and Chi² statistical tests. </p> <p>As recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 10; <a href="./references#CD014816-bbs2-0053" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Deeks 2020</a>), the interpretation of an I² value of 0% to 40% might 'not be important'; 30% to 60% may represent 'moderate' heterogeneity; 50% to 90% may represent 'substantial' heterogeneity; and 75% to 100% represents 'considerable' heterogeneity. We kept in mind that the importance of the I² statistic depends on: magnitude and direction of effects and strength of evidence for heterogeneity. </p> <p>The Chi² test was interpreted where a P ≤ 0.10 indicated evidence of statistical heterogeneity.</p> <p>If we identified substantial heterogeneity, we reported it and investigated possible causes by following the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 10; <a href="./references#CD014816-bbs2-0053" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Deeks 2020</a>). </p> </section> <section id="CD014816-sec-0038"> <h4 class="title">Assessment of reporting biases</h4> <p>We created and examined a funnel plot to explore possible small‐study biases. In interpreting funnel plots, we examined the different possible reasons for funnel plot asymmetry as outlined in Chapter 13 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and related this to the results of the review (<a href="./references#CD014816-bbs2-0086" title="PageMJ , HigginsJP , SterneJA . Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Page 2020</a>). If we were able to pool more than 10 trials, we undertook formal statistical tests to investigate funnel plot asymmetry, and followed the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 13; <a href="./references#CD014816-bbs2-0086" title="PageMJ , HigginsJP , SterneJA . Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Page 2020</a>). </p> <p>To assess outcome reporting bias, we checked trial protocols against published reports. For studies published after 1 July 2005, we screened the Clinical Trial Register at the International Clinical Trials Registry Platform of the WHO (<a href="http://apps.who.int/trialssearch" target="_blank">apps.who.int/trialssearch</a>) for the a priori trial protocol. We evaluated whether selective reporting of outcomes was present. </p> </section> <section id="CD014816-sec-0039"> <h4 class="title">Data synthesis</h4> <p>We undertook meta‐analyses only where this was meaningful (i.e. if the treatments, participants, and the underlying clinical question were similar enough for pooling to make sense). We anticipated that the following comparisons would be used. </p> <p> <ol id="CD014816-list-0007"> <li> <p>Exercise plus usual pharmacological care versus placebo</p> </li> <li> <p>Exercise plus usual pharmacological care versus usual pharmacological care</p> </li> <li> <p>Exercise plus usual pharmacological care versus another intervention (e.g. education about exercise, counselling about exercise, relaxation exercises). </p> </li> </ol> </p> <p>We used a random‐effects model. We analysed all types of exercise interventions in the pooled primary analysis. </p> </section> <section id="CD014816-sec-0040"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If there were sufficient data, we would have conducted subgroup analyses for fatigue according to components of exercise. We had restricted subgroup analyses to the primary time point. We anticipate that the following exercise components may be useful. </p> <p> <ol id="CD014816-list-0008"> <li> <p>Types of exercise (aerobic, resistance, relaxing/range of motion)</p> </li> <li> <p>Exercise setting (supervised or unsupervised/home‐based exercise)</p> </li> </ol> </p> <p>The reason for including components of an exercise programme in the subgroup analyses is to be able to identify an optimal exercise for improving fatigue in people with SLE, which has been implicated for future research in previous reviews (<a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a>; <a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>). This information will be critical for informing both practitioners and patients regarding the most appropriate exercise prescription. Pooled evidence from three studies showed that aerobic exercise training significantly decreased fatigue severity compared to relaxing exercise (<a href="./references#CD014816-bbs2-0051" title="CarvalhoMR , SatoEI , TebexreniAS , HeidecherRT , SchenkmanS , NetoTL . Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis and Rheumatism2005;53(6):838-44.">Carvalho 2005</a>; <a href="./references#CD014816-bbs2-0093" title="Ramsey-GoldmanR , SchillingEM , DunlopD , LangmanC , GreenlandP , ThomasRJ , et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2000;13(5):262-9.">Ramsey‐Goldman 2000</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>), and supervised exercise reduced fatigue symptoms to a significantly greater extent than home‐based exercise (<a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>). </p> <p>We would have used the formal test for subgroup interactions in Review Manager Web (<a href="./references#CD014816-bbs2-0094" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>), and use caution in the interpretation of subgroup analyses as advised in Section 9.6 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014816-bbs2-0079" title="McKenzieJE , BrennanSE , RyanRE , ThomsonHJ , JohnstonRV . Chapter 9: Summarizing study characteristics and preparing for synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">McKenzie 2021</a>). We would compare the magnitude of the effects between the subgroups by assessing the overlap of the CIs of the summary estimate. Non‐overlap of the CIs indicates statistical significance. </p> </section> <section id="CD014816-sec-0041"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out the following sensitivity analyses to investigate the robustness of the treatment effect on fatigue. </p> <p> <ol id="CD014816-list-0009"> <li> <p>Impact of including studies with high or unclear risk of selection, detection, and attrition biases </p> </li> <li> <p>Impact of including studies with imputed data</p> </li> </ol> </p> </section> <section id="CD014816-sec-0042"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>At least two review authors (SF, MC) assessed the certainty of the supporting evidence behind each estimate of treatment effect using the GRADE approach for the major outcomes: fatigue, functional capacity, disease activity, quality of life, pain, serious adverse events, and withdrawals due to any reason. We used methods and recommendations described in <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 14; <a href="./references#CD014816-bbs2-0097" title="SchünemannHJ , VistGE , HigginsJP , SantessoN , DeeksJJ , GlasziouP , et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Schünemann 2020a</a>). We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of a body of evidence as it relates to the studies that contributed data to the meta‐analyses for the prespecified outcomes, and reported the certainty of evidence as high, moderate, low, or very low. </p> <p>We used <a href="./references#CD014816-bbs2-0062" title="GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available from www.gradepro.org.">GRADEpro GDT</a> software to prepare and display the summary of findings tables. We justified all decisions to downgrade the certainty of evidence for each outcome using footnotes, and we made comments to aid the reader's understanding of the review where necessary. We provided the number needed to treat for an additional beneficial outcome (NNTB) or harmful outcome (NNTH) and absolute percent change in the 'Comments' column of the summary of findings table. </p> <p>We preselected the following important outcomes for inclusion in the summary of findings tables.  </p> <p> <ol id="CD014816-list-0010"> <li> <p>Mean or mean change in fatigue assessed by FSS, FACIT‐F, or other relevant fatigue scales such as POMS. </p> </li> <li> <p>Mean or mean change in functional capacity measured by the PCS of the SF‐36, or physical function subscale of the SF‐36, or other physical function or disability scales. </p> </li> <li> <p>Mean or mean change in SLE scores on validated disease activity indices such as the SLEDAI, SELENA‐SLEDAI, modified SELENA‐SLEDAI SFI; BILAG; or other similar validated indices. </p> </li> <li> <p>Mean or mean change in quality of life assessed by the MCS of the SF‐36, or similar assessments such as LupusQOL. </p> </li> <li> <p>Mean or mean change in pain measured by VAS for pain, NRS for pain, or the bodily pain subscale of the SF‐36. </p> </li> <li> <p>SAEs, number of SAEs, or number of participants with one or more SAE.</p> </li> <li> <p>Withdrawals due to any reason</p> </li> </ol> </p> <p>We produced three summary of findings tables for the following comparisons.</p> <p> <ol id="CD014816-list-0011"> <li> <p>Exercise plus usual pharmacological care versus placebo plus usual pharmacological care. </p> </li> <li> <p>Exercise plus usual pharmacological care versus usual pharmacological care.</p> </li> <li> <p>Exercise plus usual pharmacological care versus another intervention (e.g. education about exercise, counselling about exercise, relaxation exercises) plus usual pharmacological care. </p> </li> </ol> </p> <p>For efficacy outcomes, we extracted data at the end of intervention time point. We extracted adverse event outcomes at the last time point (i.e. proportion who had an event by the end of the trial). </p> <section id="CD014816-sec-0043"> <h5 class="title">Interpreting results and reaching conclusions</h5> <p>We followed the guidelines in <i>Cochrane Handbook for Systematic Reviews of Intervention</i>s (Chapter 15; <a href="./references#CD014816-bbs2-0098" title="SchünemannHJ , VistGE , HigginsJP , SantessoN , DeeksJJ , GlasziouP , et al, on behalf of the Cochrane GRADEing Methods Group. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Schünemann 2022b</a>), for interpreting results, and were aware of distinguishing a lack of evidence of effect from a lack of effect. We based our conclusions only on findings from the quantitative or narrative synthesis, according to Synthesis Without Meta‐analysis (SWiM) reporting guideline of included studies for this review (<a href="./references#CD014816-bbs2-0050" title="CampbellM , McKenzieJE , SowdenA , KatikireddiSV , BrennanSE , EllisS , et al. Synthesis Without Meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ2020;368:1-6.">Campbell 2020</a>). Our implications for research suggested priorities for future research and outlined what the remaining uncertainties are in the area. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD014816-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD014816-sec-0044"></div> <section id="CD014816-sec-0045"> <h3 class="title">Description of studies</h3> <p>Details of the included studies are listed in <a href="#CD014816-tbl-0004">Table 1</a> and the <a href="./references#CD014816-sec-0145" title="">Characteristics of included studies</a> table. </p> <div class="table" id="CD014816-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of interventions in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b> Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of usual care</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of exercise group  </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of control group</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Trials with a placebo plus usual care control</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group included:</p> <p><b>Exercise group (n = 11)</b> </p> <p> <ol id="CD014816-list-0012"> <li> <p>Mean lupus treatment prednisone (change in daily dose) 5.3 (SD 5.3) mg</p> </li> <li> <p>Mean lupus treatment prednisone (change in cumulative dose 6 months) 896 (SD 337) months </p> </li> <li> <p>Mean lupus treatment time of prednisone use: 13.3 (SD 5.4) years</p> </li> </ol> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0013"> <li> <p>hydroxychloroquine: 8 (73%)</p> </li> <li> <p>immunosuppressants: 10 (90%)</p> </li> </ol> </p> <p><b>Control group (n = 10)</b> </p> <p> <ol id="CD014816-list-0014"> <li> <p>Mean lupus treatment prednisone (change in daily dose) 5.0 (SD 1.9) mg</p> </li> <li> <p>Mean lupus treatment prednisone (change in cumulative dose 6 months) 963 (SD 950) months </p> </li> <li> <p>Mean lupus treatment time of prednisone use: 14.8 (SD 7.1) years</p> </li> </ol> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0015"> <li> <p>hydroxychloroquine: 7 (70%)</p> </li> <li> <p>immunosuppressants: 7 (70%)</p> </li> </ol> </p> <p>No further information about their usual care was reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and whole body vibration exercise 2 times/week (24 hours between sessions) for 12 weeks. WBVE is a subgroup of resistance training, better classified as muscle activation or neuromuscular training complementary to resistance training. The participants were positioned on the vibrating platform (turned on) with 130° of knee flexion. It is unclear whether this was supervised. </p> <p><b>Intensity of exercise</b> </p> <p><b>Week 1–4:</b> 10 bouts of 30 s, frequency 30 Hz, D 1.23 mm, and a peak of 2.22 g.  </p> <p><b>Week 5–8:</b> 10 bouts of 60 s, frequency 40 Hz, D 0.95 mm, and a peak of 3.06 g.  </p> <p><b>Week 9–12:</b> 10 bouts of 60 s, frequency 50 Hz, D 0.88 mm, and a peak of 4.40 g. </p> <p><b>Time of exercise session</b> </p> <p><b>Week 1–4:</b> 2‐min warm‐up, 5‐min WBVE. </p> <p><b>Week 5–12:</b> 2‐min warm‐up, 10‐min WBVE. </p> <p>3 participants dropped out; 1 withdrew before 6‐week analysis due to low back pain ("not<br/>related directly with the intervention"), and 2 withdrew before 12‐week analysis for personal reasons. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and isometry<sup>a</sup> (they did not receive any vibration), 2 times/week (24 hours between sessions) for 12 weeks.  </p> <p><sup>a</sup>Participants were requested to maintain stance with 130° of knee flexion on the same vibrating platform (vibration turned off). It is unclear whether this was supervised. </p> <p><b>Intensity of exercise:</b> light‐to‐moderate intensity, warm‐up performed in the same way as in WBVE group. Cycles, working, and rest times corresponded to the weeks, consistent with the WBVE group, but without vibration. </p> <p><b>Time of exercise session</b> </p> <p><b>Week 1–4:</b> 2‐min warm‐up, 5‐min stood on platform.  </p> <p><b>Week 5–12:</b> 2‐min warm‐up, 10‐min stood on platform. </p> <p>1 participant withdrew before the 6‐week analysis for personal reasons. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p>Trials with a <b>usual care alone control </b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care was reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus an exercise programme that was supervised or performed independently at home. All participants were asked to perform 3 hours of exercise per week for 12 weeks. At start of programme, the home‐training group and supervised training group participated in a multidisciplinary information session about the benefits of exercise in SLE, during which practical information was also delivered. Participants in both groups were asked to record their number of training hours. </p> <p><b>Exercise group 1: home training</b> </p> <p>Participants performed endurance exercise (walking or bicycle) and strengthening exercises (elastic band or weights for upper and lower limbs), at home unsupervised. The targeted intensity was moderate (60–80% of theoretical maximal HR). The modified Borg scale was used to determine participant's perception of exertion at PWC75%. </p> <p><b>Exercise group 2: supervised training</b> </p> <p>Participants performed the same exercise programme; endurance exercise (walking or bicycle) and strengthening exercises (elastic band or weights for upper and lower limbs), in the hospital‐based revalidation centre under the supervision of the multidisciplinary team. Targeted intensity was moderate (60–80% of theoretical maximal HR). The modified Borg scale was used to determine participant's perception of exertion at PWC75%. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants did not attend the information session and were asked not to change their level of physical activity. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 17)</b> </p> <p> <ol id="CD014816-list-0016"> <li> <p>Mean cumulative prednisone dose: 31.2 (SD 33.7) g</p> </li> <li> <p>Mean prednisone dose: 11.5 (SD 12.8) mg</p> </li> <li> <p>Number of participants on the following medications:</p> <ol id="CD014816-list-0017"> <li> <p>prednisone: 12 (70.6%)</p> </li> <li> <p>azathioprine: 9 (52.9%)</p> </li> <li> <p>chloroquine: 11 (64.7%)</p> </li> <li> <p>methotrexate: 1 (5.9%)</p> </li> <li> <p>mycophenolate mofetil: 5 (29.4%)</p> </li> <li> <p>cyclophosphamide: 2 (11.8%)</p> </li> </ol> </li> </ol> </p> <p><b>Control group (n = 16)</b> </p> <p> <ol id="CD014816-list-0018"> <li> <p>Mean cumulative prednisone dose: 21.8 (SD 15.6) g</p> </li> <li> <p>Mean prednisone dose: 7.2 (SD 8.6) mg</p> </li> <li> <p>Number of participants on the following medications:</p> <ol id="CD014816-list-0019"> <li> <p>prednisone: 10 (62.5%)</p> </li> <li> <p>azathioprine: 7 (43.7%)</p> </li> <li> <p>chloroquine: 10 (62.5%)</p> </li> <li> <p>methotrexate: 4 (25.0%)</p> </li> <li> <p>mycophenolate mofetil: 2 (12.5%)</p> </li> <li> <p>cyclophosphamide: 0 (0%)</p> </li> </ol> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a combined resistance and cardiovascular supervised exercise training programme for 12 weeks. Participants performed approximately 30 min of cardiovascular endurance exercise and strength exercise, 2 times/week. Intensity was set at the HR corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants remained physically inactive.</p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 9)</b> </p> <p> <ol id="CD014816-list-0020"> <li> <p>Mean cumulative glucocorticoid dose: 42.1 (SD 31.8) g/kg</p> </li> <li> <p>Mean current glucocorticoid dose: 1.7 (SD 3.5) mg</p> </li> <li> <p>Number participants on the following medications:</p> <ol id="CD014816-list-0021"> <li> <p>Glucocorticoid: 2 (22%)</p> </li> <li> <p>Hydroxychloroquine: 5 (56%)</p> </li> <li> <p>Methotrexate: 2 (22%)</p> </li> <li> <p>Azathioprine: 5 (56%)</p> </li> <li> <p>Mycophenolate: 1 (11%)</p> </li> <li> <p>Cyclophosphamide: 0 (0%)</p> </li> <li> <p>Oral contraceptive: 6 (67%)</p> </li> </ol> </li> </ol> </p> <p><b>Control group (n = 10)</b> </p> <p> <ol id="CD014816-list-0022"> <li> <p>Mean cumulative glucocorticoid dose: 32.4 (SD 19.1) g/kg</p> </li> <li> <p>Mean current glucocorticoid dose: 2.0 (SD 4.2) mg</p> </li> <li> <p>Number of participants on the following medications:</p> <ol id="CD014816-list-0023"> <li> <p>glucocorticoid: 2 (20%)</p> </li> <li> <p>hydroxychloroquine: 7 (70%)</p> </li> <li> <p>methotrexate: 2 (20%)</p> </li> <li> <p>azathioprine: 4 (40%)</p> </li> <li> <p>mycophenolate: 2 (20%)</p> </li> <li> <p>cyclophosphamide: 0 (0%)</p> </li> <li> <p>oral contraceptive: 6 (60%)</p> </li> </ol> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a supervised aerobic exercise programme in an intrahospital gymnasium for 12 weeks. Participants performed 40–60 min of aerobic exercise (5‐min warm‐up, followed by 30–50 min of treadmill walking, and 5‐min cool‐down), 2 times/week. Walking duration was gradually increased every 4 weeks, from 30 min to 50 min. Intensity was set at the HR corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants were strongly instructed to maintain their usual living activities throughout the study. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (N=18)</b> </p> <p> <ol id="CD014816-list-0024"> <li> <p>Median prednisolone: 3.1 (quartiles Q1–Q3 0–5) mg</p> </li> <li> <p>Number of participants who are on:</p> <ol id="CD014816-list-0025"> <li> <p>beta‐blockers: 3</p> </li> </ol> </li> </ol> </p> <p><b>Control group (n = 17)</b> </p> <p> <ol id="CD014816-list-0026"> <li> <p>Median prednisolone: 1.3 (quartiles Q1–Q3 0–5) mg</p> </li> <li> <p>Number of participants who are on:</p> <ol id="CD014816-list-0027"> <li> <p>beta‐blockers: 1</p> </li> </ol> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a supervised combined aerobic and resistance exercise programme for 12 weeks. Participants performed 60‐min exercise programme 2 times/week. Participants were also followed up with exercise for 12 months; however the level of exercise supervision decreased over time. Programme consisted of 3 phases </p> <p><b>Phase 1 (0–3 months)</b> </p> <p>Consisted mainly aerobic exercise (about 20 min) and muscle strength and endurance exercise (about 15 min). Intensity was set as high (65–80% of maximum HR or a rating of 13–16 out of 20 on the BORG rating of perceived exertion scale) </p> <p><i>Note: participants could alternatively choose any preferred self‐managed high‐intensity physical activity, as some participants lived far from the hospital.</i> </p> <p>Phase also included a 1‐hour education session held by a rheumatologist and another by a physiotherapist to educate them on: their disease, the risk for cardiovascular disease, the treatment of the disease, and the importance of, and how to perform, physical activity and exercise. It also included education on how to use a HR monitor, how to assess intensity according to RPE scale, and how to document physical activity with modes, frequency, durations, and intensities. This phase also included supervised exercise training, 30 min of individual coaching of physical activity at 6 and 12 weeks, loan and use of HR monitor, and use of a physical activity diary. </p> <p><b>Phase 2 (4–9 months)</b> </p> <p>During this period, the physical activity was self‐managed with the help of videotapes or sound cassettes (or both) from the high‐intensity aerobic group exercise programme performed during the first 3 months. As an alternative, any physical activity at high intensity could be chosen. </p> <p>This phase included: 30‐min of individual coaching of physical activity at 6 and 9 months, use of HR monitor, and use of the physical activity diary. Participants also received 10 min of telephone support which reduced towards the end of the 12 months. </p> <p><b>Phase 3 (9–12 months)</b> </p> <p>This phase included: use of the HR monitor, and use of physical activity diary.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants were asked not to change their physical activity lifestyle during the study period. They were not given any specific information related to the study. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a combined aerobic and anaerobic supervised exercise programme for 8 weeks. Participants performed 60 min of exercise (commencing with 40 min in week 1), 3 times/week. The exercise programme included a 10‐min warm‐up, 10‐min of running on a treadmill, and 10 min of cycling, both at an intensity of 50–60% of their VO<sub>2max</sub>, followed by 60 min of Pilates training uses bodyweight resistance, and a 10‐min cool‐down. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about the control group reported. Assumed that control group continued with their usual care alone. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a partially supervised aerobic exercise programme for 12 weeks. Participants were encouraged to perform 30–50 min of aerobic exercise (consisting of walking, cycling, or swimming) 3 times/week. The target intensity was moderate; HR corresponding to 60% of peak oxygen consumption. Participants were seen by an exercise professional every 2 weeks for a supervised exercise session.  </p> <p>Comparator group included participants who received usual care plus a different non‐pharmacological intervention (relaxation practice). Participants listened to a relaxation audiotape in a quiet, warm, and darkened room for 30 min, 3 times/week. Participants were seen by an exercise professional every 2 weeks for a supervised relaxation session. This intervention is included as a control group comparator in the description below under 'trials with another non‐pharmacological intervention plus usual care control.' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants were asked to continue with their normal daily activity pattern and specifically asked to avoid doing any extra physical activities. They were reviewed at follow‐up but not seen at any other times. </p> <p>No further information reported.</p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p>Trials with <b>another non‐pharmacological intervention plus usual care control</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no clear information about their usual care, including the medications taken by participants. However, authors reported that there were changes in the use of medication to control disease activity in the control group, but without significant differences amongst groups (P = 0.34). It is also reported that the 2 exercise intervention groups (group 1: cardiovascular training, group 2: resistance training) had no changes in the use of medications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants in the 2 exercise groups received their usual care plus they performed 1 type of exercise, described below, 3 times/week, for 50 min for 12 weeks. Both exercise groups were supervised by trained professional in the Rheumatology Services at the Interlagos Specialty Outpatient Clinic. </p> <p><b>Exercise group 1: cardiovascular training group</b> </p> <p>Participants received walking and bicycle ergometer interventions (Model CLB 10 Classic, Caloi, São Paulo,<br/>Brazil) consisting of a 10‐min warm‐up, 30 min of exercise at target HR, and 10‐min cool‐down. The targeted intensity was moderate (65–75% of maximum HR according to the ACSM guidelines), determined by the HR reserve. </p> <p><b>Exercise group 2: resistance training group</b> </p> <p>Participants received a resistance training programme comprised of 8 exercises; holds (crucifix) with free weights, extension‐machine exercises, rowing exercise with an elastic band, knee flexion with ankle weights, 2‐arm biceps curls, adduction exercises with an elastic band, French curls, and abdominal exercises. The training involved small and large muscle group exercises. Participants performed 3 sets of 15 repetitions with rest intervals of 1 min between sets. The targeted intensity was moderate (65–75% of 1 repetition maximum according to the ACSM guidelines). To establish the training intensity for each participant, their 1 repetition maximum for each exercise was determined. Training intensity changed over time as the participants progressed. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and information about the disease, but no exercise intervention. They were informed that they would receive the intervention after the study was finished, and they would be invited to participate in the intervention that proved the most effective. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 16)</b> </p> <p> <ol id="CD014816-list-0028"> <li> <p>% of participants taking steroids: 38%</p> </li> <li> <p>% of participants taking NSAIDs: 31%</p> </li> </ol> </p> <p><b>Control group (n = 18)</b> </p> <p> <ol id="CD014816-list-0029"> <li> <p>% of participants taking steroids: 61%</p> </li> <li> <p>% of participants taking NSAIDs: 67%</p> </li> </ol> </p> <p>No further information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus unsupervised home aerobic exercise for 12 weeks. Participants performed 30 min of aerobic exercise (cycling on a stationary bike that was set up in their home) 3 times/week. The target intensity was moderate to high (60–80% of maximum HR achieved on the exercise tolerance test).  </p> <p>A physiotherapist contacted the participant once a week to update their exercise log, report any symptoms, and ask about their perceived fatigue. Pulse oximeters were provided to help participants monitor their heart rates and as a compliance‐enhancing strategy. The physiotherapist instructed the participant at home when setting up the bike, and made a second visit 2–3 weeks later at an exercise session to check the participants' ability to follow the regimen correctly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus they were contacted by the research team oncer per week as an attention control group. They were also asked to fill out questionnaires, and were encouraged to maintain their current level of activity during the 12‐week programme. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 18)</b> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0030"> <li> <p>prednisone: 10 (55%)</p> <ol id="CD014816-list-0031"> <li> <p>median current prednisone dose: 2 (minimum–maximum 0–40) mg</p> </li> </ol> </li> <li> <p>antimalarials: 13 (72.2%)</p> </li> <li> <p>immunosuppressives: 8 (44.4%) </p> </li> <li> <p>antihypertensives: 3 (16.7%) </p> </li> <li> <p>aspirin: 2 (11.1%) </p> </li> <li> <p>contraceptives: 3 (16.7%)</p> </li> </ol> </p> <p><b>Control group (n = 20)</b> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0032"> <li> <p>prednisone: 13 (65%) </p> <ol id="CD014816-list-0033"> <li> <p>median of current prednisone dose: 5 (minimum–maximum 0–30)</p> </li> </ol> </li> <li> <p>antimalarials: 16 (80%) </p> </li> <li> <p>immunosuppressives: 14 (70%)</p> </li> <li> <p>antihypertensives: 7 (35%)</p> </li> <li> <p>aspirin: 3 (15%)</p> </li> <li> <p>contraceptive: 8 (40%)</p> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus an aerobic exercise programme for 16 weeks. Participants performed 60 min of outdoor walking (10‐min warm‐up, 40 min of walking, 10‐min cool‐down), 3 times/week. Target intensity set at a HR corresponding to the ventilatory 1 threshold obtained from ergospirometry and monitored by frequency meter. Participants met in the morning at a public park, supervised by a physical educator or physician. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and information about the disease, but no exercise intervention. They received clear instruction not to start any exercise programme for the next 16 weeks. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a home‐based exercise programme for 12 weeks. Participants performed approximately 40 min of combined aerobic and resistance exercise (3–5 min warm‐up, 30 min combined aerobic and resistance exercises, 5 min relaxation and stretching; the exercise programme comprised a 7‐ to 8‐min set of combined aerobic and resistance exercise such as high knees/shuffle runs/biceps curls etc., and participants had to perform 4 sets). The target intensity was moderate, determined by the HR reserve. The research team member contacted participants periodically by telephone or text messages to ensure their compliance. Each week the participants reported their maximal HR after each exercise session using written logs. Instructed by an exercise physiologist/professional exercise instructor on the performance of aerobic exercise combined with resistance training and the skills of HR measurement at rest and after exercise. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and information about the disease, but no exercise intervention. They were to maintain their usual lifestyle.  </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 32)</b> </p> <p>Number (%) of participants on the following medications: </p> <p> <ol id="CD014816-list-0034"> <li> <p>corticosteroids: 20 (54.1%) *<i>note that the percentage seems to be reported incorrectly in the study.</i> </p> <ol id="CD014816-list-0035"> <li> <p>Mean prednisolone dosage: 4.63 (SD 5.55) mg</p> </li> </ol> </li> <li> <p>hydroxychloroquine: 26 (81.3%)</p> </li> <li> <p>immunosuppressive agents: 15 (46.9%)</p> </li> <li> <p>biological agents: 1 (3.1%)</p> </li> </ol> </p> <p><b>Control group (n = 30)</b> </p> <p>Number (%) of participants on the following medications: </p> <p> <ol id="CD014816-list-0036"> <li> <p>corticosteroids: 17 (46%) *<i>note that the percentage seems to be reported incorrectly in the study.</i> </p> <ol id="CD014816-list-0037"> <li> <p>Mean prednisolone dosage: 4.97 (SD 5.80) mg</p> </li> </ol> </li> <li> <p>hydroxychloroquine: 25 (83.3%) </p> </li> <li> <p>immunosuppressive agents: 15 (50%)</p> </li> <li> <p>biological agents: 3 (10%)</p> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus an upper limb combined resistance and stretching exercise programme for 12 weeks, and were followed up at 24 weeks. Participants performed 30 min of upper limb exercises (9 strengthening and stretching exercises for the upper extremities with a stick, 10 strengthening and stretching exercises for the fingers, and 11 strengthening exercises against resistance with therapeutic putty) daily. The initial intensity was set at a moderate level, and the programme was reassessed using a modified Borg Scale (a tool to measure a persons' perception of their effort and exertion, breathlessness, and fatigue during physical work) to maintain the same intensity, in every face‐to‐face session with the hand therapist at 0, 3, 6, and 9 weeks. It is unclear whether this programme was supervised. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus they 4 sessions of training in alternative methods of performing daily activities, use of aids, joint protection, and energy conservation, additionally to assessment at baseline, 6, 12, and 24 weeks, in order to keep them committed and motivated. All participants received the same training in alternative methods of performing daily activities, use of aids, joint protection and energy conservation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 14)</b> </p> <p>Number of participants on the following medications: </p> <p> <ol id="CD014816-list-0038"> <li> <p>prednisone: 10 (66.7%)</p> </li> <li> <p>prednisone ≥ 20 mg/day: 2 (12.3%) </p> </li> <li> <p>azathioprine: 8 (53.3%)</p> </li> <li> <p>chloroquine: 12 (80%)</p> </li> <li> <p>methotrexate: 1 (6.7%) </p> </li> <li> <p>mycophenolate mofetil: 4 (26.7%)</p> </li> <li> <p>cyclophosphamide: 1 (6.7%)</p> </li> <li> <p>medroxyprogesterone: 4 (26.7%)</p> </li> </ol> </p> <p><b>Control group (n = 10)</b> </p> <p>Number of participants on the following medications: </p> <p> <ol id="CD014816-list-0039"> <li> <p>prednisone: 8 (61.5%)</p> </li> <li> <p>prednisone ≥ 20 mg/day: 1 (7.1%)</p> </li> <li> <p>azathioprine: 5 (38.4%)</p> </li> <li> <p>chloroquine: 12 (92.3%) </p> </li> <li> <p>methotrexate: 3 (23.0%)</p> </li> <li> <p>mycophenolate mofetil: 2 (15.3%)</p> </li> <li> <p>cyclophosphamide: 0 (0%)</p> </li> <li> <p>medroxyprogesterone: 7 (53.8%)</p> </li> </ol> </p> <p>No further information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The participants received usual care plus a supervised combined resistance and aerobic exercise programme for 12 weeks. Participants performed approximately 80 min of exercise (5‐min treadmill warm‐up, 35–40 min of resistance training, 30 min of treadmill aerobic training, and 5 min of stretching). Resistance training included 7 exercises for the main muscle groups (e.g. bench press, leg press, leg extension); 2 sets of 15–20 repetition maximum for each exercise in week 1, and 4 sets of 8–12 repetitions maximum every week after that, 2 times/week. Intensity was set at a HR corresponding to the interval between Ventilatory anaerobic threshold and 10% below respiratory compensation point. All sessions were monitored by 1 fitness professional. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus information about their disease, but no exercise intervention. They were advised to remain physically inactive.  </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a partially supervised aerobic exercise programme for 12 weeks. Participants were encouraged to perform 30–50 min of aerobic exercise (consisting of walking, cycling, or swimming) 3 times/week. Target intensity was moderate; HR corresponding to 60% of peak oxygen consumption. Participants were seen by an exercise professional every 2 weeks for a supervised exercise session.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a different non‐pharmacological intervention (relaxation practice). Participants listened to a relaxation audiotape in a quiet, warm, and darkened room for 30 min, 3 times/week. Participants were seen by an exercise professional every 2 weeks for a supervised relaxation session. This intervention was included as a control group comparator in the description above under 'Trials with a usual care alone control.' </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; HR: heart rate; NSAID: non‐steroidal anti‐inflammatory drug; PWC75%: 75% of the predicted maximal heart rate; RPE: rating of perceived exertion; SD: standard deviation; SLE: systemic lupus erythematosus. </p> </div> </div> <section id="CD014816-sec-0046"> <h4 class="title">Results of the search</h4> <p>The search was conducted up to 30 March 2022. It yielded 1613 records across six databases (CENTRAL, MEDLINE, Embase, CINAHL, SPORTDiscus, and Web of Science). After removal of duplicates, 1089 records remained. Of these, we retrieved 41 for full‐text screening on the basis of title and abstract. We deemed 13 RCTs eligible for inclusion (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). We excluded 27 articles, one trial is awaiting classification (<a href="./references#CD014816-bbs2-0041" title="BoedeckerSC , PhilippiKF , NeubergerE , SchmidtS , PfirrmannD , HallerN , et al. Twelve-week internet-based individualized exercise program in adults with systemic lupus erythematosus: protocol for a randomized controlled trial. Journal of Medical Internet Research Protocols2020;9(11):1-11. ">Boedecker 2020</a>), and there are no ongoing studies. See <a href="#CD014816-fig-0001">Figure 1</a> for the PRISMA flow diagram of search results (<a href="./references#CD014816-bbs2-0087" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ2021;372:1-36.">Page 2021</a>). </p> </section> <section id="CD014816-sec-0047"> <h4 class="title">Included studies</h4> <section id="CD014816-sec-0048"> <h5 class="title">Study design and setting</h5> <p>Studies were conducted in Brazil (7/13, 53%), Europe (3/13, 23%), the US (1/13, 8%), the UK (1/13, 8%), and Iran (1/13, 8%), Six studies were two‐arm parallel RCTs (<a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>), two studies were two‐arm parallel quasi‐RCTS (<a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>), four studies were three‐arm parallel RCTs (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>), and one study was a three‐arm parallel quasi‐RCT (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>). </p> </section> <section id="CD014816-sec-0049"> <h5 class="title">Participants</h5> <p>There were a total of 540 participants with SLE who commenced the intervention, and 463 participants who completed the intervention (86%). There were 77 participants who dropped out of the studies (reasons reported in the <a href="./references#CD014816-sec-0145" title="">Characteristics of included studies</a> table). Across included trials the mean age of participants ranged from 21.5 to 53 years, and mean duration of disease from 2.5 to 21 years. Most studies diagnosed SLE using the ACR criteria for SLE. It is unclear whether included participants had comorbidities as this was not clearly reported in the included studies. Participants were on various pharmacological treatments including csDMARDs such as hydroxychloroquine, prednisolone or glucocorticoids, mycophenolate mofetil, methotrexate, azathioprine, and cyclophosphamide; bDMARDs such as rituximab or belimumab; and NSAIDs such as naproxen or celecoxib. See <a href="#CD014816-tbl-0004">Table 1</a>. </p> </section> <section id="CD014816-sec-0050"> <h5 class="title">Interventions and comparators</h5> <section id="CD014816-sec-0051"> <h6 class="title">Control group interventions</h6> <p>All 13 studies compared a type of exercise, or a combination of types of exercise, plus usual care, to a control group that received either one of the following. </p> <p> <ol id="CD014816-list-0040"> <li> <p>Placebo plus usual care<sup>a</sup> (<a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>).  </p> <ol id="CD014816-list-0041"> <li> <p>In this study, the exercise intervention included whole body vibration exercise where participants were asked to stand on a vibrating platform, and the placebo intervention also stood on a vibration platform, except the vibration was turned off. </p> </li> </ol> </li> <li> <p>Usual care alone<sup>a</sup> (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> </li> <li> <p>Another non‐pharmacological intervention plus usual care<sup>a</sup> (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Other non‐pharmacological interventions included: </p> <ol id="CD014816-list-0042"> <li> <p>participants received information about the disease, and were informed that they would receive the intervention after the study was finished, and they would be invited to participate in the intervention that proved the most effective (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>); </p> </li> <li> <p>participants were contacted by the research team once per week. They were also asked to fill out questionnaires, and were encouraged to maintain their current level of activity (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>); </p> </li> <li> <p>participants received information about the disease. They received clear instruction not to start any exercise for the next 16 weeks (<a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>); </p> </li> <li> <p>participants received information about the disease. They were asked to maintain their usual lifestyle (<a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>); </p> </li> <li> <p>participants had four sessions of training in alternative methods of performing daily activities, use of aids, joint protection, and energy conservation (<a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>); </p> </li> <li> <p>participants received information about their disease. They were advised to remain physically inactive (<a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>); </p> </li> <li> <p>participants listened to a relaxation audio tape in a quiet, warm, and darkened room for 30 minutes, three times per week. Participants were seen by an exercise professional every two weeks for a supervised relaxation session (<a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> </li> </ol> </li> </ol> </p> <p><sup>a</sup>Usual care included pharmacological treatments: csDMARDs such as hydroxychloroquine, prednisolone or glucocorticoids, mycophenolate mofetil, methotrexate, azathioprine, and cyclophosphamide; bDMARDs such as rituximab or belimumab; and NSAIDs such as naproxen or celecoxib.  </p> </section> <section id="CD014816-sec-0052"> <h6 class="title">Exercise interventions</h6> <p>All 13 studies included a structured exercise programme as part of their intervention. The summary of interventions can be found in <a href="#CD014816-tbl-0005">Table 2</a>, and summarised below. </p> <div class="table" id="CD014816-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Characteristics of exercise intervention in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dosage of exercise (frequency, intensity, time, type), duration of exercise intervention, progressions to programme (if any), and equipment used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Setting of exercise (supervision, provider expertise, setting of exercise, individual or group)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Country</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Trials that compared exercise plus usual care to a placebo plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week (24 hours between sessions). </p> <p><b>Intensity of exercise</b>  </p> <p> <ol id="CD014816-list-0043"> <li> <p>Weeks 1–4: 10 bouts of 30 s, frequency 30 Hz, D 1.23 mm, and a peak of 2.22 g. </p> </li> <li> <p>Weeks 5–8: 10 bouts of 60 s, frequency 40 Hz, D 0.95 mm, and a peak of 3.06 g. </p> </li> <li> <p>Weeks 9–12: 10 bouts of 60 s, 50 Hz, D 0.88 mm, and a peak of 4.40 g.</p> </li> </ol> </p> <p>The "low" amplitude was maintained in all sessions.</p> <p><b>Time of exercise session</b> </p> <p> <ol id="CD014816-list-0044"> <li> <p>Weeks 1–4: 2‐min warm‐up on a cycle ergometer pedalling continuously with no defined load, and 5‐min WBVE. </p> </li> <li> <p>Weeks 5–12: 2‐min warm‐up on a cycle ergometer pedalling continuously with no defined load, and 10‐min WBVE. </p> </li> </ol> </p> <p><b>Type of exercise:</b> WBVE is a subgroup of resistance training, better classified as muscle activation or neuromuscular training complementary to resistance training. The participants were positioned on the vibrating platform with 130° of knee flexion.  </p> <p><b>Duration of intervention:</b> 12 weeks </p> <p><b>Progressions:</b> described above </p> <p><b>Equipment used:</b> vertical vibrating platform used in the study was of the triaxial type, where the base moves vertically and horizontally directions (with predominantly vertical displacement), model Power Plate Pro5 (Power Plate International, Performance Health Systems, USA). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> unclear if there was supervision present during the intervention.  </p> <p><b>Provider:</b> not reported </p> <p><b>Setting of exercise:</b> not clearly reported.<br/><b>Individual or group:</b> given that participants were positioned on a single vibration platform, this exercise intervention was performed individually; however, it was unclear whether multiple participants performed this together in a clinic, or unsupervised at home. </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to usual care alone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the start of the programme, the 2 groups (supervised training group and home training group) participated in a multidisciplinary information session about the benefits of exercise in SLE, during which practical information was also delivered. </p> <p><b>Frequency of exercise sessions:</b> not clearly reported. However, participants were advised to perform 3 hours of exercise per week. </p> <p><b>Intensity of exercise:</b> moderate to high (60–80% of predicted maximal heart rate) </p> <p><b>Time of exercise session:</b> not clearly reported. However, participants were advised to perform 3 hours of exercise per week. </p> <p><b>Type of exercise:</b> participants were advised to perform cardiovascular endurance exercise (walking or cycling), or strengthening exercises.  </p> <p><b>Duration of intervention:</b> 12 weeks </p> <p><b>Progression:</b> not clearly reported. </p> <p><b>Equipment used:</b> </p> <p> <ol id="CD014816-list-0045"> <li> <p>Endurance exercises (walking or bicycle)</p> </li> <li> <p>Strengthening exercises (elastic band or weights for both upper and lower limbs)</p> </li> </ol> </p> <p>Note that the intervention dosage were the same in both groups. The groups only differed by the level of supervision and setting of exercise. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise intervention group 1 (supervised training group)</b> </p> <p> <ol id="CD014816-list-0046"> <li> <p><b>Supervision:</b> yes </p> </li> <li> <p><b>Provider:</b> participant were supervised by a multidisciplinary team in the hospital </p> </li> <li> <p><b>Place of exercise:</b> hospital‐based revalidation centre </p> </li> <li> <p><b>Individual or group:</b> not clearly reported </p> </li> </ol> </p> <p><b>Exercise intervention group 2 (home training group)</b> </p> <p> <ol id="CD014816-list-0047"> <li> <p><b>Supervision:</b> no </p> </li> <li> <p><b>Place of exercise:</b> home </p> </li> <li> <p><b>Individual or group:</b> not clearly reported </p> </li> </ol> </p> <p> </p> <p> </p> <p> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Belgium</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> <p><b>Time of exercise session:</b> cardiovascular endurance exercise = 30 min and strength exercise = time not specified, per session. </p> <p><b>Type of exercise:</b> cardiovascular endurance exercise (treadmill walking) and strength exercises (7 exercises for major muscle groups: 4 sets of 8–12 repetitions maximum for each exercise) </p> <p><b>Duration of intervention:</b> 12 weeks </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not reported </p> <p><b>Place of exercise:</b> not reported </p> <p><b>Individual or group:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point </p> <p><b>Time of exercise session:</b> 40–60 min (including a 5‐min warm‐up and 5‐min cool‐down) </p> <p><b>Type of exercise:</b> cardiovascular endurance (treadmill walking) </p> <p><b>Duration of exercise intervention:</b> 12 weeks </p> <p><b>Progression:</b> walking duration gradually increased every 4 weeks, from 30 min to 50 min </p> <p><b>Equipment used:</b> treadmill </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not reported </p> <p><b>Place of exercise:</b> intrahospital gymnasium (Laboratory of Assessment and Conditioning in Rheumatology, School of Medicine, University of São Paulo) </p> <p><b>Individual or group:</b> not clearly reported. However, given that participants were walking on a treadmill, it was assumed to be individual. Whether participants performed treadmill walking with other participants in the clinic was not clear </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week (supervised) </p> <p><b>Intensity of exercise:</b> high (65–80% of MHR, or 13–16 rate of perceived exertion) </p> <p><b>Time of exercise session:</b> 60 min (20 min aerobic and 15 min strength) </p> <p><b>Type of exercise</b> </p> <p> <ol id="CD014816-list-0048"> <li> <p><b>0–3 months:</b> education about the disease and exercise (1‐off 1‐hour workshop), supervised aerobic and strength exercise, individual coaching of physical activity (30 min of individual coaching at the start and after 6 weeks and 12 weeks), loan and use of heart rate monitor, and use of a physical activity diary. </p> </li> <li> <p><b>4–9 months:</b> individual coaching of physical activity, use of heart rate monitor, and the use of a physical activity diary, self‐managed aerobic and strength exercise. </p> </li> <li> <p><b>10–12 months:</b> use of heart rate monitor and the use of a physical activity diary, self‐managed aerobic and strength exercise. </p> </li> </ol> </p> <p><b>Duration of exercise intervention</b> </p> <p> <ol id="CD014816-list-0049"> <li> <p>Phase 1: 0–3 months</p> </li> <li> <p>Phase 2: 4–12 months</p> </li> </ol> </p> <p><b>Progression:</b> participants were asked to successively increase their physical activity during the programme to achieve: 1. high intensity, ≥ 30 min per session, 2–3 days/week, and 2. low‐to‐moderate intensity, ≥ 30 min per session, 4–5 days/week. </p> <p><b>Equipment used:</b> treadmill, heart rate monitor, activity diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision/support</b>  </p> <p> <ol id="CD014816-list-0050"> <li> <p>Phase 1: more supervision; education about the disease and exercise was offered in a 1‐hour workshop at the start. 2 supervised high‐intensity aerobic exercise sessions were offered during the first 3 months in the hospital gymnasium. However, participants could choose to perform their own 2 high‐intensity exercise sessions if the hospital was not convenient for them to get to. Participants were also encouraged to perform low‐to‐moderate exercise 4–5 days per week on their own during this time. Individual coaching for 30 min was offered at the start, and 6 and 12 weeks. </p> </li> <li> <p>Phase 2: less supervision; this was assisted by videotapes and cassettes of the 2 high‐intensity exercise sessions performed during phase 1. Participants were also encouraged to perform low‐to‐moderate exercise 4–5 days/week on their own during this time. Individual coaching for 30 min was also offered at months 6 and 9. They also received telephone support for approximately 10 min and the frequency of this was reduced during the 4‐ to 12‐month period (months 4–6, every third week; months 7–9, once per month; months 10–12, no support). </p> </li> <li> <p><b>Provider:</b> physiotherapist provided the education, individual coaching, and the supervision of the exercise. A rheumatologist was also present during the education session at the start of the programme. </p> </li> <li> <p><b>Place of exercise:</b> hospital gymnasium, at home/their choice of location. </p> </li> <li> <p><b>Individual or group:</b> group‐based when under supervision, individual or group if they were performing exercise at home/their choice of location. </p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> stage 2 of the session (aerobic exercise programme, including 10 min of cycling and 10 min of running, both at intensity of 50–60% maximum, as predetermined in the peak oxygen uptake measurements). </p> <p><b>Time of exercise session:</b> 60 min per session (40 min for the first week, to allow for acclimatisation, but increased thereafter)  </p> <p><b>Type of exercise:</b> Pilates exercise, which is classified as low‐intensity resistance exercise. Each exercise session consisted of 4 stages, including 10‐min warm‐up, 10‐min aerobic exercise programme (10 min cycling and 10 min running), 60‐min Pilates training using bodyweight as the resistive load, and 10‐min cool‐down. Borg's scale was used to assess the participants' perceptions of physical exertion during the aerobic exercises that were used in stage 2. </p> <p><b>Duration of intervention:</b> 8 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> not reported </p> <p><b>Provider:</b> not reported </p> <p><b>Setting of exercise:</b> not reported </p> <p><b>Individual or group:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to 60% of peak oxygen consumption </p> <p><b>Time of exercise session:</b> 30–50 min </p> <p><b>Type of exercise:</b> home‐based cardiovascular exercise (mainly walking, swimming, or cycling) with a supervised exercise session every 2 weeks </p> <p><b>Duration of exercise intervention:</b> 12 weeks </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not clearly reported. </p> <p><b>Place of exercise:</b> home‐based, with a supervised exercise session every 2 weeks. </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to another non‐pharmacological intervention plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week  </p> <p><b>Intensity of exercise:</b> moderate intensity (65–75% of MHR according to the ACSM guidelines). Exercise intensity was determined by HRR, which was calculated by HRR = MHR – RHR. MHR determined using: MHR = 205 − (0.42 × age). </p> <p><b>Time of exercise session:</b> 50 min per session </p> <p><b>Type of exercise</b>  </p> <p> <ol id="CD014816-list-0051"> <li> <p>Cardiovascular exercise; walking and bicycle ergometry interventions. Each training session consisted of a 10‐min warm‐up followed by 30 min of exercise at the target heart rate, and 10‐min cool‐down. </p> </li> <li> <p>Resistance training exercise. Each session consisted of 8 exercises, including holds (crucifix) with free weights, extension‐machine exercises, rowing exercise with an elastic band, knee flexion with ankle weights, 2‐arm biceps curls, adduction exercises with an elastic band, French curls, and abdominal exercises. The training involved small and large muscle group exercises. Participants performed 3 sets of 15 repetitions with rest intervals of 1 min between sets. </p> </li> </ol> </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> training intensity changed over time as the participants progressed. Progression unknown.  </p> <p><b>Equipment used:</b> bicycle ergometry (Model CLB 10 Classic, Caloi, Sao Paulo, Brazil), free weights, extension‐machine, and elastic bands </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> trained professional (profession unknown) </p> <p><b>Place of exercise:</b> in the Rheumatology Services at the Interlagos Specialty Outpatient Clinic </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week  </p> <p><b>Intensity of exercise:</b> moderate–high (60–80% of MHR achieved on the exercise tolerance test) </p> <p><b>Time of exercise session:</b> 30 min per session </p> <p><b>Type of exercise:</b> aerobic exercise performed on a stationary bike that was set up in their home. </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> stationary bike </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> a physiotherapist contacted the participant once a week to update logs of exercise, report of symptoms, and perceived fatigue. The physiotherapist instructed the participant at home when setting up the bike, and made a second visit 2–3 weeks later at an exercise session to check the participants' ability to follow the regimen correctly. </p> <p><b>Place of exercise:</b> participants' homes </p> <p><b>Individual or group:</b> individual (participants completed their sessions in their own homes, independently)  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the ventilatory 1 threshold obtained from ergospirometry and monitored by frequency meter (Poland Electro, Kempele, Finland).  </p> <p><b>Time of exercise session:</b> 60 min per session (10‐min warm‐up, 40‐min of walking and 10‐min cool‐down) </p> <p><b>Type of exercise:</b> walking, outdoors in the morning </p> <p><b>Duration of exercise intervention:</b> 16 weeks  </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> none<b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes  </p> <p><b>Provider:</b> physical educator or physician </p> <p><b>Place of exercise:</b> park, outdoors  </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 5 times/week </p> <p><b>Intensity of exercise:</b> moderate intensity determined by HRR 50–50%, according to the ACSM guidelines. HRR = MHR − RHR. MHR determined using formula: MHR = 205 − (0.42 × age). </p> <p><b>Time of exercise session:</b> 30 min per session (3‐ to 5‐min warm‐up session, 4 sets of combined exercise session for approximately 30 min in total, and a final set of 3‐ to 5‐min of relaxation and stretching). Each set of combined exercise lasting for 7 min 15 s, with a brief break between sets.  </p> <p><b>Type of exercise:</b> aerobic exercise combined with bodyweight or 500–620 mL of dumbbell water weights for resistance training. Combined exercise sessions consisted of various styles of basic exercises, alternating workouts of legs with trunk movement, and arm exercises. </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> 500–620 mL of dumbbell water weights </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> instructed by an exercise physiologist/professional exercise instructor on the performance of aerobic exercise combined with resistance training and the skills of heart rate measurement at rest and after exercise. The research team member contacted participants periodically by telephone or text message to ensure their compliance. Each week, the participants reported their maximal heart rate after each exercise session by written logs.  </p> <p><b>Place of exercise:</b> participant's home </p> <p><b>Individual or group:</b> individual (considering each participant was performing the exercise intervention in their own home) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Taiwan </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 7 days/week  </p> <p><b>Intensity of exercise:</b> moderate intensity. The initial intensity of exercise was set at a moderate level and the programme was reassessed, using a modified Borg Scale (a tool to measure a persons' perception of their effort and exertion, breathlessness, and fatigue during physical work) to maintain the same intensity, in every face‐to‐face session with the hand therapist at 0, 3, 6, and 9 weeks.  </p> <p><b>Time of exercise session:</b> 30 min per session  </p> <p><b>Type of exercise:</b> upper limb resistance and range of motion exercise (9 strengthening and stretching exercises for the upper extremities with a stick, 10 strengthening and stretching exercises for the fingers and 11 strengthening exercises against resistance with therapeutic putty). </p> <p><b>Duration of exercise intervention:</b> 12 weeks (with a follow‐up assessment at 24 weeks) </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> therapeutic putty (soft or medium resistance) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> not reported  </p> <p><b>Provider:</b> team of hand therapists. Frequency of visits to the hand therapist, unknown.  </p> <p><b>Place of exercise:</b> home‐based programme  </p> <p><b>Individual or group:</b> individual (taking into account participants were performing their exercise programme at home) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greece</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> <p><b>Time of exercise session:</b> 80 min per session (5‐min treadmill warm‐up, 35–40 min of resistance training, 30 min of treadmill aerobic training, and 5‐min of stretching). </p> <p><b>Type of exercise:</b> cardiovascular exercise (treadmill walking for 30 min), and resistance training included 7 exercises for the main muscle groups (e.g. bench press, leg press, leg extension).  </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> participants were required to perform 4 sets of 8–12 repetitions maximum, except during the first week, when a reduced volume of 2 sets of 15–20 repetitions maximum for each exercise was performed (as an adaptation period to resistance training). Overload progression was implemented when the participant could perform &gt; 12 repetitions on the last training set for 2 consecutive workouts. Aerobic training intensity was set at the corresponding heart rate between the ventilatory anaerobic threshold and 10% below the respiratory compensation point. Cardiorespiratory exercise test was performed on a treadmill (Centurion, Model 200, Micromed) using a maximal‐graded exercise protocol. The recovery period was set at 2 min using the initial workload (1.7 miles per hour).  </p> <p><b>Equipment used:</b> treadmill and resistance training equipment (e.g. machine weights or dumbbells); however, this was not clearly reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> 1 fitness professional  </p> <p><b>Place of exercise:</b> hospital gymnasium  </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to 60% of peak oxygen consumption </p> <p><b>Time of exercise session:</b> 30–50 min </p> <p><b>Type of exercise:</b> home‐based cardiovascular exercise (mainly walking, swimming, or cycling) with a supervised exercise session every 2 weeks </p> <p><b>Duration of exercise intervention:</b> 12 weeks </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not clearly reported </p> <p><b>Place of exercise:</b> home‐based, with a supervised exercise session every 2 weeks </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; HRR: heart rate reserve; MHR: maximum heart rate; RHR: resting heart rate; SLE: systemic lupus erythematosus; WBVE: whole body vibration exercise. </p> </div> </div> <p> <ol id="CD014816-list-0052"> <li> <p><b>Type of exercise:</b> four studies included aerobic exercise (<a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>), seven studies included a combination of aerobic and resistance exercise (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>), one study included a combination of resistance exercise and stretching (<a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>), and one study included whole body vibration exercise, which is a subgroup of resistance training, better classified as muscle activation/neuromuscular training complementary to resistance training (<a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>).  </p> </li> <li> <p><b>Intensity of exercise:</b> one study was low intensity (<a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>), seven studies were moderate intensity (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>), one study was high intensity (<a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>), and four studies did not clearly report the intensity (<a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> </li> <li> <p><b>Frequency of exercise:</b> participants undertook two exercise sessions per week in five studies (<a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>), three sessions per week in five studies (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>), five sessions per week in one study (<a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>), daily in one study (<a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>), and a total of three hours over the entire week, with no clarity on the number of sessions per week in one study (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>).  </p> </li> <li> <p><b>Duration of the exercise intervention:</b> the exercise intervention had a duration of 12 weeks in 11 studies (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>), with a 24‐week follow‐up in three studies (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>), and a 24‐week plus 52‐week follow‐up in one study (<a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>). The exercise intervention had a duration of 16 weeks in one study (<a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>), and eight weeks in one study (<a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> </li> </ol> </p> </section> </section> <section id="CD014816-sec-0053"> <h5 class="title">Outcomes</h5> <p>See <a href="#CD014816-tbl-0006">Table 3</a> and <a href="#CD014816-tbl-0007">Table 4</a> for further details on the major and minor outcomes in the included studies. </p> <div class="table" id="CD014816-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Major outcomes reported in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fatigue</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Functional capacity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Disease activity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Quality of life </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pain</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Serious adverse events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Withdrawals due to adverse events</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Trials that compared exercise plus usual care to placebo plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>The Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT‐F)</b> </p> <p> <ol id="CD014816-list-0053"> <li> <p>Score range: score 0–52, higher scores indicate less fatigue</p> </li> </ol> </p> <p>SF‐35 Vitality domain was also used; however, this was not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Functional Capacity domain </b> </p> <p> <ol id="CD014816-list-0054"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> <p>HAQ and TUG test were also used to assess functional capacity; however, these were not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>SF‐36 was used to measure quality of life; however, authors did not report the MCS and PCS scores, so this was not used in our analyses.  </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Pain domain</b> </p> <p> <ol id="CD014816-list-0055"> <li> <p>Score range 0–100, higher scores indicate less pain</p> </li> </ol> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to usual care alone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Krupp FSS</b>  </p> <p> <ol id="CD014816-list-0056"> <li> <p>Score range: 1–7, lower score indicates less fatigue</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. 1 participant withdrew from study due to a disease flare; however, unclear which group they were part of, and, therefore, unable to be included in meta‐analysis. It is also important to note that it is unclear whether the disease flare was due to the intervention, the severity of the disease flare, or whether they were hospitalised. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>2 participants withdrew from the study. </b> </p> <p> <ol id="CD014816-list-0057"> <li> <p>1 from the control group due to a disease flare</p> </li> <li> <p>1 from the exercise group due to a disease flare</p> </li> </ol> </p> <p>However, it is important to note that it was unclear whether the disease flare was due to the intervention, the severity of the disease flare, or whether they were hospitalised. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> <p>SF‐36 Vitality domain was used; however, this was not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SF‐36 Physical Function domain </b> </p> <p> <ol id="CD014816-list-0058"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0059"> <li> <p>Score range: 0–105, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>Used SF‐36 to measure quality of life; however, authors did not report MCS and PCS scores, and, therefore, this was not used in our analyses.  </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Pain  </b> </p> <p> <ol id="CD014816-list-0060"> <li> <p>Score range 0–100, higher scores indicate less pain</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Krupp FSS</b> </p> <p> <ol id="CD014816-list-0061"> <li> <p>Score range 1–7, lower score indicates less fatigue</p> </li> </ol> </p> <p>Chalder Fatigue Scale, Visual Analogue Scale, and  SF‐36 Fatigue and Vitality domains were also used; however, these were not used in our analyses.   </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SF‐36 Physical Function domain  </b> </p> <p> <ol id="CD014816-list-0062"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Systemic Lupus Activity Measure </b> </p> <p> <ol id="CD014816-list-0063"> <li> <p>Score range 0–83, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>Used SF‐36 to measure quality of life; however, authors did not report the MCS score, PCS score, and all 8 domains, and, therefore, this was not used in our analyses. </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> <p>Used SF‐36 to measure quality of life, but authors did not report the Pain domain, and, therefore, this was not used in our analyses. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to another non‐pharmacological intervention plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐35 Physical Function domain  </b> </p> <p> <ol id="CD014816-list-0064"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0065"> <li> <p>Score range: 0–105, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>SF‐36 used to measure quality of life; however, authors did not report the MCS and PCS scores, and, therefore, this was not used in our analyses.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Pain domain </b> </p> <p> <ol id="CD014816-list-0066"> <li> <p>Score range 0–100, higher scores indicate less pain</p> </li> </ol> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the Mental Adjustment to Cancer questionnaire, and the Profile Of Moods State Fatigue questionnaire were used; however, these were not included in our analyses because the results for the participants with SLE were not presented separately from the results for participants with rheumatoid arthritis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0067"> <li> <p>Score range: 0–105, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, used SLEDAI; however, authors did not report the mean and standard deviation, and, therefore, we were unable to use in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Lupus quality of life Fatigue domain</b> </p> <p> <ol id="CD014816-list-0068"> <li> <p>Score range 0–100, higher scores indicate less fatigue</p> </li> </ol> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, used SLEDAI; however, authors do not report the mean and standard deviation, and, therefore, we were unable to use in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported</p> <p>Used Lupus Quality of Life questionnaire; however, only Physical Health and Fatigue domains were reported, and, therefore, this was not used in our analyses.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Visual Analogue Scale Pain</b> </p> <p> <ol id="CD014816-list-0069"> <li> <p>Score range 0–10, lower scores indicate less pain</p> </li> </ol> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0070"> <li> <p>Score range: 0–105, lower scores indicate less disease activity.</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Krupp FSS</b> </p> <p> <ol id="CD014816-list-0071"> <li> <p>Score range 1–7, lower score indicates less fatigue</p> </li> </ol> </p> <p>Chalder Fatigue Scale, Visual Analogue Scale, and SF‐36 Fatigue and Vitality domains were also used; however, these were not used in our analyses.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SF‐36 Physical Function domain </b> </p> <p> <ol id="CD014816-list-0072"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Systemic Lupus Activity Measure</b> </p> <p> <ol id="CD014816-list-0073"> <li> <p>Score range 0–83, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>SF‐36 was used to measure quality of life; however, authors did not report MCS score, PCS score, and all 8 domains, and, therefore, this was not used in our analyses. </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> <p>SF‐36 was used to measure quality of life but authors did not report the Pain domain, and, therefore, this was not used in our analyses. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>FACIT‐F: Functional Assessment of Chronic Illness Therapy – Fatigue; FSS: Fatigue Severity Scale; HAQ: Health Assessment Questionnaire; MCS: Mental Component Score; PCS: Physical Component Score; SF‐36: 36‐item Short Form; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; TUG: Timed Up and Go. </p> </div> </div> <div class="table" id="CD014816-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Minor outcomes reported in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Composite responder rate</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Aerobic capacity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Depression</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Anxiety</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Withdrawals due to any reason</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Trials that compared exercise plus usual care to placebo plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>4 participants withdrew from the intervention</b> </p> <p> <ol id="CD014816-list-0074"> <li> <p>3 from the exercise group (1 before the 6‐week analysis due to low back pain, and 2 before the 12‐week analysis for personal reasons) </p> </li> <li> <p>1 from the control group before the 6‐week analysis due to personal reasons</p> </li> </ol> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to usual care alone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, 2 participants withdrew from the intervention for personal reason; however, it is unclear which group they were part of, and, therefore, not included in our analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>8 participants withdrew from the intervention.</b> </p> <p> <ol id="CD014816-list-0075"> <li> <p>4 from the control group (1 pregnant, 3 for personal reasons)</p> </li> <li> <p>4 from the exercise group (1 fractured limb outside of training sessions, 3 for person reasons) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Maximum oxygen consumption (VO<sub>2max</sub> in L/min) </b> </p> <p> <ol id="CD014816-list-0076"> <li> <p>Higher scores indicate better aerobic capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>3 participants withdrew from the control group (1 depression/cognitive impairment, 1 untreated dementia, 1 suspected relapse breast cancer)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Peak oxygen consumption (VO<sub>2peak</sub> in mL/kg/min)</b> </p> <p> <ol id="CD014816-list-0077"> <li> <p>Higher scores indicate better aerobic capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Depression subscale</b> </p> <p> <ol id="CD014816-list-0078"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Anxiety subscale</b> </p> <p> <ol id="CD014816-list-0079"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>14 participants withdrew from the study.</b> </p> <p> <ol id="CD014816-list-0080"> <li> <p>4 from the exercise group</p> </li> <li> <p>5 from the active control group (relaxation)</p> </li> <li> <p>5 from the usual care control group</p> </li> </ol> </p> <p>Note that 6 participants dropped out of treatment and 8 participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to another non‐pharmacological intervention plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Beck‐Depression Inventory</b> </p> <p> <ol id="CD014816-list-0081"> <li> <p>Score range 0–63, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>2 participants withdrew from the control group for an unknown reason</b> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the 12‐min walking test was used to measure aerobic capacity; however, this was not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Center for Epidemiologic Studies – Depression Scale</b> </p> <p> <ol id="CD014816-list-0082"> <li> <p>Score range 0–60, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were clearly reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Peak oxygen consumption (VO<sub>2peak</sub> in mL/kg/min)</b> </p> <p> <ol id="CD014816-list-0083"> <li> <p>Higher scores indicate better aerobic capacity.</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were clearly reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>2 participants from the exercise intervention group withdrew; however, the reasons were not reported.</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Peak oxygen consumption (VO<sub>2peak</sub> in mL/kg/min)</b> </p> <p> <ol id="CD014816-list-0084"> <li> <p>Higher scores indicate better aerobic capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Depression subscale</b> </p> <p> <ol id="CD014816-list-0085"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Anxiety subscale</b> </p> <p> <ol id="CD014816-list-0086"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>14 participants withdrew from the study</b> </p> <p> <ol id="CD014816-list-0087"> <li> <p>4 from the exercise group</p> </li> <li> <p>5 from the active control group (relaxation)</p> </li> <li> <p>5 from the usual care control group</p> </li> </ol> </p> <p>Note that 6 participants dropped out of treatment and 8 participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>VO<sub>2peak</sub>: peak oxygen consumption. </p> </div> </div> <section id="CD014816-sec-0054"> <h6 class="title">Exercise plus usual pharmacological care versus placebo plus usual pharmacological care </h6> <section id="CD014816-sec-0055"> <p><b>Major outcomes</b></p> <p>One trial compared a structured exercise intervention to a placebo control (<a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>). The certainty of evidence was low for fatigue, functional capacity, and pain, and very low for withdrawals due to any reason. We extracted data from the end of the intervention (i.e. 12 weeks). The major outcomes are reported in <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010951.pub2/full#CD010951-tbl-0001" target="_blank">summary of findings Table 1</a>. </p> <p><b>Fatigue</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> measured overall fatigue (mean or mean change) using the FACIT‐F, which we used in our analyses. It had a scale with 13 items scored from 0 to 4. Overall scores ranged from 0 to 52, with a lower final score indicating greater fatigue. However, for consistency with other analyses of fatigue, we reversed the scale so that a lower score indicates less fatigue. </p> <p><b>Functional capacity</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> measured overall functional capacity (mean or mean change) using the SF‐36 Functional Capacity/Physical Function domain, which we used in our analyses. Scores ranged from 0 to 100, with higher scores indicating better functional capacity. </p> <p><b>Disease activity</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> did not report disease activity. </p> <p><b>Quality of life</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> partially reported quality of life using the SF‐36 Quality of Life questionnaire; however, authors did not report the MCS and PCS scores, and, therefore, this was not used in our analyses. </p> <p><b>Pain</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> measured pain using the SF‐36 Quality of Life questionnaire, Pain domain, which we used in our analyses. Scores ranged from 0 to 100, with higher scores indicating less pain. However, for consistency with other pain scales (i.e. VAS), we reversed the scale so that a lower score indicated less pain. </p> <p><b>Serious adverse events </b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> reported no SAEs. </p> <p><b>Withdrawals due to any reason</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> reported three participant dropouts from the exercise group (one participant withdrew before the six‐week analysis due to low back pain, and two withdrew before the 12‐week analysis due to personal reasons) and one participant withdrew from the control group before the six‐week analysis due to personal reasons.  </p> </section> <section id="CD014816-sec-0056"> <p><b>Minor outcomes</b></p> <p><b>Composite responder rate</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> did not report composite responder rate. </p> <p><b>Aerobic fitness</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> did not report aerobic fitness. </p> <p><b>Depression</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> did not report depression. </p> <p><b>Anxiety</b> </p> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> did not report anxiety. </p> </section> </section> <section id="CD014816-sec-0057"> <h6 class="title">Exercise plus usual pharmacological care versus usual pharmacological care alone</h6> <p>Six trials compared exercise plus usual pharmacological care versus usual pharmacological care alone (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <section id="CD014816-sec-0058"> <p><b>Major outcomes</b></p> <p><b>Fatigue</b> </p> <p>Two trials measured and reported overall fatigue (mean or mean change) using the Krupp FSS, with scores ranging from 1 to 7, lower scores indicating less fatigue, which we used in our analyses (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> also measured overall fatigue using the Chalder Fatigue Scale (CFS) and VAS for fatigue; however we extracted data from the FSS only. Four trials did not measure or report (or both) fatigue (<a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>). </p> <p><b>Functional capacity</b> </p> <p>Two trials measured overall functional capacity (mean or mean change) using the SF‐36 Physical Function domain, which we used in our analyses (<a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Scores ranged from 0 to 100, with higher scores indicating better functional capacity. Four trials  did not measure or report (or both) functional capacity (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>). </p> <p><b>Disease activity</b> </p> <p>One trial measured disease activity using the SLEDAI, which we used in our analyses (<a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>). Scores ranged from 0 to 105, with lower scores indicating less disease activity. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> measured disease activity using the SLAM measuring system, which we used in our analyses. Scores ranged from 0 to 83, with lower scores indicating less disease activity. Four trials did not measure or report (or both) change in disease activity before and after the intervention (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> <p><b>Quality of life</b> </p> <p>Two trials partially reported quality of life using the SF‐36 Quality of Life questionnaire; however, authors did not report the MCS and PCS scores, and, therefore, could not be used in our analyses (<a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Four trials  did not measure or report (or both) quality of life (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>). </p> <p><b>Pain</b> </p> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> measured and recorded pain using the SF‐36 Quality of Life questionnaire, Pain domain, which we used in our analyses. Scores ranged from 0 to 100, with higher scores indicating less pain. For consistency with other pain scales (i.e. VAS), we reversed the score so that a lower score indicated less pain. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> measured pain using the SF‐36 Quality of Life questionnaire; however, authors did not report the Pain domain, and, therefore, this was not used in our analyses. Four trials did not measure or report (or both) pain (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> <p><b>Withdrawals due to any reason</b> </p> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> had three participants withdraw from the intervention; two due to personal reasons, and one due to a disease flare; however, it is unclear which group they were part of, and they were not included in our analyses. <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> had eight participants withdraw from the intervention for the following reasons: four participants withdrew from the control group (one was pregnant, three for personal reasons) and four participants withdrew from the exercise group (one fractured a limb outside of training sessions, three for person reasons). Another two participants withdrew due to a disease flare (one from each group). <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> had three participants withdraw from the control group (one had depression/cognitive impairment, one had untreated dementia, one had suspected relapse of breast cancer). <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> had 14 participants withdraw due to any reason: four participants withdrew from the exercise group, five participants withdrew from the active control group (relaxation) and five participants withdrew from the usual care control group. Note that six participants dropped out of treatment and eight participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. Two trials had no withdrawals from the intervention due to any reason that were reported (<a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> <p><b>Serious adverse events</b> </p> <p>None of the six trials reported any SAEs (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>).  </p> </section> <section id="CD014816-sec-0059"> <p><b>Minor outcomes</b></p> <p><b>Composite responder rate</b> </p> <p>None of the six studies reported composite responder rate (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>).  </p> <p><b>Aerobic fitness</b> </p> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> recorded aerobic capacity using the maximum oxygen consumption (VO<sub>2max</sub> in litres/minute), with higher scores indicating better aerobic capacity. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> recorded aerobic capacity using peak oxygen consumption (VO<sub>2peak</sub> in millilitres/kilogram/minute), with higher scores indicating better aerobic capacity. Four trials did not measure or report (or both) aerobic capacity (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> <p><b>Depression</b> </p> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> recorded depression using the HADS – Depression subscale. Scores ranged from 0 to 21, with lower scores indicating a better outcome. Five trials did not measure or report (or both) depression (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> <p><b>Anxiety</b> </p> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> recorded anxiety using the HADS – Anxiety subscale. Scores ranged from 0 to 21, with lower scores indicating a better outcome. Five trials did not measure or report (or both) anxiety (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> </section> </section> <section id="CD014816-sec-0060"> <h6 class="title">Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care </h6> <p>Seven studies compared exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <section id="CD014816-sec-0061"> <p><b>Major outcomes</b></p> <p><b>Fatigue</b> </p> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> measured fatigue using the MAC questionnaire and POMS Fatigue questionnaires; however, these were not included in our analyses because the results for the participants with SLE were not available separately from those of the participants with rheumatoid arthritis. <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> measured overall fatigue using the LupusQOL – Fatigue questionnaire, which we used in our analyses. Scores ranged from 0 to 100, with higher scores indicating less fatigue. For consistency with other fatigue scales (i.e. FSS), we reversed the scale so that a lower score indicated less fatigue. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> measured fatigue using the Krupp FSS, which we used in our analyses. Scores ranged from 1 to 7, with lower scores indicating less fatigue. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> used the CFS, VAS Fatigue, and the SF‐36 Quality of Life questionnaire, Vitality domain; however, these were not used in our analyses. Four trials did not measure or report (or both) overall fatigue (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> <p><b>Functional capacity</b> </p> <p>Two trials measured functional capacity using the SF‐36 Quality of Life questionnaire, Physical Function domain, which we used in our analyses (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Scores ranged from 0 to 100, with higher scores indicating better functional capacity. <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> measured functional capacity using the LupusQOL questionnaire Physical Health domain, which we used in our analyses. Scores ranged from 0 to 100, with higher scores indicating better functional capacity. <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> also assessed functional capacity using the Health Assessment Questionnaire (HAQ); however, this was not used in our analyses. Four trials did not measure or report (or both) functional capacity (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>). </p> <p><b>Disease activity</b> </p> <p>Three trials measured disease activity using the SLEDAI, which we used in our analyses (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>). Scores ranged from 0 to 105, with lower scores indicating less disease activity. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> measured disease activity using the SLAM measuring system, which we used in our analyses. Scores ranged from 0 to 83, with lower scores indicating less disease activity. Two trials measured fatigue using the SLEDAI; however, authors do not report the mean and SD, and, therefore, we were unable to use these in our analyses (<a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>). Two trials did not measure or report (or both) change in disease activity before and after the intervention (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> <p><b>Quality of life</b> </p> <p>Two trials partially reported quality of life using the SF‐36 Quality of Life questionnaire; however, authors did not report the MCS and PCS scores, and, therefore, these were not used in our analyses (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> partially reported quality of life using the LupusQOL questionnaire; however, they reported only Physical Health and Fatigue domains, and, therefore, were not used in our analyses. Four trials did not measure or report (or both) quality of life (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> <p><b>Pain</b> </p> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> measured pain using the SF‐36 Quality of Life Pain questionnaire, which we used in our analyses. Scores ranged from 0 to 100, with higher scores indicating less pain. For consistency with other scales (i.e. VAS), we reversed the scale so that lower scores indicated less pain. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> also used the SF‐36 Quality of Life questionnaire to measure quality of life; however, authors did not report the Pain domain, and, therefore, this was not used in our analyses. <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> measured pain using the VAS Pain, which we used in our analyses. Scores ranged from 0 to 10, with lower scores indicating less pain. Four trials did not report quality of life (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> <p><b>Withdrawals due to any reason</b> </p> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> had two participants withdraw from the control group for an unknown reason. <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> had two participants from the exercise group withdraw; however, the reasons were not reported. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> had 14 participants withdraw from the study: four participants withdrew from the exercise group, five participants withdrew from the active control group (relaxation), and five participants withdrew from the usual care control group. Note that six participants dropped out of treatment and eight participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. Four trials did not clearly report withdrawals due to any reason (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> <p><b>Serious adverse events</b> </p> <p>Seven trials reported no SAEs (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>).  </p> </section> <section id="CD014816-sec-0062"> <p><b>Minor outcomes</b></p> <p><b>Composite responder rate</b> </p> <p>None of the seven trials measured or reported (or both) composite responder rate (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>).  </p> <p><b>Aerobic fitness</b> </p> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> measured aerobic capacity using a 12‐minute walking test; however, this was not used in our analyses. Two trials measured aerobic capacity using VO<sub>2peak</sub> (in millilitres/kilogram/minute), which we used in our analyses (<a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Higher scores indicated better aerobic capacity. Four trials did not measure or report (or both) aerobic capacity (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> <p><b>Depression</b> </p> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> measured depression using the BDI, which we used in our analyses. Scores ranged from 0 to 63, with lower scores indicating a better outcome. <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> measured depression using the Center for Epidemiologic Studies Depression Scale (CES‐D) and was not used in our analyses because we were unable to differentiate the participants with SLEW from those with rheumatoid arthritis. Scores ranged from 0 to 60, with lower scores indicating a better outcome. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> measured depression using the HADS – Depression subscale and was not used in our analyses. Scores ranged from 0 to 21, with lower scores indicating a better outcome. Four trials did not measure or report (or both) depression (<a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> <p><b>Anxiety</b> </p> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> measured anxiety using the HADS – Anxiety subscale. Scores ranged from 0 to 21, with lower scores indicating a better outcome. Six trials did not measure anxiety (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> </section> </section> </section> </section> <section id="CD014816-sec-0063"> <h4 class="title">Excluded studies</h4> <p>We excluded 27 studies for the following reasons.</p> <p> <ol id="CD014816-list-0088"> <li> <p><b>Ineligible intervention:</b> exercise was either acute (one single bout of exercise) or did not meet our inclusion criteria of an exercise intervention being structured, recurring, and including specific dosage information (i.e. frequency, intensity, timing, type). </p> </li> <li> <p><b>Ineligible participant population:</b> intervention group included participants with SLE, however, control group participants were healthy controls. </p> </li> <li> <p><b>Ineligible study design:</b> studies were not randomised, or did not include a control group, and did not meet the inclusion criterion of an RCT. </p> </li> <li> <p><b>Duplicate study:</b> this was the abstract to one of our included studies (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>). </p> </li> </ol> </p> <p>The list of all 27 excluded studies, with reason, can be found in the <a href="./references#CD014816-sec-0146" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD014816-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <p>The overall risk of bias assessment of the included studies is presented in <a href="#CD014816-fig-0002">Figure 2</a> and <a href="#CD014816-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD014816-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD014816-fig-0002" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD014816-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD014816-fig-0003" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD014816-sec-0065"> <h4 class="title">Allocation</h4> <section id="CD014816-sec-0066"> <h5 class="title">Random sequence</h5> <p>We judged five studies at low risk of bias because they used and reported an appropriate method of randomisation (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>We assessed five studies at unclear risk of bias because the methods used to generate allocation sequence were not described, or were unclear (<a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>). </p> <p>We judged three studies at high risk of bias because their methods of randomisation were not truly random (i.e. quasi‐randomised), despite authors reporting the study to be randomised (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>). </p> </section> <section id="CD014816-sec-0067"> <h5 class="title">Allocation concealment</h5> <p>We judged two studies at low risk of bias, since they provided adequate information on the method of allocation concealment (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>). </p> <p>For 10 studies, the method used to conceal allocation sequence was unclear, or not described (<a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>We judged one study at high risk of bias because the selection of participants based on their geographical location was deemed as selection bias (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>). </p> </section> </section> <section id="CD014816-sec-0068"> <h4 class="title">Blinding</h4> <section id="CD014816-sec-0069"> <h5 class="title">Participant blinding</h5> <p>We judged all studies at high risk of bias. Blinding participants and care providers is difficult because of the nature of the intervention. Most of the included studies did not report information on blinding, or a masking procedure for treatment allocation or delivery. No studies reported using a blinding procedure (sham or attentional comparator, or blinding of study hypothesis). </p> </section> <section id="CD014816-sec-0070"> <h5 class="title">Outcome assessor </h5> <p>We judged all studies at high (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>) or unclear risk of bias (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Most included studies used subjective outcomes (self‐reporting). Because participants were not blind to the treatment allocation (i.e. inability to bind an exercise trial), we considered the outcomes assessors to be unblinded.  </p> </section> </section> <section id="CD014816-sec-0071"> <h4 class="title">Incomplete outcome data</h4> <p>We judged seven studies at low risk of attrition bias (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>We judged six studies at high risk of attrition bias because of withdrawals throughout the intervention with no clear reporting of ITT analyses (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>). </p> </section> <section id="CD014816-sec-0072"> <h4 class="title">Selective reporting</h4> <p>We judged five studies at low risk of reporting bias, because all outcomes reported were prespecified in their methods (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>). </p> <p>We judged seven studies at a high risk of bias because we found outcomes listed in their methods and not reported in the results (e.g. the MCS of the SF‐36) (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> </section> <section id="CD014816-sec-0073"> <h4 class="title">Other potential sources of bias</h4> <p>We judged all studies at low risk of other bias because we identified no other potential sources of bias. </p> </section> </section> <section id="CD014816-sec-0074"> <h3 class="title" id="CD014816-sec-0074">Effects of interventions</h3> <p>See: <a href="./full#CD014816-tbl-0001"><b>Summary of findings 1</b> Summary of findings table ‐ Exercise plus usual pharmacological care compared to placebo plus usual pharmacological care for systemic lupus erythematosus</a>; <a href="./full#CD014816-tbl-0002"><b>Summary of findings 2</b> Summary of findings table ‐ Exercise plus usual pharmacological care compared to usual pharmacological care alone for systemic lupus erythematosus</a>; <a href="./full#CD014816-tbl-0003"><b>Summary of findings 3</b> Summary of findings table ‐ Exercise plus usual pharmacological care compared to another intervention (education, joint aids, or relaxation) plus usual pharmacological care for systemic lupus erythematosus</a> </p> <section id="CD014816-sec-0075"> <h4 class="title">Exercise plus usual pharmacological care versus placebo plus usual pharmacological care </h4> <p>One study compared exercise plus usual care versus placebo plus usual care (<a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>). </p> <section id="CD014816-sec-0076"> <h5 class="title">Major outcomes</h5> <p>See: <a href="./full#CD014816-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD014816-sec-0077"> <h6 class="title">Fatigue (FACIT‐Fatigue, 0 to 52 scale, lower score indicates less fatigue severity, MCID 5.9 points) </h6> <p>One study (17 participants) found that exercise may result in little to no effect on fatigue. The mean fatigue score for the placebo plus usual care group was 38 points, and the mean fatigue score for the exercise plus usual care group was 33 points (MD −5.00 points, 95% CI −3.29 lower to 13.29; <a href="./references#CD014816-fig-0004" title="">Analysis 1.1</a>). There was no clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision; we rated the certainty of evidence as low. </p> </section> <section id="CD014816-sec-0078"> <h6 class="title">Functional capacity (SF‐36 Physical Function, 0 to 100 scale, higher scores indicate better function, MCID 10 points) </h6> <p>One study (17 participants) found that exercise may have little to no effect on functional capacity. The mean functional capacity score for the placebo plus usual care group was 70 points, and the mean functional capacity score for the exercise plus usual care group 67.5 points (MD −2.50 points, 95% CI −23.78 to 18.78; <a href="./references#CD014816-fig-0005" title="">Analysis 1.2</a>). There was no important clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision; we rated the certainty of evidence as low. </p> </section> <section id="CD014816-sec-0079"> <h6 class="title">Disease activity</h6> <p>The study did not report disease activity.</p> </section> <section id="CD014816-sec-0080"> <h6 class="title">Quality of life</h6> <p>The study did not report quality of life.</p> </section> <section id="CD014816-sec-0081"> <h6 class="title">Pain (SF‐36 Pain, 0 to 100 scale, lower scores indicate less pain, MCID 10 points)</h6> <p>One study (17 participants) found that exercise may have little to no effect on pain. The mean pain score was 43 points for the placebo plus usual care group, and the mean pain score was 34 points for the exercise plus usual care group (MD −9.00 points, 95% CI −28.88 to 10.88; <a href="./references#CD014816-fig-0011" title="">Analysis 2.4</a>). There was no important clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision; we rated the certainty of evidence as low. </p> </section> <section id="CD014816-sec-0082"> <h6 class="title">Serious adverse events</h6> <p>No SAEs reported.</p> </section> <section id="CD014816-sec-0083"> <h6 class="title">Withdrawals due to any reason</h6> <p>We are uncertain whether exercise results in fewer or more withdrawals (RR 2.73, 95% CI 0.34 to 22.16; 1 study; <a href="./references#CD014816-fig-0007" title="">Analysis 1.4</a>). The study reported three dropouts from the exercise group; one participant withdrew before the six‐week analysis due to low back pain ("not related directly with the intervention"), and two withdrew before the 12‐week analysis for personal reasons, and one participant withdrew from the control group before the six‐week analysis for personal reasons.  </p> </section> </section> <section id="CD014816-sec-0084"> <h5 class="title">Minor outcomes</h5> <section id="CD014816-sec-0085"> <h6 class="title">Composite responder rate</h6> <p>The study did not measure or report composite responder rate.</p> </section> <section id="CD014816-sec-0086"> <h6 class="title">Aerobic fitness</h6> <p>The study did not measure or report aerobic fitness.</p> </section> <section id="CD014816-sec-0087"> <h6 class="title">Depression</h6> <p>The study did not measure or report depression.</p> </section> <section id="CD014816-sec-0088"> <h6 class="title">Anxiety</h6> <p>The study did not measure or report anxiety.</p> </section> </section> </section> <section id="CD014816-sec-0089"> <h4 class="title">Exercise plus usual pharmacological care versus usual pharmacological care alone</h4> <p>Six studies compared exercise plus usual care versus usual care alone (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>).  </p> <section id="CD014816-sec-0090"> <h5 class="title">Major outcomes</h5> <p>See: <a href="./full#CD014816-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD014816-sec-0091"> <h6 class="title">Fatigue (FSS, scale 1 to 7, lower score indicates less fatigue, MCID 1 point)</h6> <p>Two studies (104 participants) found that exercise plus usual care may have little to no effect on mean fatigue. The mean fatigue score in the usual care alone group was 5.4 points, and the mean fatigue score for the exercise plus usual care group was 4.8 points (MD −0.59 points, 95% CI −1.40 to 0.22; <a href="./references#CD014816-fig-0008" title="">Analysis 2.1</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Statistical heterogeneity was not important (I<sup>2</sup> = 0%). There was no clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision; we rated the certainty of evidence as low. </p> </section> <section id="CD014816-sec-0092"> <h6 class="title">Functional capacity (SF‐36 Physical Function, scale 0 to 100, higher score indicates better function, MCID 10 points) </h6> <p>Two studies (96 participants) found that exercise plus usual care may have little to no effect on functional capacity. The mean physical function score in the usual care alone group was 60 points, and the mean physical function score for the exercise plus usual care group was 65.4 points (MD 5.39 points, 95% CI −5.97 to 16.75; <a href="./references#CD014816-fig-0009" title="">Analysis 2.2</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Statistical heterogeneity was not important (I<sup>2</sup> = 0%). There was no clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision; we rated the certainty of evidence as low. </p> </section> <section id="CD014816-sec-0093"> <h6 class="title">Disease activity (SLEDAI, scale 0 to 105, lower score indicates less disease activity, MCID 4 points) </h6> <p>Two studies (100 participants) found that exercise plus usual care may have little to no effect on disease activity. The mean disease activity score in the usual care alone group was 0.5 points, and the mean disease activity score for the exercise plus usual care group was 0.43 points (MD −0.07 points, 95% CI −2.8 to 2.66; <a href="./references#CD014816-fig-0010" title="">Analysis 2.3</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Statistical heterogeneity was significant (I² = 88%). There was no clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision. We rated the certainty of evidence as low. </p> <p>We back‐translated the SMD by multiplying the SMD by the SD of the control group at baseline from the most representative trial (<a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>Note one of the two studies used SLAM to measure disease activity (<a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> </section> <section id="CD014816-sec-0094"> <h6 class="title">Quality of life</h6> <p>No studies reported quality of life.</p> </section> <section id="CD014816-sec-0095"> <h6 class="title">Pain (SF‐36 Bodily Pain, scale 0 to 100, lower scores indicate less pain, MCID 10 points) </h6> <p>One study (31 participants) reported pain. We are uncertain whether exercise improves pain. The mean pain score in the usual care alone group was 38 points, and the mean pain score for the exercise plus usual care group was 52 points (MD 16.00 points, 95% −CI 0.18 to 32.18; <a href="./references#CD014816-fig-0011" title="">Analysis 2.4</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>). There was no important clinically meaningful benefit. Because of study limitations, we downgraded the evidence three levels for high risk of bias and imprecision (low participant numbers and the CIs included a large effect and no effect). We rated the certainty of evidence as very low. </p> </section> <section id="CD014816-sec-0096"> <h6 class="title">Serious adverse events</h6> <p>No SAEs were reported.</p> </section> <section id="CD014816-sec-0097"> <h6 class="title">Withdrawals due to any reason</h6> <p>We are uncertain whether exercise results in fewer or more withdrawals (RR 0.92, 95% CI 0.53 to 1.60; <a href="./references#CD014816-fig-0012" title="">Analysis 2.5</a>). <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> reported three withdrawals from the study; two for personal reasons, and one due to a disease flare; however, it is unclear which group they were part of, and, therefore, they were not included in our analyses. <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> had eight participants withdraw from the intervention; four participants withdrew from the control group (one was pregnant, three for personal reasons) and four participants withdrew from the exercise group (one fractured limb outside of training sessions, three for person reasons). Another two participants withdrew due to a disease flare (one from each group). <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> had three participants withdraw from the control group (one had depression/cognitive impairment, one had untreated dementia, one had suspected relapse of breast cancer). <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> had 14  participants withdraw due to any reason. Four participants withdrew from the exercise group, five participants withdrew from the active control group (relaxation), and five participants withdrew from the usual care control group. Note that six participants dropped out of treatment and eight participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. Two trials had no withdrawals from the intervention due to any reason that were reported (<a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>).  </p> </section> </section> <section id="CD014816-sec-0098"> <h5 class="title">Minor outcomes</h5> <section id="CD014816-sec-0099"> <h6 class="title">Composite responder rate</h6> <p>No studies measured or reported (or both) composite responder rate.</p> </section> <section id="CD014816-sec-0100"> <h6 class="title">Aerobic capacity (peak VO<sub>2</sub>, higher scores indicate better aerobic capacity) </h6> <p>Three studies (109 participants) found that exercise plus usual pharmacological care may improve aerobic capacity score when compared to usual pharmacological care alone; however, the improvement was not clinically important (MD 1.27 points, 95% CI −0.59 to 3.12; <a href="./references#CD014816-fig-0013" title="">Analysis 2.6</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> </section> <section id="CD014816-sec-0101"> <h6 class="title">Depression (BDI, scale 0 to 63, lower scores indicate less depression)</h6> <p>One study (65 participants) found that exercise plus usual pharmacological care may improve depression score when compared to usual pharmacological care alone; however, the improvement was not clinically important (MD −0.29 points, 95% CI −0.78 to 0.20; <a href="./references#CD014816-fig-0014" title="">Analysis 2.7</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> </section> <section id="CD014816-sec-0102"> <h6 class="title">Anxiety (HADS, scale 0 to 21, lower scores indicate less anxiety)</h6> <p>One study (65 participants) found that exercise plus usual pharmacological care may improve anxiety score when compared to usual pharmacological care alone; however, the improvement was not clinically important (MD −0.80 points, 95% CI −3.02 to 1.42; <a href="./references#CD014816-fig-0015" title="">Analysis 2.8</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>).  </p> </section> </section> </section> <section id="CD014816-sec-0103"> <h4 class="title">Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care </h4> <p>Seven studies compared exercise plus usual care versus another non‐pharmacological intervention plus usual care (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <section id="CD014816-sec-0104"> <h5 class="title">Major outcomes</h5> <p>See: <a href="./full#CD014816-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD014816-sec-0105"> <h6 class="title">Fatigue (FSS, scale 1 to 7, lower scores indicate less fatigue severity, MCID 1 point)</h6> <p>Two studies (119 participants) found that exercise plus usual care may reduce fatigue. The mean fatigue score in the non‐pharmacological interventions (joint aids and information about their disease, education, and relaxation therapy) plus usual care was 5.3 points, and the mean fatigue score for the exercise plus usual care group was 4.79 points (MD −0.51 points, 95% CI −0.88 to −0.14; <a href="./references#CD014816-fig-0016" title="">Analysis 3.1</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Statistical heterogeneity was not important (I<sup>2</sup> = 0%). There was no clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision; we rated the certainty of evidence as low. </p> <p>We back‐translated the SMD by multiplying the SMD by the SD of the control group at baseline from the most representative trial (<a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>Note one of the two studies used LupusQOL Fatigue to measure fatigue (<a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> </section> <section id="CD014816-sec-0106"> <h6 class="title">Functional capacity (SF‐36 Physical Function, scale 0 to 100, higher scores indicate better functional capacity, MCID 10 points) </h6> <p>Three studies (182 participants) found that exercise plus usual care may increase functional capacity. The mean functional capacity score in the other non‐pharmacological interventions (joint aids and information about their disease, education, and relaxation therapy) plus usual care was 41.4 points, and the mean functional capacity score for the exercise plus usual care group was 54.6 points (MD 13.20 points, 95% CI 6.17 to 20.22; <a href="./references#CD014816-fig-0017" title="">Analysis 3.2</a>; <a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). There was a clinically meaningful benefit. Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision. We rated the certainty of evidence as low. </p> <p>Note that one of the three studies used LupusQOL to assess functional capacity (scale 0 to 100, higher scores indicate better functional capacity) (<a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>). </p> <p>We back‐translated the SMD by multiplying the SMD by the SD of the control group at baseline from the most representative trial (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>). </p> </section> <section id="CD014816-sec-0107"> <h6 class="title">Disease activity (SLEDAI, scale 0 to 52, lower scores indicate lower disease activity, MCID 4 points) </h6> <p>Four studies (184 participants) founds that exercise plus usual care probably results in little to no difference in disease activity. The mean disease activity score in the other non‐pharmacological interventions (joint aids and information about their disease, education, and relaxation therapy) plus usual care was 1.2 points, and the mean disease activity score for the exercise plus usual care group was 1.22 points (SMD 0.02 points, 95% CI −0.28 to 0.32; MD 0.034 points, 95% CI −0.476 to 0.544; <a href="./references#CD014816-fig-0018" title="">Analysis 3.3</a>; <a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Baseline control group SD for converting SMD to MD was 1.7 and taken from <a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>. Statistical heterogeneity was not significant (I<sup>2</sup> = 1%). There was no clinically meaningful benefit. Because of study limitations, we downgraded the evidence one level for high risk of bias We rated the certainty of evidence as moderate. </p> <p>Note that one of the four studies used SLAM to measure disease activity (scale 0 to 83, lower scores indicate less disease activity) (<a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>We back‐translated the SMD by multiplying the SMD by the SD of the control group at baseline from the most representative trial (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>). </p> </section> <section id="CD014816-sec-0108"> <h6 class="title">Quality of life</h6> <p>This outcome was measured; however, the MCS score of the SF‐36 Quality of Life questionnaire was not reported and, therefore was unable to be included in the analysis. </p> </section> <section id="CD014816-sec-0109"> <h6 class="title">Pain (VAS, scale 0 to 10, lower scores indicate less pain, MCID 1.5 points)</h6> <p>Two studies (121 participants) found that exercise plus usual care may result in little to no difference in pain. The mean pain score in the other non‐pharmacological interventions (joint aids and information about their disease, education, and relaxation therapy) plus usual care was 4.97 points, and the mean pain score for the exercise plus usual care group was −0.29 points (MD −1.59 points, 95% CI −2.46 to −0.71; <a href="./references#CD014816-fig-0019" title="">Analysis 3.4</a>; <a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>). Statistical heterogeneity was significant (I<sup>2</sup> = 74%). Because of study limitations, we downgraded the evidence two levels for high risk of bias and imprecision. We rated the certainty of evidence as low. </p> <p>Note that one of the two studies used the SF‐36 Bodily Pain domain to measure pain (scale 0 to 100, lower score indicates less pain) (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>). </p> <p>We back‐translated the SMD by multiplying the SMD by the SD of the control group at baseline from the most representative trial (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>). </p> </section> <section id="CD014816-sec-0110"> <h6 class="title">Serious adverse events</h6> <p>No SAEs were reported.</p> </section> <section id="CD014816-sec-0111"> <h6 class="title">Withdrawals due to any reason</h6> <p>We are uncertain whether exercise results in fewer or more withdrawals (RR 0.89, 95% CI 0.13 to 5.94; <a href="./references#CD014816-fig-0012" title="">Analysis 2.5</a>). <a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> reported two participant withdrawals from the control group for an unknown reason. <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> reported two participant withdrawals from the exercise group; however, the reasons were not reported. <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> reported 14 participant withdrawals from the intervention; four participants withdrew from the exercise group, five participants withdrew from the active control group (relaxation), and five participants withdrew from the usual care group. Note that six participants dropped out of treatment and eight participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. Four trials did not clearly report withdrawals due to any reason (<a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>).  </p> </section> </section> <section id="CD014816-sec-0112"> <h5 class="title">Minor outcomes</h5> <section id="CD014816-sec-0113"> <h6 class="title">Composite responder rate</h6> <p>No studies measured or reported (or both) composite responder rate.</p> </section> <section id="CD014816-sec-0114"> <h6 class="title">Aerobic fitness (peak VO<sub>2</sub>, higher scores indicate better aerobic capacity) </h6> <p>Two studies (99 participants) found an improvement in aerobic capacity score with exercise plus usual care compared to another non‐pharmacological intervention (joint aids and information about their disease, education, and relaxation therapy) (MD 1.19 points, 95% CI −1.64 to 4.02; <a href="./references#CD014816-fig-0021" title="">Analysis 3.6</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). There was no clinically meaningful benefit. </p> </section> <section id="CD014816-sec-0115"> <h6 class="title">Depression (BDI, scale 0 to 63, lower scores indicate less depression)</h6> <p>One study (61 participants) found that exercise plus usual pharmacological care may improve depression score when compared to another non‐pharmacological intervention (joint aids and information about their disease, education, or relaxation therapy); however, the improvement was not clinically important (MD −1.40 points, 95% CI −4.61 to 1.81; <a href="./references#CD014816-fig-0022" title="">Analysis 3.7</a>; <a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>).  </p> </section> <section id="CD014816-sec-0116"> <h6 class="title">Anxiety (HADS, scale 0 to 21, lower scores indicate less anxiety)</h6> <p>One study (61 participants) found that exercise plus usual pharmacological care may improve anxiety score when compared to another non‐pharmacological intervention (joint aids and information about their disease, education, or relaxation therapy); however, the improvement was not clinically important (MD −1.10 points, 95% CI −3.61 to 1.41; <a href="./references#CD014816-fig-0023" title="">Analysis 3.8</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>).  </p> </section> </section> </section> <section id="CD014816-sec-0117"> <h4 class="title">Subgroup and sensitivity analyses</h4> <p>Given the small number of studies, we did not conduct subgroup analysis to explore the possible effect of type of exercise (resistance versus cardiorespiratory) on estimated effect size. Neither did we conduct a sensitivity analysis, because we judged all studies at unclear or high risk of bias for most items. </p> </section> <section id="CD014816-sec-0118"> <h4 class="title">Assessment of publication bias</h4> <p>We had planned to assess publication bias by visual inspection of funnel plots, but we did not generate funnel plots because of the limited number of studies (fewer than 10), and the risk of an underpowered test. We were unable to determine the existence of publication bias. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD014816-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD014816-sec-0119"></div> <section id="CD014816-sec-0120"> <h3 class="title" id="CD014816-sec-0120">Summary of main results</h3> <p>The main purpose of this review was to evaluate the effectiveness of structured exercise as an adjunctive therapy to usual pharmacological care for people with SLE. Overall, 13 RCTs (540 participants) met the inclusion criteria. The structured exercise programmes amongst the 13 included studies varied; see <a href="#CD014816-tbl-0005">Table 2</a>, therefore the results of this review are not specific to one type or dosage of exercise. All studies compared a type of exercise, or a combination of types of exercise, plus usual pharmacological care, to a control group that received one of the following; placebo plus usual pharmacological care (<a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>); usual pharmacological care alone (<a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>); or another non‐pharmacological intervention (education about the disease/exercise, relaxation therapy, etc.) plus usual pharmacological care (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). </p> <p>We found low‐certainty evidence indicating that structured exercise plus usual pharmacological care compared to placebo plus usual pharmacological care may result in little to no effect on fatigue, functional capacity, and pain, measured after the completion of the intervention. And we are uncertain whether exercise results in fewer or more withdrawals (very low‐certainty evidence). </p> <p>We found low‐certainty evidence that structured exercise plus usual pharmacological care compared with usual pharmacological care alone may result in little to no effect on fatigue, functional capacity, and disease activity, measured after the completion of the intervention. And we are uncertain whether exercise improves pain (very low‐certainty evidence) or results in fewer or more withdrawals (very low‐certainty evidence). </p> <p>We found low‐ to moderate‐certainty evidence that structured exercise plus usual pharmacological care compared to another non‐pharmacological intervention (relaxation, education, support aids) plus usual pharmacological care may reduce fatigue (low‐certainty evidence), may improve functional capacity (low‐certainty evidence), probably results in little to no difference in disease activity (moderate‐certainty evidence), and may result in little to no difference in pain (low‐certainty evidence), measured after the completion of the intervention. We are uncertain whether exercise results in fewer or more withdrawals (very low‐certainty evidence). </p> <p>We have no clear evidence that structured exercise can induce more adverse events. No studies clearly reported an adverse event as an outcome, or elaborated further on the reasons for a withdrawal and whether this led to further complications, hospitalisation, or death. We were unable to draw any conclusions. </p> </section> <section id="CD014816-sec-0121"> <h3 class="title" id="CD014816-sec-0121">Overall completeness and applicability of evidence</h3> <p>The evidence provided by this review is limited to the 13 included RCTs that assessed the effectiveness of exercise plus usual pharmacological care versus a control group (placebo plus usual pharmacological care, usual pharmacological care alone, another non‐pharmacological intervention plus usual pharmacological care). One RCT that is potentially eligible for this review is awaiting classification because their results have not yet been reported in full (<a href="./references#CD014816-bbs2-0041" title="BoedeckerSC , PhilippiKF , NeubergerE , SchmidtS , PfirrmannD , HallerN , et al. Twelve-week internet-based individualized exercise program in adults with systemic lupus erythematosus: protocol for a randomized controlled trial. Journal of Medical Internet Research Protocols2020;9(11):1-11. ">Boedecker 2020</a>).  </p> <p>All studies compared exercise in addition to their usual pharmacological care to no additional exercise; however, there was heterogeneity between exercise interventions with no dose control between the studies. The included studies investigated several different types and combinations of exercise components. Aerobic exercise, in particular walking, was the most frequent exercise type. However, the components were incompletely described in most trials. For example, the material used, who provided the intervention, how it was supervised, and where the exercise was delivered were often missing. The exercise dosage, and level of supervision, could not be explored with indirect statistical techniques, such as meta‐regression. Thus, we did not investigate heterogeneity by the type of exercise, or supervision because we were unable to isolate these components from the included studies. </p> <p>Twelve studies assessed outcome measures at the end of the intervention only (i.e. 12 weeks), which may not have accounted for the long‐term effect of exercise, and its feasibility (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a>; <a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a>; <a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a>; <a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>; <a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>). Importantly, because SLE may progress or vary over time, it is necessary to assess outcome measurements at more time points, and over a longer period of time (greater than 12 months) to verify the relationship between treatment effect and outcomes (i.e. fatigue). </p> <p>Most exercise programmes were delivered in conjunction with drug therapy (standard NSAIDs, DMARDs, or biological agents). The benefits of exercise interventions, depending on the type of drug therapy received, could not be determined. Therefore, we do not know if some drugs in addition to exercise have better or worse outcomes for people with SLE. Also, no study specifically evaluated the efficacy of exercise with biological medication versus standard NSAID or DMARD therapy.  </p> <p>An important consideration is that most participants in the studies had minimal disease activity (SLEDAI score less than 4) at baseline, and, therefore, the overall results could not be applicable to all people with SLE. Also, considering that people with SLE can experience varying symptoms and degree of symptoms over time, the change in outcomes from baseline to the end of intervention need to be read with caution (i.e. the change in outcome reporting might be more a reflection of how they were feeling on that day of testing, rather than a change in feelings before and after the intervention).  </p> <p>Other outcomes needed to understand more about the risk/benefit ratio of exercise, which have been included in this review, is participant‐reported fatigue, quality of life, pain, depression, and anxiety. Importantly, these outcomes should be evaluated using standardised outcome tools that are validated in SLE (e.g. FACIT) (<a href="./references#CD014816-bbs2-0070" title="Lai J-S, BeaumontJL , OgaleS , BrunettaP , CellaD . Validation of the Functional Assessment of Chronic Illness Therapy – Fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. Journal of Rheumatology2011;38(4):672-9.">Lai 2011</a>), as well as dynamic muscle strength and aerobic fitness, which could be observed to link the relationship between disease‐related outcomes and exercise. With respect to the instruments used to measure health‐related quality of life, the SF‐36 was the most frequently used tool in the included studies. Although the use of the SF‐36 allows for comparison of quality of life in various diseases, it lacks characteristic details that are specific in SLE, such as body image and intimate relationships (<a href="./references#CD014816-bbs2-0077" title="McElhoneK , AbbottJ , GrayJ , WilliamsA , TehLS . Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus2010;19:1640-7.">McElhone 2010</a>). SLE‐specific instruments, such as the 34‐item LupusQOL developed by McElhone and colleagues in 2007 (<a href="./references#CD014816-bbs2-0076" title="McElhoneK , AbbottJ , ShelmerdineJ , BruceIN , AhmadY , GordonC , et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis &amp; Rheumatology2007;57:972–9.">McElhone 2007</a>) and the 40‐item SLEQOL developed by Leong and colleagues in 2005 (<a href="./references#CD014816-bbs2-0071" title="LeongKP , KongKO , ThongBY , KohET , LianTY , TehCL , et al. Development and preliminary validation of a Systemic Lupus Erythematosus-specific Quality-Of-Life instrument (SLEQOL). Rheumatology2005;44:1267–76.">Leong  2005</a>), might be able to offer enhanced responsiveness to changes in health‐related quality of life than the SF‐36. Future studies may want to use these instruments either alone or in combination with a generic measure to ensure that both disease‐specific and wider aspects of quality of life are assessed. </p> <p>Inherent with exercise trials, it is difficult to blind participants to the intervention. Therefore, bias introduced by a placebo effect can potentially overestimate the efficacy of an intervention, particularly in the evaluation of subjective outcomes. As such, future trial designs could instead be double blinded and compare different modes (aerobic, resistance, range of motion), intensities (low, moderate, and high according to RPE or percentage of maximum heart rate), time of exercise (i.e. 10‐minute or 60‐minutes bouts), or a combination of these to increase our understanding of exercise guidelines in SLE. In addition, to minimise detection bias, consistent blinding of outcomes assessors is recommended, since participants cannot be blinded to the intervention.  </p> <p>There was heterogeneity between outcome measures amongst studies and outcomes that were included in dose‐matched studies. There was also methodological limitations, risk of bias, and an overall limited number of participants in the studies. The evidence derived from the included studies does not allow strong conclusions to be drawn about which specific components of exercise are best in terms of dose of exercise, and level of supervision. There needs to be 1. more studies completed assessing the effects of exercise in people with varying levels of disease activity; 2. more participants in the trials; 3. homogeneous outcomes that are more sensitive to change in SLE (i.e. FACIT‐Fatigue, LupusQOL, SLEDAI, etc.); 4. trials that compare various doses of exercise (i.e. aerobic versus resistance training on fatigue, disease activity etc.); and 5. longitudinal study designs that focus on change in disease‐related outcomes as well as exercise adherence, physical activity levels, and sustainability of outcomes over a longer period of time.  </p> </section> <section id="CD014816-sec-0122"> <h3 class="title" id="CD014816-sec-0122">Quality of the evidence</h3> <p>We had concerns about the risk of bias for all studies included: eight (62%) studies had either high or unclear allocation concealment; all failed to blind participants or outcome assessors; six (46%) had incomplete outcome data; and seven (54%) had a high risk of selective reporting. Given the number of studies included in the review, we cannot rule out the existence of a small‐study effect, explaining the magnitude of the positive results we found. </p> <p>We considered statistically significant group differences between exercise plus usual pharmacological care versus a control group (placebo plus usual pharmacological care, usual pharmacological care alone, or another non‐pharmacological intervention such as relaxation therapy, support aids, or education about the disease plus usual pharmacological care). For each comparison, the number of studies (fewer than 10), and small samples (many studies were small, with fewer than 100 participants) might have contributed to a low‐power analysis. Low power is associated with bias (<a href="./references#CD014816-bbs2-0049" title="ButtonKS , IoannidisJP , MokryszC , NosekBA , FlintJ , RobinsonES , et al. Power failure: why small sample size undermines the reliability of neuroscience. Nature Reviews. Neuroscience2013;14(5):365-76.">Button 2013</a>). Most studies we included were at high or unclear risk of bias, which suggests that the estimated effects might be overestimated, and reduces the likelihood that they reflect a true effect. We cannot provide conclusions with a high level of confidence. The magnitude of the estimated effects may change with larger studies. </p> <p>We only presented the findings of trials that reported the major outcomes of interest in <a href="./full#CD014816-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD014816-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD014816-tbl-0003">summary of findings Table 3</a>; and used the GRADE approach to assess the certainty of the evidence examined for each outcome (<a href="./references#CD014816-bbs2-0097" title="SchünemannHJ , VistGE , HigginsJP , SantessoN , DeeksJJ , GlasziouP , et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Schünemann 2020a</a>). Most of the evidence was downgraded to low or very low certainty, based on two factors: risk of bias and imprecision with small trials and large CIs. </p> </section> <section id="CD014816-sec-0123"> <h3 class="title" id="CD014816-sec-0123">Potential biases in the review process</h3> <p>We made all attempts to reduce the bias involved in the review process by including the best available evidence. All studies included were RCTs or quasi‐RCTs. However, by restricting the inclusion criteria to RCTs only, we may have limited the number of included trials and potentially missed useful additional evidence. We conducted an extensive search of the literature in all relevant databases and identified all relevant trials meeting the reviews' eligibility criteria. None of the review authors have been involved in the conduct of the included trials. A minimum of two review authors independently selected studies, extracted data, assessed the risk of bias, and graded the certainty of evidence in all studies. Even though we searched as extensively as possible, we may have missed eligible studies, such as studies reported only in dissertations or conference proceedings. For missing data, we systematically sought information from study authors. However, most of our attempts to contact study authors were unsuccessful, and most data came from published sources. </p> <p>This review has some limitations. We could not determine whether participants who received usual pharmacological care also completed their own exercise independent of the trials exercise intervention, because the included studies poorly described the content of usual pharmacological care interventions. In some studies, we could not determine what constituted usual care. Participants in the usual pharmacological care groups could have practised exercises, or could have been on more drugs than outlined in the study, which could explain why there was a smaller effect size or no effect when comparing exercise to a control group. A possible explanation could also be the result of performance bias, due to lack of blinding, inherent in exercise interventions and when using subjective participant‐reported outcome measures (PROMs). Another limitation was the heterogeneous use of outcome measures amongst the included studies, making it difficult to meta‐analyse the data. </p> <p>We found wide variations amongst the trials, likely related to different exercise components. Despite the prespecification stated in our protocol, we could not perform subgroup analyses to explore heterogeneity for factors such as exercise supervision or modalities of exercises. We had to decide what type of 'exercise' should be included; we excluded single bouts of exercise (i.e. one exercise session or exercise test), or unstructured exercise (i.e. no clear dosage prescription). The cutoff might be contentious, particularly with unstructured exercise, and discussion regarding whether to include structured and unstructured exercise into another review should be considered. Last, the number of included studies and participants in this review was too small. </p> </section> <section id="CD014816-sec-0124"> <h3 class="title" id="CD014816-sec-0124">Agreements and disagreements with other studies or reviews</h3> <p>Three different systematic reviews have examined the effects of exercise in people with SLE (<a href="./references#CD014816-bbs2-0073" title="Lu M-C, KooM . Effects of exercise intervention on health-related quality of life in patients with systemic lupus erythematosus: a systematic review and meta-analysis of controlled trials. Healthcare (Basel)2021;9(1215):1-15.">Lu 2021</a>; <a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a>; <a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a>). None included all the RCTs we identified, all of which compared the effects of exercise to placebo, usual care alone, or another non‐pharmacological intervention.  </p> <p><a href="./references#CD014816-bbs2-0085" title="O'DwyerT , DurcanL , WilsonF . Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Seminars in Arthritis and Rheumatism2017;47(2):204-15.">O'Dwyer 2017</a> performed a systematic review and included 11 studies (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a>; <a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a>; <a href="./references#CD014816-bbs2-0045" title="BogdanovicG , StojanovichL , DjokovicA , StanisavljevicN . Physical activity program is helpful for improving quality of life in patients with systemic lupus erythematosus. Tohoku Journal of Experimental Medicine2015;237:193-9.">Bogdanovic 2015</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0051" title="CarvalhoMR , SatoEI , TebexreniAS , HeidecherRT , SchenkmanS , NetoTL . Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis and Rheumatism2005;53(6):838-44.">Carvalho 2005</a>; <a href="./references#CD014816-bbs2-0055" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52:2187-95.">Dos Reis‐Neto  2013</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0093" title="Ramsey-GoldmanR , SchillingEM , DunlopD , LangmanC , GreenlandP , ThomasRJ , et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2000;13(5):262-9.">Ramsey‐Goldman 2000</a>; <a href="./references#CD014816-bbs2-0095" title="Robb-NicholsonLC , DaltroyL , EatonH , GallV , WrightE , HartleyLH , et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. British Journal of Rheumatology1989;28:500-5.">Robb‐Nicholson 1989</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>), consisting of six RCTs and five quasi‐RCTs. Five studies compared an exercise intervention to a control group (usual care, or unchanged physical activity status) (<a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0051" title="CarvalhoMR , SatoEI , TebexreniAS , HeidecherRT , SchenkmanS , NetoTL . Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis and Rheumatism2005;53(6):838-44.">Carvalho 2005</a>; <a href="./references#CD014816-bbs2-0055" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52:2187-95.">Dos Reis‐Neto  2013</a>; <a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0095" title="Robb-NicholsonLC , DaltroyL , EatonH , GallV , WrightE , HartleyLH , et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. British Journal of Rheumatology1989;28:500-5.">Robb‐Nicholson 1989</a>), and two studies compared an aerobic exercise programme to a range of movement/muscle strength programme  (<a href="./references#CD014816-bbs2-0045" title="BogdanovicG , StojanovichL , DjokovicA , StanisavljevicN . Physical activity program is helpful for improving quality of life in patients with systemic lupus erythematosus. Tohoku Journal of Experimental Medicine2015;237:193-9.">Bogdanovic 2015</a>; <a href="./references#CD014816-bbs2-0093" title="Ramsey-GoldmanR , SchillingEM , DunlopD , LangmanC , GreenlandP , ThomasRJ , et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2000;13(5):262-9.">Ramsey‐Goldman 2000</a>). The systematic review included seven studies in the meta‐analyses (<a href="./references#CD014816-bbs2-0042" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201.">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0047" title="BoströmC , ElfvingB , DupréB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25:602-16.">Boström 2016</a>; <a href="./references#CD014816-bbs2-0051" title="CarvalhoMR , SatoEI , TebexreniAS , HeidecherRT , SchenkmanS , NetoTL . Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis and Rheumatism2005;53(6):838-44.">Carvalho 2005</a>; <a href="./references#CD014816-bbs2-0055" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52:2187-95.">Dos Reis‐Neto  2013</a>; <a href="./references#CD014816-bbs2-0081" title="MiossiR , BenattiFB , Lúciade de Sá PintoA , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counter balance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64:1159-66.">Miossi 2012</a>; <a href="./references#CD014816-bbs2-0095" title="Robb-NicholsonLC , DaltroyL , EatonH , GallV , WrightE , HartleyLH , et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. British Journal of Rheumatology1989;28:500-5.">Robb‐Nicholson 1989</a>; <a href="./references#CD014816-bbs2-0104" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology2003;42(9):1050-4.">Tench 2003</a>). Meta‐analyses were deemed appropriate for four outcomes: disease activity, fatigue, aerobic capacity, and depression. Results showed that disease activity was not changed following exercise interventions (MD 0.01, 95% CI −0.54 to 0.56), fatigue decreased in the exercise intervention group compared to controls (MD −0.52, 95% CI −0.91 to −0.13), and depression scores lowered in the exercise groups compared to the controls (SMD −0.40 SD, 95% CI −0.71 to −0.09). Most of these studies were at risk of selection and reporting bias. </p> <p><a href="./references#CD014816-bbs2-0105" title="Wu M-L, Yu K-H, Tsai J-C. The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews on Evidence-Based Nursing2017;14(4):306-15.">Wu 2017</a> performed a systematic review and included three studies (<a href="./references#CD014816-bbs2-0051" title="CarvalhoMR , SatoEI , TebexreniAS , HeidecherRT , SchenkmanS , NetoTL . Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis and Rheumatism2005;53(6):838-44.">Carvalho 2005</a>; <a href="./references#CD014816-bbs2-0093" title="Ramsey-GoldmanR , SchillingEM , DunlopD , LangmanC , GreenlandP , ThomasRJ , et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2000;13(5):262-9.">Ramsey‐Goldman 2000</a>; <a href="./references#CD014816-bbs2-0104" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology2003;42(9):1050-4.">Tench 2003</a>), consisting of two RCTs and one quasi‐experimental study. Aerobic exercise, three times a week and of moderate intensity, was a common component of the three studies. Two studies were conducted in a supervised setting and one study was based at home. One study had a duration of eight weeks and two studies had a duration of 12 weeks. All three studies were included in the meta‐analyses and showed that compared to controls aerobic exercise training decreased fatigue severity (MD −0.52, 95% CI −0.91 to −0.13), and showed a positive effect on the SF‐36 Vitality subscale (MD 14.98, 95% CI 7.45 to 22.52). However, the quality of evidence assessed using PEDro was downgraded to fair (<a href="./references#CD014816-bbs2-0104" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology2003;42(9):1050-4.">Tench 2003</a>) or poor (<a href="./references#CD014816-bbs2-0093" title="Ramsey-GoldmanR , SchillingEM , DunlopD , LangmanC , GreenlandP , ThomasRJ , et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care &amp; Research2000;13(5):262-9.">Ramsey‐Goldman 2000</a>). </p> <p><a href="./references#CD014816-bbs2-0073" title="Lu M-C, KooM . Effects of exercise intervention on health-related quality of life in patients with systemic lupus erythematosus: a systematic review and meta-analysis of controlled trials. Healthcare (Basel)2021;9(1215):1-15.">Lu 2021</a> performed a systematic review on the effects of exercise on health‐related quality of life and included nine studies, consisting of five RCTs (<a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a>; <a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a>; <a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a>; <a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a>; <a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a>), and four non‐RCTs (random allocation or control group were not available). Not all studies used the SF‐36 Health‐related Quality of Life measure or all of its subscales, therefore, nine separate meta‐analyses were conducted, including: one analysis on all five studies regardless of the health‐related quality of life measure; another analysis on four studies that used the SF‐36 Physical Function domain; and seven analyses on studies that used the remaining seven domains of the SF‐36. The results of the meta‐analysis of the five RCTs showed a positive effect of exercise on the physical health and function aspect (SF‐36 Physical Function and LupusQOL Physical Health) of health‐related quality of life amongst participants with SLE (Hedges' g: 0.468, 95% CI 0.206 to 0.730; P &lt; 0.001). Heterogeneity between studies was low  (I<sup>2</sup> = 19.2%; P = 0.292). </p> <p>Our findings are largely consistent with the findings of the above systematic reviews in terms of exercise effectiveness. The differences with our review are that we have included an updated trial (<a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a>), and we have only included RCTs, whereas the other reviews also included other study designs. In addition, we included three separate analyses to evaluate the effectiveness of exercise as 'adjunctive therapy' in SLE (exercise plus usual pharmacological care versus 1. placebo plus usual pharmacological care, 2. usual pharmacological care alone, and 3. another non‐pharmacological intervention plus usual pharmacological care). This review adds to the existing knowledge of exercise in SLE by emphasising that exercise can be used as an adjunctive therapy to the usual pharmacological care for SLE. The reason this is important is that most people with SLE will be taking or practising one or more pharmaceutical or non‐pharmaceutical interventions (or both), thus exercise should be considered as adjunctive to this; it would be difficult to know the true effect of exercise alone on people with SLE. Furthermore, this review revealed the lack of homogeneous study designs, outcome tools used, and lack of detail in exercise prescription amongst trials, and has shown the need for more rigorous studies in SLE and exercise to be considered.  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD014816-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD014816-fig-0001" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD014816-fig-0002" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD014816-fig-0003" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 1: Fatigue (FACIT fatigue, score 0–52, lower scores indicate less fatigue)" data-id="CD014816-fig-0004" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 1: Fatigue (FACIT fatigue, score 0–52, lower scores indicate less fatigue) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 2: Functional capacity (SF‐36 Function Capacity domain, score 0–100, higher scores indicate better functional capacity)" data-id="CD014816-fig-0005" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 2: Functional capacity (SF‐36 Function Capacity domain, score 0–100, higher scores indicate better functional capacity) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 3: Pain (SF‐36 Pain domain, score 0–100, lower scores indicate less pain)" data-id="CD014816-fig-0006" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 3: Pain (SF‐36 Pain domain, score 0–100, lower scores indicate less pain) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 4: Withdrawals for any reason" data-id="CD014816-fig-0007" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo), Outcome 4: Withdrawals for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 1: Fatigue (Fatigue Severity Scale, score 1–7, lower score indicates less fatigue)" data-id="CD014816-fig-0008" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 1: Fatigue (Fatigue Severity Scale, score 1–7, lower score indicates less fatigue) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 2: Functional capacity (SF‐36 Physical Function domain, score 0–100, higher scores indicate better functional capacity)" data-id="CD014816-fig-0009" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 2: Functional capacity (SF‐36 Physical Function domain, score 0–100, higher scores indicate better functional capacity) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 3: Disease activity (various scales, lower scores indicate less disease activity)" data-id="CD014816-fig-0010" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 3: Disease activity (various scales, lower scores indicate less disease activity) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 4: Pain (SF‐36 Pain domain, score 0–100, lower scores indicate less pain)" data-id="CD014816-fig-0011" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 4: Pain (SF‐36 Pain domain, score 0–100, lower scores indicate less pain) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 5: Withdrawals for any reason" data-id="CD014816-fig-0012" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 5: Withdrawals for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 6: Aerobic capacity (peak oxygen uptake, higher scores indicate better aerobic capacity)" data-id="CD014816-fig-0013" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 6: Aerobic capacity (peak oxygen uptake, higher scores indicate better aerobic capacity) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 7: Depression (various scales, lower score indicates less depression)" data-id="CD014816-fig-0014" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 7: Depression (various scales, lower score indicates less depression) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 8: Anxiety (HADS Anxiety, score 0–21, lower score indicates less anxiety)" data-id="CD014816-fig-0015" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone), Outcome 8: Anxiety (HADS Anxiety, score 0–21, lower score indicates less anxiety) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 1: Fatigue (various scales, lower score indicate less fatigue)" data-id="CD014816-fig-0016" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 1: Fatigue (various scales, lower score indicate less fatigue) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 2: Functional capacity (various scales, higher scores indicate better functional capacity)" data-id="CD014816-fig-0017" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 2: Functional capacity (various scales, higher scores indicate better functional capacity) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 3: Disease activity (various scales, lower scores indicate less disease activity)" data-id="CD014816-fig-0018" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 3: Disease activity (various scales, lower scores indicate less disease activity) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 4: Pain (various scales, lower score indicates less pain)" data-id="CD014816-fig-0019" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 4: Pain (various scales, lower score indicates less pain) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 5: Withdrawals for any reason" data-id="CD014816-fig-0020" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 5: Withdrawals for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 6: Aerobic capacity (peak oxygen uptake, higher scores indicate better aerobic capacity)" data-id="CD014816-fig-0021" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 6: Aerobic capacity (peak oxygen uptake, higher scores indicate better aerobic capacity) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 7: Depression (BDI, score 0–63, lower scores indicate less depression)" data-id="CD014816-fig-0022" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 7: Depression (BDI, score 0–63, lower scores indicate less depression) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014816-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/urn:x-wiley:14651858:media:CD014816:CD014816-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 8: Anxiety (HADS Anxiety, score 0–21, lower score indicates less anxiety)" data-id="CD014816-fig-0023" src="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_t/tCD014816-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control), Outcome 8: Anxiety (HADS Anxiety, score 0–21, lower score indicates less anxiety) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/media/CDSR/CD014816/image_n/nCD014816-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD014816-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to placebo plus usual pharmacological care for systemic lupus erythematosus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise plus usual pharmacological care compared to placebo plus usual pharmacological care for systemic lupus erythematosus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> systemic lupus erythematosus<br/><b>Setting:</b> community<br/><b>Intervention:</b> exercise plus usual pharmacological care <br/><b>Comparison:</b> placebo plus usual pharmacological care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo plus usual pharmacological care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with exercise plus usual pharmacological care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue (FACIT‐Fatigue, score 0‐52, lower scores indicate less fatigue)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fatigue (FACIT‐Fatigue, score 0‐52, lower scores indicate less fatigue) was <b>38</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>5 points lower</b><br/>(13.29 lower to 3.29 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may have little to no effect on fatigue.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional capacity (SF‐36 Function Capacity domain, score 0‐100, higher scores indicate better functional capacity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional capacity (SF‐36 Function Capacity domain, score 0‐100, higher scores indicate better functional capacity) was <b>70</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.5 points lower</b><br/>(23.78 lower to 18.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may have little to no effect on functional capacity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (SF‐36 Pain domain, score 0‐100, lower scores indicate less pain)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain (SF‐36 Pain domain, score 0‐100, lower scores indicate less pain) was <b>43</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>9 points lower</b><br/>(28.88 lower to 10.88 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may have little to no effect on pain.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease activity ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured at baseline, but it was not reported at end of intervention.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured, but the Mental Component Summary score was not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals due to any reason<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>273 per 1000</b><br/>(34 to 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.73</b><br/>(0.34 to 22.16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise results in fewer or more withdrawals.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_432987629440706015" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_432987629440706015</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Usual pharmacological care consisted of immunosuppressants and glucocorticoids.<br/><sup>b</sup> Downgraded one level due to risk of detection and potentially selection bias.<br/><sup>c</sup> Downgraded one level due to small number of participants from a single trial. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to placebo plus usual pharmacological care for systemic lupus erythematosus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014816-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to usual pharmacological care alone for systemic lupus erythematosus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise plus usual pharmacological care compared to usual pharmacological care alone for systemic lupus erythematosus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> systemic lupus erythematosus<br/><b>Setting:</b> community<br/><b>Intervention:</b> exercise plus usual pharmacological care<br/><b>Comparison:</b> usual pharmacological care alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with usual pharmacological care alone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with exercise plus usual pharmacological care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue (Fatigue Severity Scale, score 1‐7, lower score indicates less fatigue)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fatigue (Fatigue Severity Scale, score 1‐7, lower score indicates less fatigue) was <b>5.4</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 points lower</b><br/>(1.4 lower to 0.2 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may have little to no effect on fatigue.<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity) was <b>60</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>5.4 points higher</b><br/>(5.97 lower to 16.75 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may have little to no effect on functional capacity. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease activity (SLEDAI scale, scores 0‐105, lower scores indicate less disease activity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease activity (SLEDAI scale, scores 0‐105, lower scores indicate less disease activity) was <b>0.5</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.26 points lower</b><br/>(3.69 lower to 3.17 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may have little to no effect on disease activity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured, but the Mental Component Summary score was not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) was <b>38</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>16 points higher</b><br/>(0.18 lower to 32.18 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise improves pain.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals due to any reason<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>161 per 1000</b><br/>(93 to 280) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b><br/>(0.53 to 1.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise results in fewer or more withdrawals.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149155812397472" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149155812397472</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for risk of detection bias in unblinded trials with self‐reported outcomes.<br/><sup>b</sup> Downgraded one level due to low participant numbers and the confidence intervals included a large effect and no effect.<br/><sup>c</sup> Usual pharmacological care consists of immunosuppressants, steroids and antimalarials </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to usual pharmacological care alone for systemic lupus erythematosus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014816-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to another intervention (education, joint aids, or relaxation) plus usual pharmacological care for systemic lupus erythematosus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise plus usual pharmacological care compared to another intervention (education, joint aids, or relaxation) plus usual pharmacological care for systemic lupus erythematosus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> systemic lupus erythematosus<br/><b>Setting:</b> community<br/><b>Intervention:</b> exercise plus usual pharmacological care<br/><b>Comparison:</b> another intervention (education, joint aids, or relaxation) plus usual pharmacological care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with another intervention (education, joint aids, or relaxation) plus usual pharmacological care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with exercise plus usual pharmacological care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue (Fatigue Severity Scale, scores 0‐7, lower scores indicate less fatigue)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fatigue (Fatigue Severity Scale, scores 0‐7, lower scores indicate less fatigue) was <b>5.3</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.51 points lower</b><br/>(0.88 lower to 0.14 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may reduce fatigue slightly.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional capacity (SF‐36 Physical Function domain, score 0‐100, higher scores indicate better functional capacity) was <b>41.4</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>13.2 points higher</b><br/>(6.17 higher to 20.22 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>182<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may increase functional capacity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease activity (SLEDAI scale, score 0‐105, lower scores indicate less disease activity)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease activity (SLEDAI scale, score 0‐105, lower scores indicate less disease activity) was <b>1.2</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.034 points higher</b><br/>(0.476 lower to 0.544 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care probably results in little to no difference in disease activity. SMD 0.02 (95% CI ‐0.28 to 0.32). Baseline control group SD for converting SMD to MD was 1.7 and taken from Abrahão 2016. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (VAS Pain scale, score 0‐10, lower scores indicate less pain)<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain (VAS Pain scale, score 0‐10, lower scores indicate less pain) was <b>4.97</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.59 points lower</b><br/>(2.46 lower to 0.71 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise plus usual pharmacological care may result in little to no difference in pain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals due to any reason<br/>follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b><br/>(6 to 289) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b><br/>(0.13 to 5.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether exercise results in fewer or more withdrawals.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was measured, but the Mental Component Summary score was not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149459092821699" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_433149459092821699</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level due to risk of detection bias in unblinded trials with self‐reported outcomes.<br/><sup>b</sup> Downgraded one level due to low participant numbers and the confidence intervals included a large effect and no effect.<br/><sup>c</sup> Downgraded one level due to possible imprecision. The confidence intervals included a small effect and a large effect.<br/><sup>d</sup> Downgraded two levels due to very few events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings table ‐ Exercise plus usual pharmacological care compared to another intervention (education, joint aids, or relaxation) plus usual pharmacological care for systemic lupus erythematosus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD014816-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of interventions in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b> Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of usual care</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of exercise group  </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of control group</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Trials with a placebo plus usual care control</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group included:</p> <p><b>Exercise group (n = 11)</b> </p> <p> <ol id="CD014816-list-0012"> <li> <p>Mean lupus treatment prednisone (change in daily dose) 5.3 (SD 5.3) mg</p> </li> <li> <p>Mean lupus treatment prednisone (change in cumulative dose 6 months) 896 (SD 337) months </p> </li> <li> <p>Mean lupus treatment time of prednisone use: 13.3 (SD 5.4) years</p> </li> </ol> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0013"> <li> <p>hydroxychloroquine: 8 (73%)</p> </li> <li> <p>immunosuppressants: 10 (90%)</p> </li> </ol> </p> <p><b>Control group (n = 10)</b> </p> <p> <ol id="CD014816-list-0014"> <li> <p>Mean lupus treatment prednisone (change in daily dose) 5.0 (SD 1.9) mg</p> </li> <li> <p>Mean lupus treatment prednisone (change in cumulative dose 6 months) 963 (SD 950) months </p> </li> <li> <p>Mean lupus treatment time of prednisone use: 14.8 (SD 7.1) years</p> </li> </ol> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0015"> <li> <p>hydroxychloroquine: 7 (70%)</p> </li> <li> <p>immunosuppressants: 7 (70%)</p> </li> </ol> </p> <p>No further information about their usual care was reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and whole body vibration exercise 2 times/week (24 hours between sessions) for 12 weeks. WBVE is a subgroup of resistance training, better classified as muscle activation or neuromuscular training complementary to resistance training. The participants were positioned on the vibrating platform (turned on) with 130° of knee flexion. It is unclear whether this was supervised. </p> <p><b>Intensity of exercise</b> </p> <p><b>Week 1–4:</b> 10 bouts of 30 s, frequency 30 Hz, D 1.23 mm, and a peak of 2.22 g.  </p> <p><b>Week 5–8:</b> 10 bouts of 60 s, frequency 40 Hz, D 0.95 mm, and a peak of 3.06 g.  </p> <p><b>Week 9–12:</b> 10 bouts of 60 s, frequency 50 Hz, D 0.88 mm, and a peak of 4.40 g. </p> <p><b>Time of exercise session</b> </p> <p><b>Week 1–4:</b> 2‐min warm‐up, 5‐min WBVE. </p> <p><b>Week 5–12:</b> 2‐min warm‐up, 10‐min WBVE. </p> <p>3 participants dropped out; 1 withdrew before 6‐week analysis due to low back pain ("not<br/>related directly with the intervention"), and 2 withdrew before 12‐week analysis for personal reasons. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and isometry<sup>a</sup> (they did not receive any vibration), 2 times/week (24 hours between sessions) for 12 weeks.  </p> <p><sup>a</sup>Participants were requested to maintain stance with 130° of knee flexion on the same vibrating platform (vibration turned off). It is unclear whether this was supervised. </p> <p><b>Intensity of exercise:</b> light‐to‐moderate intensity, warm‐up performed in the same way as in WBVE group. Cycles, working, and rest times corresponded to the weeks, consistent with the WBVE group, but without vibration. </p> <p><b>Time of exercise session</b> </p> <p><b>Week 1–4:</b> 2‐min warm‐up, 5‐min stood on platform.  </p> <p><b>Week 5–12:</b> 2‐min warm‐up, 10‐min stood on platform. </p> <p>1 participant withdrew before the 6‐week analysis for personal reasons. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p>Trials with a <b>usual care alone control </b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care was reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus an exercise programme that was supervised or performed independently at home. All participants were asked to perform 3 hours of exercise per week for 12 weeks. At start of programme, the home‐training group and supervised training group participated in a multidisciplinary information session about the benefits of exercise in SLE, during which practical information was also delivered. Participants in both groups were asked to record their number of training hours. </p> <p><b>Exercise group 1: home training</b> </p> <p>Participants performed endurance exercise (walking or bicycle) and strengthening exercises (elastic band or weights for upper and lower limbs), at home unsupervised. The targeted intensity was moderate (60–80% of theoretical maximal HR). The modified Borg scale was used to determine participant's perception of exertion at PWC75%. </p> <p><b>Exercise group 2: supervised training</b> </p> <p>Participants performed the same exercise programme; endurance exercise (walking or bicycle) and strengthening exercises (elastic band or weights for upper and lower limbs), in the hospital‐based revalidation centre under the supervision of the multidisciplinary team. Targeted intensity was moderate (60–80% of theoretical maximal HR). The modified Borg scale was used to determine participant's perception of exertion at PWC75%. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants did not attend the information session and were asked not to change their level of physical activity. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 17)</b> </p> <p> <ol id="CD014816-list-0016"> <li> <p>Mean cumulative prednisone dose: 31.2 (SD 33.7) g</p> </li> <li> <p>Mean prednisone dose: 11.5 (SD 12.8) mg</p> </li> <li> <p>Number of participants on the following medications:</p> <ol id="CD014816-list-0017"> <li> <p>prednisone: 12 (70.6%)</p> </li> <li> <p>azathioprine: 9 (52.9%)</p> </li> <li> <p>chloroquine: 11 (64.7%)</p> </li> <li> <p>methotrexate: 1 (5.9%)</p> </li> <li> <p>mycophenolate mofetil: 5 (29.4%)</p> </li> <li> <p>cyclophosphamide: 2 (11.8%)</p> </li> </ol> </li> </ol> </p> <p><b>Control group (n = 16)</b> </p> <p> <ol id="CD014816-list-0018"> <li> <p>Mean cumulative prednisone dose: 21.8 (SD 15.6) g</p> </li> <li> <p>Mean prednisone dose: 7.2 (SD 8.6) mg</p> </li> <li> <p>Number of participants on the following medications:</p> <ol id="CD014816-list-0019"> <li> <p>prednisone: 10 (62.5%)</p> </li> <li> <p>azathioprine: 7 (43.7%)</p> </li> <li> <p>chloroquine: 10 (62.5%)</p> </li> <li> <p>methotrexate: 4 (25.0%)</p> </li> <li> <p>mycophenolate mofetil: 2 (12.5%)</p> </li> <li> <p>cyclophosphamide: 0 (0%)</p> </li> </ol> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a combined resistance and cardiovascular supervised exercise training programme for 12 weeks. Participants performed approximately 30 min of cardiovascular endurance exercise and strength exercise, 2 times/week. Intensity was set at the HR corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants remained physically inactive.</p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 9)</b> </p> <p> <ol id="CD014816-list-0020"> <li> <p>Mean cumulative glucocorticoid dose: 42.1 (SD 31.8) g/kg</p> </li> <li> <p>Mean current glucocorticoid dose: 1.7 (SD 3.5) mg</p> </li> <li> <p>Number participants on the following medications:</p> <ol id="CD014816-list-0021"> <li> <p>Glucocorticoid: 2 (22%)</p> </li> <li> <p>Hydroxychloroquine: 5 (56%)</p> </li> <li> <p>Methotrexate: 2 (22%)</p> </li> <li> <p>Azathioprine: 5 (56%)</p> </li> <li> <p>Mycophenolate: 1 (11%)</p> </li> <li> <p>Cyclophosphamide: 0 (0%)</p> </li> <li> <p>Oral contraceptive: 6 (67%)</p> </li> </ol> </li> </ol> </p> <p><b>Control group (n = 10)</b> </p> <p> <ol id="CD014816-list-0022"> <li> <p>Mean cumulative glucocorticoid dose: 32.4 (SD 19.1) g/kg</p> </li> <li> <p>Mean current glucocorticoid dose: 2.0 (SD 4.2) mg</p> </li> <li> <p>Number of participants on the following medications:</p> <ol id="CD014816-list-0023"> <li> <p>glucocorticoid: 2 (20%)</p> </li> <li> <p>hydroxychloroquine: 7 (70%)</p> </li> <li> <p>methotrexate: 2 (20%)</p> </li> <li> <p>azathioprine: 4 (40%)</p> </li> <li> <p>mycophenolate: 2 (20%)</p> </li> <li> <p>cyclophosphamide: 0 (0%)</p> </li> <li> <p>oral contraceptive: 6 (60%)</p> </li> </ol> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a supervised aerobic exercise programme in an intrahospital gymnasium for 12 weeks. Participants performed 40–60 min of aerobic exercise (5‐min warm‐up, followed by 30–50 min of treadmill walking, and 5‐min cool‐down), 2 times/week. Walking duration was gradually increased every 4 weeks, from 30 min to 50 min. Intensity was set at the HR corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants were strongly instructed to maintain their usual living activities throughout the study. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (N=18)</b> </p> <p> <ol id="CD014816-list-0024"> <li> <p>Median prednisolone: 3.1 (quartiles Q1–Q3 0–5) mg</p> </li> <li> <p>Number of participants who are on:</p> <ol id="CD014816-list-0025"> <li> <p>beta‐blockers: 3</p> </li> </ol> </li> </ol> </p> <p><b>Control group (n = 17)</b> </p> <p> <ol id="CD014816-list-0026"> <li> <p>Median prednisolone: 1.3 (quartiles Q1–Q3 0–5) mg</p> </li> <li> <p>Number of participants who are on:</p> <ol id="CD014816-list-0027"> <li> <p>beta‐blockers: 1</p> </li> </ol> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a supervised combined aerobic and resistance exercise programme for 12 weeks. Participants performed 60‐min exercise programme 2 times/week. Participants were also followed up with exercise for 12 months; however the level of exercise supervision decreased over time. Programme consisted of 3 phases </p> <p><b>Phase 1 (0–3 months)</b> </p> <p>Consisted mainly aerobic exercise (about 20 min) and muscle strength and endurance exercise (about 15 min). Intensity was set as high (65–80% of maximum HR or a rating of 13–16 out of 20 on the BORG rating of perceived exertion scale) </p> <p><i>Note: participants could alternatively choose any preferred self‐managed high‐intensity physical activity, as some participants lived far from the hospital.</i> </p> <p>Phase also included a 1‐hour education session held by a rheumatologist and another by a physiotherapist to educate them on: their disease, the risk for cardiovascular disease, the treatment of the disease, and the importance of, and how to perform, physical activity and exercise. It also included education on how to use a HR monitor, how to assess intensity according to RPE scale, and how to document physical activity with modes, frequency, durations, and intensities. This phase also included supervised exercise training, 30 min of individual coaching of physical activity at 6 and 12 weeks, loan and use of HR monitor, and use of a physical activity diary. </p> <p><b>Phase 2 (4–9 months)</b> </p> <p>During this period, the physical activity was self‐managed with the help of videotapes or sound cassettes (or both) from the high‐intensity aerobic group exercise programme performed during the first 3 months. As an alternative, any physical activity at high intensity could be chosen. </p> <p>This phase included: 30‐min of individual coaching of physical activity at 6 and 9 months, use of HR monitor, and use of the physical activity diary. Participants also received 10 min of telephone support which reduced towards the end of the 12 months. </p> <p><b>Phase 3 (9–12 months)</b> </p> <p>This phase included: use of the HR monitor, and use of physical activity diary.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants were asked not to change their physical activity lifestyle during the study period. They were not given any specific information related to the study. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a combined aerobic and anaerobic supervised exercise programme for 8 weeks. Participants performed 60 min of exercise (commencing with 40 min in week 1), 3 times/week. The exercise programme included a 10‐min warm‐up, 10‐min of running on a treadmill, and 10 min of cycling, both at an intensity of 50–60% of their VO<sub>2max</sub>, followed by 60 min of Pilates training uses bodyweight resistance, and a 10‐min cool‐down. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about the control group reported. Assumed that control group continued with their usual care alone. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a partially supervised aerobic exercise programme for 12 weeks. Participants were encouraged to perform 30–50 min of aerobic exercise (consisting of walking, cycling, or swimming) 3 times/week. The target intensity was moderate; HR corresponding to 60% of peak oxygen consumption. Participants were seen by an exercise professional every 2 weeks for a supervised exercise session.  </p> <p>Comparator group included participants who received usual care plus a different non‐pharmacological intervention (relaxation practice). Participants listened to a relaxation audiotape in a quiet, warm, and darkened room for 30 min, 3 times/week. Participants were seen by an exercise professional every 2 weeks for a supervised relaxation session. This intervention is included as a control group comparator in the description below under 'trials with another non‐pharmacological intervention plus usual care control.' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants were asked to continue with their normal daily activity pattern and specifically asked to avoid doing any extra physical activities. They were reviewed at follow‐up but not seen at any other times. </p> <p>No further information reported.</p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p>Trials with <b>another non‐pharmacological intervention plus usual care control</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no clear information about their usual care, including the medications taken by participants. However, authors reported that there were changes in the use of medication to control disease activity in the control group, but without significant differences amongst groups (P = 0.34). It is also reported that the 2 exercise intervention groups (group 1: cardiovascular training, group 2: resistance training) had no changes in the use of medications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants in the 2 exercise groups received their usual care plus they performed 1 type of exercise, described below, 3 times/week, for 50 min for 12 weeks. Both exercise groups were supervised by trained professional in the Rheumatology Services at the Interlagos Specialty Outpatient Clinic. </p> <p><b>Exercise group 1: cardiovascular training group</b> </p> <p>Participants received walking and bicycle ergometer interventions (Model CLB 10 Classic, Caloi, São Paulo,<br/>Brazil) consisting of a 10‐min warm‐up, 30 min of exercise at target HR, and 10‐min cool‐down. The targeted intensity was moderate (65–75% of maximum HR according to the ACSM guidelines), determined by the HR reserve. </p> <p><b>Exercise group 2: resistance training group</b> </p> <p>Participants received a resistance training programme comprised of 8 exercises; holds (crucifix) with free weights, extension‐machine exercises, rowing exercise with an elastic band, knee flexion with ankle weights, 2‐arm biceps curls, adduction exercises with an elastic band, French curls, and abdominal exercises. The training involved small and large muscle group exercises. Participants performed 3 sets of 15 repetitions with rest intervals of 1 min between sets. The targeted intensity was moderate (65–75% of 1 repetition maximum according to the ACSM guidelines). To establish the training intensity for each participant, their 1 repetition maximum for each exercise was determined. Training intensity changed over time as the participants progressed. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and information about the disease, but no exercise intervention. They were informed that they would receive the intervention after the study was finished, and they would be invited to participate in the intervention that proved the most effective. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 16)</b> </p> <p> <ol id="CD014816-list-0028"> <li> <p>% of participants taking steroids: 38%</p> </li> <li> <p>% of participants taking NSAIDs: 31%</p> </li> </ol> </p> <p><b>Control group (n = 18)</b> </p> <p> <ol id="CD014816-list-0029"> <li> <p>% of participants taking steroids: 61%</p> </li> <li> <p>% of participants taking NSAIDs: 67%</p> </li> </ol> </p> <p>No further information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus unsupervised home aerobic exercise for 12 weeks. Participants performed 30 min of aerobic exercise (cycling on a stationary bike that was set up in their home) 3 times/week. The target intensity was moderate to high (60–80% of maximum HR achieved on the exercise tolerance test).  </p> <p>A physiotherapist contacted the participant once a week to update their exercise log, report any symptoms, and ask about their perceived fatigue. Pulse oximeters were provided to help participants monitor their heart rates and as a compliance‐enhancing strategy. The physiotherapist instructed the participant at home when setting up the bike, and made a second visit 2–3 weeks later at an exercise session to check the participants' ability to follow the regimen correctly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus they were contacted by the research team oncer per week as an attention control group. They were also asked to fill out questionnaires, and were encouraged to maintain their current level of activity during the 12‐week programme. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 18)</b> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0030"> <li> <p>prednisone: 10 (55%)</p> <ol id="CD014816-list-0031"> <li> <p>median current prednisone dose: 2 (minimum–maximum 0–40) mg</p> </li> </ol> </li> <li> <p>antimalarials: 13 (72.2%)</p> </li> <li> <p>immunosuppressives: 8 (44.4%) </p> </li> <li> <p>antihypertensives: 3 (16.7%) </p> </li> <li> <p>aspirin: 2 (11.1%) </p> </li> <li> <p>contraceptives: 3 (16.7%)</p> </li> </ol> </p> <p><b>Control group (n = 20)</b> </p> <p>Number (%) of participants on the following medications:</p> <p> <ol id="CD014816-list-0032"> <li> <p>prednisone: 13 (65%) </p> <ol id="CD014816-list-0033"> <li> <p>median of current prednisone dose: 5 (minimum–maximum 0–30)</p> </li> </ol> </li> <li> <p>antimalarials: 16 (80%) </p> </li> <li> <p>immunosuppressives: 14 (70%)</p> </li> <li> <p>antihypertensives: 7 (35%)</p> </li> <li> <p>aspirin: 3 (15%)</p> </li> <li> <p>contraceptive: 8 (40%)</p> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus an aerobic exercise programme for 16 weeks. Participants performed 60 min of outdoor walking (10‐min warm‐up, 40 min of walking, 10‐min cool‐down), 3 times/week. Target intensity set at a HR corresponding to the ventilatory 1 threshold obtained from ergospirometry and monitored by frequency meter. Participants met in the morning at a public park, supervised by a physical educator or physician. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and information about the disease, but no exercise intervention. They received clear instruction not to start any exercise programme for the next 16 weeks. </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a home‐based exercise programme for 12 weeks. Participants performed approximately 40 min of combined aerobic and resistance exercise (3–5 min warm‐up, 30 min combined aerobic and resistance exercises, 5 min relaxation and stretching; the exercise programme comprised a 7‐ to 8‐min set of combined aerobic and resistance exercise such as high knees/shuffle runs/biceps curls etc., and participants had to perform 4 sets). The target intensity was moderate, determined by the HR reserve. The research team member contacted participants periodically by telephone or text messages to ensure their compliance. Each week the participants reported their maximal HR after each exercise session using written logs. Instructed by an exercise physiologist/professional exercise instructor on the performance of aerobic exercise combined with resistance training and the skills of HR measurement at rest and after exercise. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care and information about the disease, but no exercise intervention. They were to maintain their usual lifestyle.  </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 32)</b> </p> <p>Number (%) of participants on the following medications: </p> <p> <ol id="CD014816-list-0034"> <li> <p>corticosteroids: 20 (54.1%) *<i>note that the percentage seems to be reported incorrectly in the study.</i> </p> <ol id="CD014816-list-0035"> <li> <p>Mean prednisolone dosage: 4.63 (SD 5.55) mg</p> </li> </ol> </li> <li> <p>hydroxychloroquine: 26 (81.3%)</p> </li> <li> <p>immunosuppressive agents: 15 (46.9%)</p> </li> <li> <p>biological agents: 1 (3.1%)</p> </li> </ol> </p> <p><b>Control group (n = 30)</b> </p> <p>Number (%) of participants on the following medications: </p> <p> <ol id="CD014816-list-0036"> <li> <p>corticosteroids: 17 (46%) *<i>note that the percentage seems to be reported incorrectly in the study.</i> </p> <ol id="CD014816-list-0037"> <li> <p>Mean prednisolone dosage: 4.97 (SD 5.80) mg</p> </li> </ol> </li> <li> <p>hydroxychloroquine: 25 (83.3%) </p> </li> <li> <p>immunosuppressive agents: 15 (50%)</p> </li> <li> <p>biological agents: 3 (10%)</p> </li> </ol> </p> <p>No further information about their usual care reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus an upper limb combined resistance and stretching exercise programme for 12 weeks, and were followed up at 24 weeks. Participants performed 30 min of upper limb exercises (9 strengthening and stretching exercises for the upper extremities with a stick, 10 strengthening and stretching exercises for the fingers, and 11 strengthening exercises against resistance with therapeutic putty) daily. The initial intensity was set at a moderate level, and the programme was reassessed using a modified Borg Scale (a tool to measure a persons' perception of their effort and exertion, breathlessness, and fatigue during physical work) to maintain the same intensity, in every face‐to‐face session with the hand therapist at 0, 3, 6, and 9 weeks. It is unclear whether this programme was supervised. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus they 4 sessions of training in alternative methods of performing daily activities, use of aids, joint protection, and energy conservation, additionally to assessment at baseline, 6, 12, and 24 weeks, in order to keep them committed and motivated. All participants received the same training in alternative methods of performing daily activities, use of aids, joint protection and energy conservation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The SLE treatment outlined at baseline for each intervention group.</p> <p><b>Exercise group (n = 14)</b> </p> <p>Number of participants on the following medications: </p> <p> <ol id="CD014816-list-0038"> <li> <p>prednisone: 10 (66.7%)</p> </li> <li> <p>prednisone ≥ 20 mg/day: 2 (12.3%) </p> </li> <li> <p>azathioprine: 8 (53.3%)</p> </li> <li> <p>chloroquine: 12 (80%)</p> </li> <li> <p>methotrexate: 1 (6.7%) </p> </li> <li> <p>mycophenolate mofetil: 4 (26.7%)</p> </li> <li> <p>cyclophosphamide: 1 (6.7%)</p> </li> <li> <p>medroxyprogesterone: 4 (26.7%)</p> </li> </ol> </p> <p><b>Control group (n = 10)</b> </p> <p>Number of participants on the following medications: </p> <p> <ol id="CD014816-list-0039"> <li> <p>prednisone: 8 (61.5%)</p> </li> <li> <p>prednisone ≥ 20 mg/day: 1 (7.1%)</p> </li> <li> <p>azathioprine: 5 (38.4%)</p> </li> <li> <p>chloroquine: 12 (92.3%) </p> </li> <li> <p>methotrexate: 3 (23.0%)</p> </li> <li> <p>mycophenolate mofetil: 2 (15.3%)</p> </li> <li> <p>cyclophosphamide: 0 (0%)</p> </li> <li> <p>medroxyprogesterone: 7 (53.8%)</p> </li> </ol> </p> <p>No further information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The participants received usual care plus a supervised combined resistance and aerobic exercise programme for 12 weeks. Participants performed approximately 80 min of exercise (5‐min treadmill warm‐up, 35–40 min of resistance training, 30 min of treadmill aerobic training, and 5 min of stretching). Resistance training included 7 exercises for the main muscle groups (e.g. bench press, leg press, leg extension); 2 sets of 15–20 repetition maximum for each exercise in week 1, and 4 sets of 8–12 repetitions maximum every week after that, 2 times/week. Intensity was set at a HR corresponding to the interval between Ventilatory anaerobic threshold and 10% below respiratory compensation point. All sessions were monitored by 1 fitness professional. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus information about their disease, but no exercise intervention. They were advised to remain physically inactive.  </p> <p>No further information reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about their usual care described.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a partially supervised aerobic exercise programme for 12 weeks. Participants were encouraged to perform 30–50 min of aerobic exercise (consisting of walking, cycling, or swimming) 3 times/week. Target intensity was moderate; HR corresponding to 60% of peak oxygen consumption. Participants were seen by an exercise professional every 2 weeks for a supervised exercise session.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received usual care plus a different non‐pharmacological intervention (relaxation practice). Participants listened to a relaxation audiotape in a quiet, warm, and darkened room for 30 min, 3 times/week. Participants were seen by an exercise professional every 2 weeks for a supervised relaxation session. This intervention was included as a control group comparator in the description above under 'Trials with a usual care alone control.' </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; HR: heart rate; NSAID: non‐steroidal anti‐inflammatory drug; PWC75%: 75% of the predicted maximal heart rate; RPE: rating of perceived exertion; SD: standard deviation; SLE: systemic lupus erythematosus. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of interventions in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD014816-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Characteristics of exercise intervention in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dosage of exercise (frequency, intensity, time, type), duration of exercise intervention, progressions to programme (if any), and equipment used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Setting of exercise (supervision, provider expertise, setting of exercise, individual or group)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Country</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Trials that compared exercise plus usual care to a placebo plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week (24 hours between sessions). </p> <p><b>Intensity of exercise</b>  </p> <p> <ol id="CD014816-list-0043"> <li> <p>Weeks 1–4: 10 bouts of 30 s, frequency 30 Hz, D 1.23 mm, and a peak of 2.22 g. </p> </li> <li> <p>Weeks 5–8: 10 bouts of 60 s, frequency 40 Hz, D 0.95 mm, and a peak of 3.06 g. </p> </li> <li> <p>Weeks 9–12: 10 bouts of 60 s, 50 Hz, D 0.88 mm, and a peak of 4.40 g.</p> </li> </ol> </p> <p>The "low" amplitude was maintained in all sessions.</p> <p><b>Time of exercise session</b> </p> <p> <ol id="CD014816-list-0044"> <li> <p>Weeks 1–4: 2‐min warm‐up on a cycle ergometer pedalling continuously with no defined load, and 5‐min WBVE. </p> </li> <li> <p>Weeks 5–12: 2‐min warm‐up on a cycle ergometer pedalling continuously with no defined load, and 10‐min WBVE. </p> </li> </ol> </p> <p><b>Type of exercise:</b> WBVE is a subgroup of resistance training, better classified as muscle activation or neuromuscular training complementary to resistance training. The participants were positioned on the vibrating platform with 130° of knee flexion.  </p> <p><b>Duration of intervention:</b> 12 weeks </p> <p><b>Progressions:</b> described above </p> <p><b>Equipment used:</b> vertical vibrating platform used in the study was of the triaxial type, where the base moves vertically and horizontally directions (with predominantly vertical displacement), model Power Plate Pro5 (Power Plate International, Performance Health Systems, USA). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> unclear if there was supervision present during the intervention.  </p> <p><b>Provider:</b> not reported </p> <p><b>Setting of exercise:</b> not clearly reported.<br/><b>Individual or group:</b> given that participants were positioned on a single vibration platform, this exercise intervention was performed individually; however, it was unclear whether multiple participants performed this together in a clinic, or unsupervised at home. </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to usual care alone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the start of the programme, the 2 groups (supervised training group and home training group) participated in a multidisciplinary information session about the benefits of exercise in SLE, during which practical information was also delivered. </p> <p><b>Frequency of exercise sessions:</b> not clearly reported. However, participants were advised to perform 3 hours of exercise per week. </p> <p><b>Intensity of exercise:</b> moderate to high (60–80% of predicted maximal heart rate) </p> <p><b>Time of exercise session:</b> not clearly reported. However, participants were advised to perform 3 hours of exercise per week. </p> <p><b>Type of exercise:</b> participants were advised to perform cardiovascular endurance exercise (walking or cycling), or strengthening exercises.  </p> <p><b>Duration of intervention:</b> 12 weeks </p> <p><b>Progression:</b> not clearly reported. </p> <p><b>Equipment used:</b> </p> <p> <ol id="CD014816-list-0045"> <li> <p>Endurance exercises (walking or bicycle)</p> </li> <li> <p>Strengthening exercises (elastic band or weights for both upper and lower limbs)</p> </li> </ol> </p> <p>Note that the intervention dosage were the same in both groups. The groups only differed by the level of supervision and setting of exercise. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise intervention group 1 (supervised training group)</b> </p> <p> <ol id="CD014816-list-0046"> <li> <p><b>Supervision:</b> yes </p> </li> <li> <p><b>Provider:</b> participant were supervised by a multidisciplinary team in the hospital </p> </li> <li> <p><b>Place of exercise:</b> hospital‐based revalidation centre </p> </li> <li> <p><b>Individual or group:</b> not clearly reported </p> </li> </ol> </p> <p><b>Exercise intervention group 2 (home training group)</b> </p> <p> <ol id="CD014816-list-0047"> <li> <p><b>Supervision:</b> no </p> </li> <li> <p><b>Place of exercise:</b> home </p> </li> <li> <p><b>Individual or group:</b> not clearly reported </p> </li> </ol> </p> <p> </p> <p> </p> <p> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Belgium</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> <p><b>Time of exercise session:</b> cardiovascular endurance exercise = 30 min and strength exercise = time not specified, per session. </p> <p><b>Type of exercise:</b> cardiovascular endurance exercise (treadmill walking) and strength exercises (7 exercises for major muscle groups: 4 sets of 8–12 repetitions maximum for each exercise) </p> <p><b>Duration of intervention:</b> 12 weeks </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not reported </p> <p><b>Place of exercise:</b> not reported </p> <p><b>Individual or group:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point </p> <p><b>Time of exercise session:</b> 40–60 min (including a 5‐min warm‐up and 5‐min cool‐down) </p> <p><b>Type of exercise:</b> cardiovascular endurance (treadmill walking) </p> <p><b>Duration of exercise intervention:</b> 12 weeks </p> <p><b>Progression:</b> walking duration gradually increased every 4 weeks, from 30 min to 50 min </p> <p><b>Equipment used:</b> treadmill </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not reported </p> <p><b>Place of exercise:</b> intrahospital gymnasium (Laboratory of Assessment and Conditioning in Rheumatology, School of Medicine, University of São Paulo) </p> <p><b>Individual or group:</b> not clearly reported. However, given that participants were walking on a treadmill, it was assumed to be individual. Whether participants performed treadmill walking with other participants in the clinic was not clear </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week (supervised) </p> <p><b>Intensity of exercise:</b> high (65–80% of MHR, or 13–16 rate of perceived exertion) </p> <p><b>Time of exercise session:</b> 60 min (20 min aerobic and 15 min strength) </p> <p><b>Type of exercise</b> </p> <p> <ol id="CD014816-list-0048"> <li> <p><b>0–3 months:</b> education about the disease and exercise (1‐off 1‐hour workshop), supervised aerobic and strength exercise, individual coaching of physical activity (30 min of individual coaching at the start and after 6 weeks and 12 weeks), loan and use of heart rate monitor, and use of a physical activity diary. </p> </li> <li> <p><b>4–9 months:</b> individual coaching of physical activity, use of heart rate monitor, and the use of a physical activity diary, self‐managed aerobic and strength exercise. </p> </li> <li> <p><b>10–12 months:</b> use of heart rate monitor and the use of a physical activity diary, self‐managed aerobic and strength exercise. </p> </li> </ol> </p> <p><b>Duration of exercise intervention</b> </p> <p> <ol id="CD014816-list-0049"> <li> <p>Phase 1: 0–3 months</p> </li> <li> <p>Phase 2: 4–12 months</p> </li> </ol> </p> <p><b>Progression:</b> participants were asked to successively increase their physical activity during the programme to achieve: 1. high intensity, ≥ 30 min per session, 2–3 days/week, and 2. low‐to‐moderate intensity, ≥ 30 min per session, 4–5 days/week. </p> <p><b>Equipment used:</b> treadmill, heart rate monitor, activity diary. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision/support</b>  </p> <p> <ol id="CD014816-list-0050"> <li> <p>Phase 1: more supervision; education about the disease and exercise was offered in a 1‐hour workshop at the start. 2 supervised high‐intensity aerobic exercise sessions were offered during the first 3 months in the hospital gymnasium. However, participants could choose to perform their own 2 high‐intensity exercise sessions if the hospital was not convenient for them to get to. Participants were also encouraged to perform low‐to‐moderate exercise 4–5 days per week on their own during this time. Individual coaching for 30 min was offered at the start, and 6 and 12 weeks. </p> </li> <li> <p>Phase 2: less supervision; this was assisted by videotapes and cassettes of the 2 high‐intensity exercise sessions performed during phase 1. Participants were also encouraged to perform low‐to‐moderate exercise 4–5 days/week on their own during this time. Individual coaching for 30 min was also offered at months 6 and 9. They also received telephone support for approximately 10 min and the frequency of this was reduced during the 4‐ to 12‐month period (months 4–6, every third week; months 7–9, once per month; months 10–12, no support). </p> </li> <li> <p><b>Provider:</b> physiotherapist provided the education, individual coaching, and the supervision of the exercise. A rheumatologist was also present during the education session at the start of the programme. </p> </li> <li> <p><b>Place of exercise:</b> hospital gymnasium, at home/their choice of location. </p> </li> <li> <p><b>Individual or group:</b> group‐based when under supervision, individual or group if they were performing exercise at home/their choice of location. </p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> stage 2 of the session (aerobic exercise programme, including 10 min of cycling and 10 min of running, both at intensity of 50–60% maximum, as predetermined in the peak oxygen uptake measurements). </p> <p><b>Time of exercise session:</b> 60 min per session (40 min for the first week, to allow for acclimatisation, but increased thereafter)  </p> <p><b>Type of exercise:</b> Pilates exercise, which is classified as low‐intensity resistance exercise. Each exercise session consisted of 4 stages, including 10‐min warm‐up, 10‐min aerobic exercise programme (10 min cycling and 10 min running), 60‐min Pilates training using bodyweight as the resistive load, and 10‐min cool‐down. Borg's scale was used to assess the participants' perceptions of physical exertion during the aerobic exercises that were used in stage 2. </p> <p><b>Duration of intervention:</b> 8 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> not reported </p> <p><b>Provider:</b> not reported </p> <p><b>Setting of exercise:</b> not reported </p> <p><b>Individual or group:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to 60% of peak oxygen consumption </p> <p><b>Time of exercise session:</b> 30–50 min </p> <p><b>Type of exercise:</b> home‐based cardiovascular exercise (mainly walking, swimming, or cycling) with a supervised exercise session every 2 weeks </p> <p><b>Duration of exercise intervention:</b> 12 weeks </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not clearly reported. </p> <p><b>Place of exercise:</b> home‐based, with a supervised exercise session every 2 weeks. </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to another non‐pharmacological intervention plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week  </p> <p><b>Intensity of exercise:</b> moderate intensity (65–75% of MHR according to the ACSM guidelines). Exercise intensity was determined by HRR, which was calculated by HRR = MHR – RHR. MHR determined using: MHR = 205 − (0.42 × age). </p> <p><b>Time of exercise session:</b> 50 min per session </p> <p><b>Type of exercise</b>  </p> <p> <ol id="CD014816-list-0051"> <li> <p>Cardiovascular exercise; walking and bicycle ergometry interventions. Each training session consisted of a 10‐min warm‐up followed by 30 min of exercise at the target heart rate, and 10‐min cool‐down. </p> </li> <li> <p>Resistance training exercise. Each session consisted of 8 exercises, including holds (crucifix) with free weights, extension‐machine exercises, rowing exercise with an elastic band, knee flexion with ankle weights, 2‐arm biceps curls, adduction exercises with an elastic band, French curls, and abdominal exercises. The training involved small and large muscle group exercises. Participants performed 3 sets of 15 repetitions with rest intervals of 1 min between sets. </p> </li> </ol> </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> training intensity changed over time as the participants progressed. Progression unknown.  </p> <p><b>Equipment used:</b> bicycle ergometry (Model CLB 10 Classic, Caloi, Sao Paulo, Brazil), free weights, extension‐machine, and elastic bands </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> trained professional (profession unknown) </p> <p><b>Place of exercise:</b> in the Rheumatology Services at the Interlagos Specialty Outpatient Clinic </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week  </p> <p><b>Intensity of exercise:</b> moderate–high (60–80% of MHR achieved on the exercise tolerance test) </p> <p><b>Time of exercise session:</b> 30 min per session </p> <p><b>Type of exercise:</b> aerobic exercise performed on a stationary bike that was set up in their home. </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> stationary bike </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> a physiotherapist contacted the participant once a week to update logs of exercise, report of symptoms, and perceived fatigue. The physiotherapist instructed the participant at home when setting up the bike, and made a second visit 2–3 weeks later at an exercise session to check the participants' ability to follow the regimen correctly. </p> <p><b>Place of exercise:</b> participants' homes </p> <p><b>Individual or group:</b> individual (participants completed their sessions in their own homes, independently)  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the ventilatory 1 threshold obtained from ergospirometry and monitored by frequency meter (Poland Electro, Kempele, Finland).  </p> <p><b>Time of exercise session:</b> 60 min per session (10‐min warm‐up, 40‐min of walking and 10‐min cool‐down) </p> <p><b>Type of exercise:</b> walking, outdoors in the morning </p> <p><b>Duration of exercise intervention:</b> 16 weeks  </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> none<b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes  </p> <p><b>Provider:</b> physical educator or physician </p> <p><b>Place of exercise:</b> park, outdoors  </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 5 times/week </p> <p><b>Intensity of exercise:</b> moderate intensity determined by HRR 50–50%, according to the ACSM guidelines. HRR = MHR − RHR. MHR determined using formula: MHR = 205 − (0.42 × age). </p> <p><b>Time of exercise session:</b> 30 min per session (3‐ to 5‐min warm‐up session, 4 sets of combined exercise session for approximately 30 min in total, and a final set of 3‐ to 5‐min of relaxation and stretching). Each set of combined exercise lasting for 7 min 15 s, with a brief break between sets.  </p> <p><b>Type of exercise:</b> aerobic exercise combined with bodyweight or 500–620 mL of dumbbell water weights for resistance training. Combined exercise sessions consisted of various styles of basic exercises, alternating workouts of legs with trunk movement, and arm exercises. </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> 500–620 mL of dumbbell water weights </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> instructed by an exercise physiologist/professional exercise instructor on the performance of aerobic exercise combined with resistance training and the skills of heart rate measurement at rest and after exercise. The research team member contacted participants periodically by telephone or text message to ensure their compliance. Each week, the participants reported their maximal heart rate after each exercise session by written logs.  </p> <p><b>Place of exercise:</b> participant's home </p> <p><b>Individual or group:</b> individual (considering each participant was performing the exercise intervention in their own home) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Taiwan </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 7 days/week  </p> <p><b>Intensity of exercise:</b> moderate intensity. The initial intensity of exercise was set at a moderate level and the programme was reassessed, using a modified Borg Scale (a tool to measure a persons' perception of their effort and exertion, breathlessness, and fatigue during physical work) to maintain the same intensity, in every face‐to‐face session with the hand therapist at 0, 3, 6, and 9 weeks.  </p> <p><b>Time of exercise session:</b> 30 min per session  </p> <p><b>Type of exercise:</b> upper limb resistance and range of motion exercise (9 strengthening and stretching exercises for the upper extremities with a stick, 10 strengthening and stretching exercises for the fingers and 11 strengthening exercises against resistance with therapeutic putty). </p> <p><b>Duration of exercise intervention:</b> 12 weeks (with a follow‐up assessment at 24 weeks) </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> therapeutic putty (soft or medium resistance) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> not reported  </p> <p><b>Provider:</b> team of hand therapists. Frequency of visits to the hand therapist, unknown.  </p> <p><b>Place of exercise:</b> home‐based programme  </p> <p><b>Individual or group:</b> individual (taking into account participants were performing their exercise programme at home) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greece</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 2 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to the interval between ventilatory anaerobic threshold and 10% below respiratory compensation point. </p> <p><b>Time of exercise session:</b> 80 min per session (5‐min treadmill warm‐up, 35–40 min of resistance training, 30 min of treadmill aerobic training, and 5‐min of stretching). </p> <p><b>Type of exercise:</b> cardiovascular exercise (treadmill walking for 30 min), and resistance training included 7 exercises for the main muscle groups (e.g. bench press, leg press, leg extension).  </p> <p><b>Duration of exercise intervention:</b> 12 weeks  </p> <p><b>Progression:</b> participants were required to perform 4 sets of 8–12 repetitions maximum, except during the first week, when a reduced volume of 2 sets of 15–20 repetitions maximum for each exercise was performed (as an adaptation period to resistance training). Overload progression was implemented when the participant could perform &gt; 12 repetitions on the last training set for 2 consecutive workouts. Aerobic training intensity was set at the corresponding heart rate between the ventilatory anaerobic threshold and 10% below the respiratory compensation point. Cardiorespiratory exercise test was performed on a treadmill (Centurion, Model 200, Micromed) using a maximal‐graded exercise protocol. The recovery period was set at 2 min using the initial workload (1.7 miles per hour).  </p> <p><b>Equipment used:</b> treadmill and resistance training equipment (e.g. machine weights or dumbbells); however, this was not clearly reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> 1 fitness professional  </p> <p><b>Place of exercise:</b> hospital gymnasium  </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of exercise sessions:</b> 3 times/week </p> <p><b>Intensity of exercise:</b> heart rate corresponding to 60% of peak oxygen consumption </p> <p><b>Time of exercise session:</b> 30–50 min </p> <p><b>Type of exercise:</b> home‐based cardiovascular exercise (mainly walking, swimming, or cycling) with a supervised exercise session every 2 weeks </p> <p><b>Duration of exercise intervention:</b> 12 weeks </p> <p><b>Progression:</b> not reported </p> <p><b>Equipment used:</b> not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supervision:</b> yes </p> <p><b>Provider:</b> not clearly reported </p> <p><b>Place of exercise:</b> home‐based, with a supervised exercise session every 2 weeks </p> <p><b>Individual or group:</b> not clearly reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; HRR: heart rate reserve; MHR: maximum heart rate; RHR: resting heart rate; SLE: systemic lupus erythematosus; WBVE: whole body vibration exercise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Characteristics of exercise intervention in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD014816-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Major outcomes reported in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fatigue</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Functional capacity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Disease activity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Quality of life </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pain</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Serious adverse events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Withdrawals due to adverse events</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Trials that compared exercise plus usual care to placebo plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>The Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT‐F)</b> </p> <p> <ol id="CD014816-list-0053"> <li> <p>Score range: score 0–52, higher scores indicate less fatigue</p> </li> </ol> </p> <p>SF‐35 Vitality domain was also used; however, this was not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Functional Capacity domain </b> </p> <p> <ol id="CD014816-list-0054"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> <p>HAQ and TUG test were also used to assess functional capacity; however, these were not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>SF‐36 was used to measure quality of life; however, authors did not report the MCS and PCS scores, so this was not used in our analyses.  </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Pain domain</b> </p> <p> <ol id="CD014816-list-0055"> <li> <p>Score range 0–100, higher scores indicate less pain</p> </li> </ol> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to usual care alone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Krupp FSS</b>  </p> <p> <ol id="CD014816-list-0056"> <li> <p>Score range: 1–7, lower score indicates less fatigue</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. 1 participant withdrew from study due to a disease flare; however, unclear which group they were part of, and, therefore, unable to be included in meta‐analysis. It is also important to note that it is unclear whether the disease flare was due to the intervention, the severity of the disease flare, or whether they were hospitalised. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>2 participants withdrew from the study. </b> </p> <p> <ol id="CD014816-list-0057"> <li> <p>1 from the control group due to a disease flare</p> </li> <li> <p>1 from the exercise group due to a disease flare</p> </li> </ol> </p> <p>However, it is important to note that it was unclear whether the disease flare was due to the intervention, the severity of the disease flare, or whether they were hospitalised. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> <p>SF‐36 Vitality domain was used; however, this was not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SF‐36 Physical Function domain </b> </p> <p> <ol id="CD014816-list-0058"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0059"> <li> <p>Score range: 0–105, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>Used SF‐36 to measure quality of life; however, authors did not report MCS and PCS scores, and, therefore, this was not used in our analyses.  </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Pain  </b> </p> <p> <ol id="CD014816-list-0060"> <li> <p>Score range 0–100, higher scores indicate less pain</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Krupp FSS</b> </p> <p> <ol id="CD014816-list-0061"> <li> <p>Score range 1–7, lower score indicates less fatigue</p> </li> </ol> </p> <p>Chalder Fatigue Scale, Visual Analogue Scale, and  SF‐36 Fatigue and Vitality domains were also used; however, these were not used in our analyses.   </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SF‐36 Physical Function domain  </b> </p> <p> <ol id="CD014816-list-0062"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Systemic Lupus Activity Measure </b> </p> <p> <ol id="CD014816-list-0063"> <li> <p>Score range 0–83, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>Used SF‐36 to measure quality of life; however, authors did not report the MCS score, PCS score, and all 8 domains, and, therefore, this was not used in our analyses. </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> <p>Used SF‐36 to measure quality of life, but authors did not report the Pain domain, and, therefore, this was not used in our analyses. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to another non‐pharmacological intervention plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐35 Physical Function domain  </b> </p> <p> <ol id="CD014816-list-0064"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0065"> <li> <p>Score range: 0–105, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>SF‐36 used to measure quality of life; however, authors did not report the MCS and PCS scores, and, therefore, this was not used in our analyses.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SF‐36 Pain domain </b> </p> <p> <ol id="CD014816-list-0066"> <li> <p>Score range 0–100, higher scores indicate less pain</p> </li> </ol> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the Mental Adjustment to Cancer questionnaire, and the Profile Of Moods State Fatigue questionnaire were used; however, these were not included in our analyses because the results for the participants with SLE were not presented separately from the results for participants with rheumatoid arthritis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0067"> <li> <p>Score range: 0–105, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, used SLEDAI; however, authors did not report the mean and standard deviation, and, therefore, we were unable to use in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Lupus quality of life Fatigue domain</b> </p> <p> <ol id="CD014816-list-0068"> <li> <p>Score range 0–100, higher scores indicate less fatigue</p> </li> </ol> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, used SLEDAI; however, authors do not report the mean and standard deviation, and, therefore, we were unable to use in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported</p> <p>Used Lupus Quality of Life questionnaire; however, only Physical Health and Fatigue domains were reported, and, therefore, this was not used in our analyses.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Visual Analogue Scale Pain</b> </p> <p> <ol id="CD014816-list-0069"> <li> <p>Score range 0–10, lower scores indicate less pain</p> </li> </ol> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>SLEDAI</b> </p> <p> <ol id="CD014816-list-0070"> <li> <p>Score range: 0–105, lower scores indicate less disease activity.</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Krupp FSS</b> </p> <p> <ol id="CD014816-list-0071"> <li> <p>Score range 1–7, lower score indicates less fatigue</p> </li> </ol> </p> <p>Chalder Fatigue Scale, Visual Analogue Scale, and SF‐36 Fatigue and Vitality domains were also used; however, these were not used in our analyses.  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b>  </p> <p><b>SF‐36 Physical Function domain </b> </p> <p> <ol id="CD014816-list-0072"> <li> <p>Score range 0–100, higher scores indicate better functional capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Systemic Lupus Activity Measure</b> </p> <p> <ol id="CD014816-list-0073"> <li> <p>Score range 0–83, lower scores indicate less disease activity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partially reported.</p> <p>SF‐36 was used to measure quality of life; however, authors did not report MCS score, PCS score, and all 8 domains, and, therefore, this was not used in our analyses. </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> <p>SF‐36 was used to measure quality of life but authors did not report the Pain domain, and, therefore, this was not used in our analyses. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to adverse events were reported.</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>FACIT‐F: Functional Assessment of Chronic Illness Therapy – Fatigue; FSS: Fatigue Severity Scale; HAQ: Health Assessment Questionnaire; MCS: Mental Component Score; PCS: Physical Component Score; SF‐36: 36‐item Short Form; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; TUG: Timed Up and Go. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Major outcomes reported in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD014816-tbl-0007"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Minor outcomes reported in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Composite responder rate</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Aerobic capacity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Depression</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Anxiety</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Withdrawals due to any reason</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Trials that compared exercise plus usual care to placebo plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0011" title="Lopes-SouzaP , DionelloCF , Bernardes-OliveiraCL , Moreira-MarconiE , MarchonRM , Teixeira-SilvaY , et al. Effects of 12-week whole-body vibration exercise on fatigue, functional ability and quality of life in women with systemic lupus erythematosus: a randomized controlled trial. Journal of Bodywork &amp; Movement Therapies2021;27:191-9. ">Lopes‐Souza 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>4 participants withdrew from the intervention</b> </p> <p> <ol id="CD014816-list-0074"> <li> <p>3 from the exercise group (1 before the 6‐week analysis due to low back pain, and 2 before the 12‐week analysis for personal reasons) </p> </li> <li> <p>1 from the control group before the 6‐week analysis due to personal reasons</p> </li> </ol> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to usual care alone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0002" title="AvauxM , HoellingerP , Nieuwland-HussonS , FraselleV , DepresseuxG , HoussiauFA . Effects of two different exercise programs on chronic fatigue in lupus patients. International Journal of Clinical and Laboratory Medicine2016;71(6):403-6. ">Avaux 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, 2 participants withdrew from the intervention for personal reason; however, it is unclear which group they were part of, and, therefore, not included in our analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0003" title="BenattiFB , MiossiR , PassareliM , NakandakareER , PerandiniL , LimaFR , et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatology International2015;35(1):61-9. ">Benatti 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0004" title="BenattiFB , MiyakeCN , DantasWS , ZambelliVO , ShinjoSK , PereiraRM , et al. Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Frontiers in Immunology2018;9(906):1-10. ">Benatti 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>8 participants withdrew from the intervention.</b> </p> <p> <ol id="CD014816-list-0075"> <li> <p>4 from the control group (1 pregnant, 3 for personal reasons)</p> </li> <li> <p>4 from the exercise group (1 fractured limb outside of training sessions, 3 for person reasons) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0005" title="BostromC , ElfvingB , DupreB , OpavaCH , LundbergIE , JanssonE . Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study. Lupus2016;25(6):602-16. ">Bostrom 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Maximum oxygen consumption (VO<sub>2max</sub> in L/min) </b> </p> <p> <ol id="CD014816-list-0076"> <li> <p>Higher scores indicate better aerobic capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>3 participants withdrew from the control group (1 depression/cognitive impairment, 1 untreated dementia, 1 suspected relapse breast cancer)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0008" title="HashemiS , HabibagahiZ , HeidariM , Abdollahpour-AlitappehM , KarimicMH . Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE): a randomized controlled trial. Transplant Immunology2022;70:1-6. ">Hashemi 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Peak oxygen consumption (VO<sub>2peak</sub> in mL/kg/min)</b> </p> <p> <ol id="CD014816-list-0077"> <li> <p>Higher scores indicate better aerobic capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Depression subscale</b> </p> <p> <ol id="CD014816-list-0078"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Anxiety subscale</b> </p> <p> <ol id="CD014816-list-0079"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>14 participants withdrew from the study.</b> </p> <p> <ol id="CD014816-list-0080"> <li> <p>4 from the exercise group</p> </li> <li> <p>5 from the active control group (relaxation)</p> </li> <li> <p>5 from the usual care control group</p> </li> </ol> </p> <p>Note that 6 participants dropped out of treatment and 8 participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Trials that compared exercise plus usual care to another non‐pharmacological intervention plus usual care</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0001" title="AbrahãoMI , GomieroAB , PeccinMS , GrandeAJ , TrevisaniVF . Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial. Scandinavian Journal of Rheumatology2016;45:197-201. ">Abrahão 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Beck‐Depression Inventory</b> </p> <p> <ol id="CD014816-list-0081"> <li> <p>Score range 0–63, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>2 participants withdrew from the control group for an unknown reason</b> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0006" title="DaltroyLH , Robb-NicholsonC , IversenMD , WrightEA , LiangMH . Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British Journal of Rheumatology1995;34(11):1064-9. ">Daltroy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the 12‐min walking test was used to measure aerobic capacity; however, this was not used in our analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Center for Epidemiologic Studies – Depression Scale</b> </p> <p> <ol id="CD014816-list-0082"> <li> <p>Score range 0–60, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were clearly reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0007" title="Dos Reis-NetoET , Da SilvaAE , MonteiroCM , De CamargoLM , SatoEI . Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology2013;52(12):2187-95. ">Dos Reis‐Neto 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Peak oxygen consumption (VO<sub>2peak</sub> in mL/kg/min)</b> </p> <p> <ol id="CD014816-list-0083"> <li> <p>Higher scores indicate better aerobic capacity.</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were clearly reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0009" title="KaoVP , WenHJ , PanYJ , PaiCS , TsaiST , SuKY . Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus. Lupus2021;30(6):946-55. ">Kao 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0010" title="KeramiotouK , AnagnostouC , KataxakiE , GalanosA , SfikakisPP , TektonidouMG . The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. Rheumatic and Musculoskeletal Diseases2020;6(1):1-10. ">Keramiotou 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>2 participants from the exercise intervention group withdrew; however, the reasons were not reported.</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0012" title="MiossiR , BenattiFB , PintoAL , LimaFR , BorbaEF , PradoDM , et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care &amp; Research2012;64(8):1159-66. ">Miossi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No withdrawals due to any reason were reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD014816-bbs2-0013" title="TenchCM , McCarthyJ , McCurdieI , WhitePD , D'CruzDP . Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. British Society for Rheumatology2003;42:1050-4. ">Tench 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Peak oxygen consumption (VO<sub>2peak</sub> in mL/kg/min)</b> </p> <p> <ol id="CD014816-list-0084"> <li> <p>Higher scores indicate better aerobic capacity</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Depression subscale</b> </p> <p> <ol id="CD014816-list-0085"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>Hospital Anxiety and Depression Scale – Anxiety subscale</b> </p> <p> <ol id="CD014816-list-0086"> <li> <p>Score range 0–21, lower scores indicate a better outcome</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yes</b> </p> <p><b>14 participants withdrew from the study</b> </p> <p> <ol id="CD014816-list-0087"> <li> <p>4 from the exercise group</p> </li> <li> <p>5 from the active control group (relaxation)</p> </li> <li> <p>5 from the usual care control group</p> </li> </ol> </p> <p>Note that 6 participants dropped out of treatment and 8 participants completed the study but did not wish to repeat the walking test to exhaustion at the end of the intervention. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>VO<sub>2peak</sub>: peak oxygen consumption. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Minor outcomes reported in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/full#CD014816-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014816-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Fatigue (FACIT fatigue, score 0–52, lower scores indicate less fatigue) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.00 [‐13.29, 3.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Functional capacity (SF‐36 Function Capacity domain, score 0–100, higher scores indicate better functional capacity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.50 [‐23.78, 18.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Pain (SF‐36 Pain domain, score 0–100, lower scores indicate less pain) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.00 [‐28.88, 10.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Withdrawals for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.73 [0.34, 22.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Exercise plus usual pharmacological care versus placebo plus usual pharmacological care (exercises versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014816-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Fatigue (Fatigue Severity Scale, score 1–7, lower score indicates less fatigue) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐1.40, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Functional capacity (SF‐36 Physical Function domain, score 0–100, higher scores indicate better functional capacity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.39 [‐5.97, 16.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Disease activity (various scales, lower scores indicate less disease activity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐3.69, 3.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Pain (SF‐36 Pain domain, score 0–100, lower scores indicate less pain) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Withdrawals for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.53, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Aerobic capacity (peak oxygen uptake, higher scores indicate better aerobic capacity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [‐0.59, 3.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Depression (various scales, lower score indicates less depression) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.78, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Anxiety (HADS Anxiety, score 0–21, lower score indicates less anxiety) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐3.02, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Exercise plus usual pharmacological care versus usual pharmacological care alone (exercise versus usual care alone)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014816-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Fatigue (various scales, lower score indicate less fatigue) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐0.88, ‐0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Functional capacity (various scales, higher scores indicate better functional capacity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.20 [6.17, 20.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Disease activity (various scales, lower scores indicate less disease activity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.28, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Pain (various scales, lower score indicates less pain) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.59 [‐2.46, ‐0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Withdrawals for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.13, 5.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Aerobic capacity (peak oxygen uptake, higher scores indicate better aerobic capacity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [‐1.64, 4.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Depression (BDI, score 0–63, lower scores indicate less depression) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐4.61, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Anxiety (HADS Anxiety, score 0–21, lower score indicates less anxiety) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐3.61, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Exercise plus usual pharmacological care versus another non‐pharmacological intervention plus usual pharmacological care (exercise versus active control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014816.pub2/references#CD014816-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD014816.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD014816-note-0020">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD014816-note-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD014816-note-0019">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD014816-note-0017">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD014816-note-0016">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD014816-note-0013">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD014816-note-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD014816-note-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD014816-note-0011">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD014816-note-0012">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014816\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014816\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014816\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014816\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014816\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014816.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD014816.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD014816.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD014816.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014816.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729140918"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD014816.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729140921"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD014816.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed5a0bed5f55b',t:'MTc0MDcyOTE0MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 